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ABSTRACT 
This dissertation includes several studies regarding the impact of grief and suicide on 
economic and quality of life outcomes in the US. Measuring this impact allows for comparisons 
to other health conditions and provides a foundation for understanding the value of investing in 
grief support and suicide prevention interventions. 
The first study examined the impacts of grief on medical expenditures. Individuals whose 
spouse died had expenditure increases of $498 in the year following the death (p=0.018), and 
children ages 1-24 whose parent died had an average decrease of $334 in expenditures 
(p=0.032). In identifying the sample, two-thirds of bereaved individuals were excluded from the 
analysis because of changes in health insurance the year before or the year after the death.  
The remaining studies explored the prevalence and burden of suicide-related 
bereavement. A US nationally-representative survey was conducted with adolescents and adults 
who knew someone who died by suicide. Among adolescents ages 15-17, 44% knew someone 
who died by suicide and an additional 17% knew someone who attempted suicide. An estimated 
7% of adolescents were currently experiencing emotional, mental, or physical health effects from 
a suicide death or attempt. In the adult US population, 58% of people knew someone who died 
by suicide and 7% were experiencing complicated grief.  
Multiple measures of health-related quality of life were used in the survey. The 
preference weighted measure of health utility was measured using both a time trade-off (TTO) 
question and the EuroQol 5 dimensions (EQ-5D). Only those who were currently experiencing 
health effects from the suicide exposure were asked the TTO question and 94% either skipped 
 xviii 
 
the question or were unwilling to trade off time. Respondents’ current health, as reported in a 
visual analogue scale, was transformed to approximate their health utility as measured with the 
EQ-5D. 
 Retrospective approximations of health utility over time were combined to measure the 
quality adjusted life years (QALYs) lost from suicide-related bereavement. QALYs lost from 
suicide decedents were also estimated based on health utility estimates by age and sex among 
those with fair or good health, and average life-expectancy. Each suicide resulted in 
approximately 16.4 QALYs lost from the bereaved and 14.3 QALYs lost from the deceased, or a 
total of 30.6 per suicide.  At a national level, the 44,965 suicides in 2016 resulted in 
approximately 1.4 million QALYs lost.  
 Absenteeism losses (not being at work) and presenteeism losses (being at work but not 
being as productive as normal) were quantified from the national survey on suicide bereavement. 
Estimates of net productivity losses among the suicide decedents were also generated. Together 
the productivity losses totaled $3.0 million per suicide death, or $134 billion from all the suicides 
in 2016. 
 These studies found substantial economic and quality-of-life losses from suicide deaths 
alone; thus grief in general poses very substantial losses each year. The majority of these losses 
appear to take place outside the health care sector. A public health approach is needed to support 
and help those bereaved from suicide and all causes of death.  
 1 
CHAPTER I: An Introduction to Grief 
Most people’s introduction to grief is through lived experience that is unwanted and often 
unexpected. Almost everyone will be introduced to grief at some stage in their life, if they have 
not already been introduced.  
Grief is a companion to death. It may arrive before death occurs and may linger long 
afterward. The initial phase of grief following death is an acute experience that is manifest 
outwardly through mourning and manifest inwardly through emotional, mental, spiritual, and 
physical reactions to the loss. The internal disruption of grief, as well as stigma and social 
awkwardness talking about death, can significantly disrupt social relationships. In some cultures 
social interactions are very supportive during the acute phase of grief; however, in many 
American cultures grief can be socially isolating because surrounding individuals do not know 
what to say or how best to support the bereaved.
1–4
  
There are many theories that explain the grief experience. In 1969, Dr. Kübler-Ross 
introduced a framework of stages for experiencing grief.
5
  These stages include denial and 
isolation, anger, bargaining, depression, and acceptance. These have been researched, critiqued, 
and expanded upon throughout the years.
6–10
 A more recent theory of the grief experience is the 
dual process model by Stroebe and Schut.
11,12
 This theory captures the dynamic and non-linear 
experience of grief, suggesting that people oscillate between loss-oriented and restoration-
oriented activities. Within these two orientations and pursuits, people may engage in positive or 
negative behaviors. Problems arise when one does not oscillate and gets stuck in restoration-
 2 
oriented or loss-oriented tasks.  This theory has helped guide the development of recent grief-
related therapies.
12–15
 
Other researchers have developed a clinical distinction of grief when it has become 
abnormally disruptive and long-lasting in one’s life. One group of researchers has called this 
experience prolonged grief disorder, and another has called this complicated grief.
16–19
 The two 
slightly different but overlapping perspectives on grief-related disorders have been combined 
into one set of proposed clinical criteria in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5), and is called persistent complex bereavement disorder.
20
 The “complex” or 
“complicated” aspect of grief is when an individual has complications that inhibit a successful 
transition from an acute phase of grief to an integrated phase of grief, or where one has regained 
control and function in life despite the continued feelings of loss and longing.   
One of the most tragic types of death, and one that results in high rates of complicated 
grief among the bereaved, is suicide.
18,21–25
 Many studies have shown substantial decreases in the 
physical, psychological, and social well-being of those bereaved by suicide.
26–30
 There is much 
more stigma associated with suicide deaths than deaths from natural or accidental causes.
30,31
 
Those bereaved by suicide also experience the harrowing feelings of guilt, shame, and often 
anger.
32–34
  
 The purpose of this dissertation is to explore the overall economic and quality of life 
impacts of grief in the United States, with a special focus on suicide and suicide-related 
bereavement. Chapter II explores how the death of a family member in a US hospital can affect 
medical expenditures in adults and children the year following the death. That chapter pertains to 
any cause of death. The remaining chapters focus on the impact of knowing someone who died 
by suicide. They are based on a national survey I conducted among individuals who were 
 3 
exposed to a suicide death. Chapter III provides an overview of initial findings from the survey, 
including the prevalence of suicide exposure, the prevalence of complicated grief from a suicide, 
the impact of the death on respondents’ health-related quality of life, and the impact on other 
domains of life. Chapter IV explores and compares the different measures of health utility and 
health related-quality of life that were used in the survey. Chapter V quantifies the total quality 
adjusted life years (QALYs) and productivity losses from suicide and suicide-related 
bereavement in 2016. A summary of contributions and recommendations for future research in 
the area of grief from suicide and other types of death is provided in Chapter VI.   
 4 
CHAPTER II: Medical Costs Associated with Grief and Bereavement 
Introduction 
Following the death of a family member, individuals may experience grief that can have 
a significant impact on their medical use and expenditures. This impact has been documented in 
countries throughout the world.
35–39
 Bereaved individuals may experience increases in medical 
expenditures because they seek out professional help with their grief. The stress of bereavement 
can also impact the physical and psychological health of individuals, resulting in symptoms such 
as sleep disturbances, increased heart rate and blood pressure, weight loss, physical pain, 
depression, loneliness, and anxiety.
19,40–42
 These health impacts can potentially lead to increases 
in emergency care services and outpatient services where grief may or may not be identified as 
one underlying cause. Among children, the decision to receive care is filtered by their parents, 
which may be associated with limited access to care during a time of family bereavement.  
There are few studies that have examined changes in medical expenditures among 
bereaved individuals in the United States.
38,43
 One used self-reported information to identify 
increases in out-of-pocket prescription among mothers whose child had died,
38
 and the other 
examined Medicare claims to understand the changes in medical expenditures among those 65 
and older whose spouse died in the hospital.
43
 The present study uses health insurance claims 
rather than self-reported expenditures. It also adds to the literature by examining the effect 
among men, women and children less than 65, and examines the effect of bereavement on 
medical expenditures for different types of relationships to the deceased.   
 5 
Understanding these dynamics and the potential economic impacts of grief on the 
healthcare system can provide society with a foundation for determining the value of investing in 
additional medical and community support services for bereaved family members. The aim of 
this study was to quantify changes in medical expenditures the year following the death of a 
family member in a US hospital.  
Methods 
Study Population 
Using a large database of employer-sponsored health insurance claims, the MarketScan® 
Commercial Claims and Encounters database, I identified individuals aged 1 to 64 who died in a 
US hospital in 2009. Deaths were identified by the discharge status of the insurance claim 
record. The date of discharge was assumed to be the date of death.  
I also identified individuals aged 1 to 64 who were discharged from the hospital in 2009 
but did not die in the hospital. These individuals were required to have some inpatient, 
outpatient, or medication use 180 days after the event to ensure they had survived the 
hospitalization and did not die at home. I also required that the primary diagnosis for their 
hospitalization was similar to those of the deceased individuals based on the clinical 
classification software level 2 diagnostic categories.
44
 
Family members of the deceased (i.e., the bereaved) and family members of the 
hospitalized but not deceased (i.e., the not bereaved) were identified using the family id for all 
those covered under the same family insurance plan. All were less than 65 years old. A 
relationship to the deceased or hospitalized was assigned based on each family member’s 
relationship to the primary beneficiary of the insurance plan (see Appendix A for details). There 
 6 
were some individuals with erroneous ages, but 99% or more of the adults were ages 19 to 64 
and 99% or more of the children had recorded ages of 1 to 24. I required that the bereaved and 
not bereaved individuals have the same relationship to the deceased or hospitalized. 
One study exclusion criteria was if the deceased or injured individual was the primary 
beneficiary. These situations were excluded because a primary beneficiary’s death results in a 
disruption in insurance coverage and a change in the family insurance plan id, which change I 
was unable to track in the dataset. I also excluded bereaved and not bereaved family members if 
they had some other disruption in their enrollment the year before or the year after the event. 
These two requirements removed about two thirds of the bereaved individuals from the study. As 
a comparison, requiring continuous enrollment for two years in the non-bereaved population 
reduced the sample by half. I also excluded situations among the non-bereaved population where 
the hospitalized family member was the primary beneficiary. Other study exclusion criteria were 
missing medication or mental health coverage information in the dataset, or the bereaved or not 
bereaved individual had an overlapping hospitalization with the injured or deceased family 
member’s hospitalization. The latter exclusion was to avoid increases in medical expenditures 
associated with an injury that may have also caused the death or hospitalization (e.g., a car 
accident affecting both the bereaved and the deceased).  
Study Design  
Since family members may not all be under the same insurance plan, this study focuses 
on changes in medical expenditures for specific family relationship types rather than the entire 
family household. In particular, I examined the effect on adults whose spouse died, adults whose 
child died, children ages 1 to 24 whose parent died, and children ages 1 to 24 whose sibling died. 
I used a difference-in-differences approach to measure the effect. Changes in medical 
 7 
expenditures from the year before to the year after a family member’s death among bereaved 
individuals were compared to the changes before and after a family member’s hospitalization 
among not bereaved individuals. 
Outcomes 
There were six cost outcomes for which I calculated the post-year minus pre-year 
differences: 
 Total medical expenditures 
 Inpatient or emergency room expenditures 
 Outpatient grief-related expenditures 
 Outpatient mental health or substance abuse expenditures where grief was not diagnosed 
 Other outpatient expenditures 
 Medication expenditures 
These outcomes were examined for each of the four relationship types. I assumed that 
bereavement would not have extreme effects on changes in medical expenditures, and so all 
differences were capped at -$100,000 and $100,000. This approached minimized the impact of 
outliers and still allowed there to be an effect, if there was any, for those differences more than 
$100,000 or less than -$100,000. In a trend analysis, I also examined the average monthly 
expenditures of the six cost categories in the 12 months leading up to the event and the 12 
months following the event. For the bereaved and not bereaved spouses, pregnancy-related costs 
were removed from all analyses since the bereaved spouses would be less likely to incur these 
costs than the not bereaved spouses.  
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Outpatient grief-related expenditures were determined as outpatient visits where there 
was a primary or secondary diagnosis of the following ICD-9-CM codes: 309.0 (adjustment 
disorder with depressed mood), V62.82 (bereavement, uncomplicated), or V61.07 (family 
disruption due to death of family member). Outpatient mental health or substance abuse 
expenditures were those visits that did not have a primary or secondary grief diagnosis but did 
have a primary or secondary diagnosis that was in the following single-level clinical 
classification software categories
44
: adjustment disorders (650); anxiety disorders (651); 
attention-deficit, conduct, and disruptive behavior disorders (652); impulse control disorders not 
elsewhere classified (656); mood disorders (657); personality disorders (658); schizophrenia and 
other psychotic disorders (659); alcohol-related disorders (660); substance-related disorders 
(661); suicide and intentional self-inflicted injury (662); and miscellaneous mental health 
disorders (670). I also included part of the diagnoses in the category of disorders usually 
diagnosed in infancy, childhood or adolescence (655), excluding those regarding autism or 
Asperger’s syndrome.  
Predictors 
Thousands of potential predictor variables were generated from the information available 
in the claims database. These variables pertained to age, sex, indicators for different industries 
and employment status of the primary beneficiary, state and region indicators, prescription drug 
categories using Redbook® therapeutic groups and classes, number of unique categories of 
medications being taken, major diagnostic categories of visits and hospitalizations, clinical 
classification software multi-level diagnostic categories of visits and hospitalizations, number of 
different categories of diagnoses in the past year, clinical classification software current 
procedural terminology categories for procedures performed, Charlson Comorbidity Index score 
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and indicators, utilization by health care setting, and indicators of having no use by setting or 
outcome category in the pre-period.   
All the variables generated pertained to the year prior to the event. Variables were 
generated for the bereaved and not bereaved groups as well as their family members who died or 
were injured. For all the different predictors I created indicator variables for having any event in 
the past year as well as a second variable that was a count of the number of events in the past 
year.  
To capture experiences among the deceased or injured I also included variables 
pertaining to how much money was spent on the events in the past year, capping the cost at 
$100,000 and including indicators when the costs were capped. The predictors were capped to 
match what was done for the outcomes and to give the outliers less influence in predicting the 
outcomes. Variables for the 60 days prior to the event were included, as well as variables for the 
day of discharge when the event occurred. The dataset of variables pertaining to the injured or 
deceased was merged to the dataset of bereaved and not bereaved.  Only those variables that 
were present in 5% of the bereaved were kept for the analysis. 
Given that there were still over a thousand predictor variables, I further restricted the set 
of variables to those that were potential confounders or those that were related to the six 
outcomes of interest. To do this I used lasso regression.
45,46
 Lasso regression fits the coefficients 
based on their ability to reduce the residual sum of squares while also penalizing them by the 
sum of their absolute values. This trade-off in the fitting process can act as a selection process for 
identifying the variables that are the strongest predictors of the outcome. A Gaussian distribution 
was assumed for the six outcomes in these regression models. Many of the outcomes were 
peaked near 0 and had long tails in the distribution that went out to -$100,000 and $100,000. To 
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adjust for this, in the lasso selection models only, I transformed the outcome using a square root 
function while maintaining the negative and positive values of the outcome. The number of 
predictor variables selected for each of the relationship types and outcomes is provided in Table 
II-1. 
 
Table II-1. Number of Potential Confounders Identified, by Outcome and Relationship Type 
Outcomes 
Adult Whose 
Spouse Was 
Hospitalized 
Adult Whose 
Child Was 
Hospitalized 
Child Whose 
Parent Was 
Hospitalized 
Child Whose 
Sibling Was 
Hospitalized 
Total medical expenditures 476 191 426 222 
Inpatient or emergency room 
expenditures 
328 170 287 109 
Outpatient grief-related 
expenditures 
159 118 187 134 
Outpatient mental health or 
substance abuse expenditures 
where grief was not diagnosed 
220 191 177 84 
Other outpatient expenditures 565 216 238 125 
Medication expenditures 276 132 289 49 
Note: Some adults had erroneous ages, but more than 99% of them had recorded ages of 19 to 
64. Children were, at a minimum, 16 years younger than their parent who died. 99% of children 
had a recorded age of 1 to 24 with a few outliers or erroneous ages greater than 24.  
Statistical Analysis 
Average monthly expenditures and standard errors for the bereaved and not bereaved 
groups were plotted for each of the relationships and outcomes. Adjusted analyses for the annual 
difference-in-differences were performed using two approaches: one that measured the average 
effect assuming no heterogeneity, and the other that measured the effect accounting for the 
heterogeneity in the outcomes.    
To measure the effect without capturing potential heterogeneity I used inverse probability 
of treatment weighting
47
 and then calculated the weighted mean difference in the outcomes for 
the bereaved and not bereaved groups. The statistical significance in these differences was 
calculated using a non-parametric Mann-Whitney U test. The probability of treatment used for 
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weighting, or in this case the probability of bereavement, was calculated using a random forest 
model with all the potential confounders. Such an approach has been done in other studies,
48,49
 
and using the potential confounders rather than all possible covariates to calculate a propensity 
score has been shown to achieve greater precision in treatment effect estimates.
47,50
  
The random forest method is a non-parametric approach that averages predictions 
generated across multiple decision trees that are fitted to the data.
51
 There are many advantages 
to using random forests compared to the traditional logistic regression models for calculating 
propensity scores. The decision tree framework allows for any meaningful interactions between 
covariates to be included in the prediction of the outcome. Random forest models also do not 
automatically use all the potential confounders in the model, as would a parametric logistic 
regression model, but instead the approach uses the potential confounders that are most strongly 
predictive of the propensity for bereavement. Overall, propensity weights developed using 
random forests have been shown to perform better than propensity weights using logistic 
regression models.
49
 
Each random forest was generated with 100 decision trees and allowed for a minimum of 
5 observations to be within each node of every tree. Over the 100 trees I calculated a predicted 
probability that the observation was classified as being bereaved. I removed observations where 
the predicted probability was 0 in order to calculate the inverse weights.  
The common support in predicted probabilities for the bereaved and not bereaved was 
also examined, and all cases where there was no common support were removed (Table II-2 and 
Table II-3, for details see Appendix A). The situations with no common support included 
hospitalizations where the death was fairly imminent based on the diagnosis-related groups 
(DRGs) of the hospitalization. Some of the most frequent DRGs without common support were 
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ventilator support DRGs, severe sepsis with major complications or comorbidities, and poisoning 
or toxic effects of drugs with major complications or comorbidities.   
To measure the effect of bereavement while identifying and accounting for heterogeneity, 
I use the method of causal forests. Causal forests are a generalization of random forests. 
52,53
 
Instead of developing trees to predict an outcome the approach generates trees based on the 
treatment effect within each node. The treatment effect in this study was the difference in the 
pre-post effect for the bereaved compared to the pre-post effect for the not-bereaved within each 
node. Heterogeneity is captured because each split within a causal tree is based on the threshold 
for a given covariate that would maximize the difference in the treatment effects of the two sub 
nodes.  
For this approach 2,000 trees were developed with a threshold of 10 observations or less 
to stop the splitting process for each node. The R package “grf” was used. This package also 
adjusted for differences in the predicted probability of treatment by transforming the 
bereavement indicator to be the bereavement indicator minus the probability of bereavement. 
Running the model with this transformed indicator is similar to using an inverse probability of 
treatment weighting when measuring the effect.
52
  
Parametric regression models were considered but not used to measure the overall effect 
of bereavement on different expenditure outcomes. The main reason for this was because some 
of the outcomes have atypical distributions that do not fit within the assumptions of generalized 
linear models. Most of the cost outcomes would require a two-stage hurdle model and some 
would also require additional transformations of the outcome. These approaches would have 
complicated the interpretation of the outcome. Parametric regression models can include 
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heterogeneous effects, but are not designed to identify the heterogeneity as is possible with the 
causal forest method used.  
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Table II-2. Sample Size by Outcome Among Adult Relationship Categories 
Expenditure Outcomes Adults Whose Spouse Was Hospitalized Adults Whose Child Was Hospitalized 
Bereaved Not Bereaved Bereaved Not Bereaved 
Sample with 
Common 
Support 
No Common 
Support 
(Excluded) 
Sample with 
Common 
Support
a
 
Common 
Support & No 0 
Propensities
b 
Sample with 
Common 
Support 
No Common 
Support 
(Excluded) 
Sample with 
Common 
Support
a
 
Common 
Support & No 0 
Propensities
b
 
Overall 1,143 52 112,429 17,067 195 102 42,011 5,814 
Inpatient or emergency room  1,141 54 112,427 18,349 168 129 41,994 5,407 
Outpatient grief-related 1,095 100 112,369 14,449 151 146 41,964 4,695 
Outpatient mental or 
substance use expenditures, 
no grief diagnosis 
1,097 98 112,431 16,599 145 152 42,002 4,868 
Other outpatient  1,147 48 112,440 16,603 181 116 42,060 5,491 
Medications 1,153 42 112,363 18,050 235 62 41,969 6,404 
a
This was the comparison group in the causal forests. 
b
Individuals with a propensity score of zero were excluded from the propensity 
weighted analysis 
 
Table II-3. Sample Size by Outcome Among Child Relationship Categories 
Expenditure Outcomes 
Children Whose Parent Was Hospitalized Children Whose Sibling Was Hospitalized 
Bereaved Not Bereaved Bereaved Not Bereaved 
Sample with 
Common 
Support 
No Common 
Support 
(Excluded) 
Sample with 
Common 
Support
a
 
Common 
Support & No 0 
Propensities
b 
Sample with 
Common 
Support 
No Common 
Support 
(Excluded) 
Sample with 
Common 
Support
a
 
Common 
Support & No 0 
Propensities
b 
Overall 235 404 47,536 6,639 99 140 24,953 3,191 
Inpatient or emergency room  224 415 47,519 6,539 138 101 24,999 4,144 
Outpatient grief-related 261 378 47,590 6,820 90 149 25,017 3,044 
Outpatient mental or 
substance use expenditures, 
no grief diagnosis 
295 344 47,653 8,137 150 89 24,980 4,257 
Other outpatient  352 287 47,548 8,888 127 112 25,061 3,833 
Medications 251 388 47,548 7,243 201 38 24,949 4,200 
a
This was the comparison group in the causal forests. 
b
Individuals with a propensity score of zero were excluded from the propensity 
weighted analysis
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Results 
Unadjusted Trend Analysis  
The four family relationship types showed very different trajectories in their overall 
monthly expenditures. Adults whose spouse died showed the clearest increase in medical 
expenditures in the year following the death (Figure II-1). There were two major peaks in 
expenditures following the death, one at three months and another at seven to eight months. 
Adults whose child died showed substantial increases in expenditures the first three months after 
death; however, they also had an increase in expenditures in the third and fourth months before 
the death of the child (Figure II-2). Children whose parents died had highly variable costs in the 
year before and after, fluctuating up to $200 on average per month, with no apparent trend over 
time except for a potential decline near the end of the year after the death (Figure II-3). Children 
whose sibling died had some increases in expenditures around the time of the death and then 
large increases at the very end of the year following the death (Figure II-4). Across all 
relationship groups and months there were large 95% confidence intervals that most often 
overlapped with the estimates for the not bereaved group. 
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Figure II-1. Unadjusted Trend Analysis of Average Monthly Medical Expenditures for the 
Bereaved and Not Bereaved Family Members Among Adults Whose Spouse Was Hospitalized 
 Note: The error bars are 95% confidence intervals around the mean. See Appendix A for trends 
among the other outcomes. Adults were ages 19 to 64. 
 
Figure II-2. Unadjusted Trend Analysis of Average Monthly Medical Expenditures for the 
Bereaved and Not Bereaved Family Members Among Adults Whose Child Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. See Appendix A for trends 
among the other outcomes. Adults were ages 19 to 64. Children were ages 1 to 24. 
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Figure II-3. Unadjusted Trend Analysis of Average Monthly Medical Expenditures for the 
Bereaved and Not Bereaved Family Members Among Children Whose Parent Was Hospitalized 
 Note: The error bars are 95% confidence intervals around the mean. See Appendix A for trends 
among the other outcomes. Children were ages 1 to 24. Adults were ages 19 to 64. 
 
Figure II-4. Unadjusted Trend Analysis of Average Monthly Medical Expenditures for the 
Bereaved and Not Bereaved Family Members Among Children Whose Sibling Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. See Appendix A for trends 
among the other outcomes. Children were ages 1 to 24. 
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Comparison of Baseline Characteristics 
There were significant differences in baseline characteristics between the bereaved and 
not bereaved groups (Table II-4). The proportion of males was higher among bereaved than not 
bereaved for the adults whose spouse was hospitalized; however, among all other relationships 
there were no significant differences between the subgroups. Across all relationship types the 
bereaved group had a higher average age than the not bereaved group, were more likely living in 
the South, and the primary beneficiary of the family insurance was retired or on disability leave.  
These differences were evidence for the need to do further adjustments to control for potential 
confounding. 
Effect of Bereavement Without Heterogeneity 
Total medical expenditures in the year following the event increased by $496 (p=0.018) 
for the bereaved spouses compared to the not-bereaved spouses (Table II-5). The largest 
contributors to the overall increases were from increases in inpatient or emergency room services 
($186 on average, p=0.026) and increases in other outpatient services not related to grief or 
mental or substance use disorders ($130 on average, p=0.015). Increases in grief-related 
outpatient expenditures were only $9 on average (p<0.001). 
The impact on parents whose child died varied largely by cost outcome, with an overall 
statistically nonsignificant increase of $225 (Table II-5). Bereaved parents did experience a 
significant average increase of $52 for outpatient mental or substance abuse services (p=0.023) 
and $307 in outpatient expenditures not related to grief or mental or substance abuse services 
(p=0.026). 
Children whose parent died experienced an average decrease of $334 in total medical 
expenditures compared to the not-bereaved children (p=0.032) (Table II-5). Despite the 
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significant decreases overall and for most subcategories of medical expenditures, bereaved 
children did experience a small but significant increase of $37 per child for medication 
expenditures (p=0.041). 
Children whose sibling died did not experience significant changes overall ($238, 
p=0.197) (Table II-5). They did, however, experienced a statistically significant average increase 
of $26 in outpatient mental health or substance abuse expenditures compared to not-bereaved 
children (p=0.026). 
Effect of Bereavement with Heterogeneity 
The estimates accounting for heterogeneity had very large standard errors (Table II-6). 
Changes in medical expenditures from year to year are highly variable and hard to predict with 
precision. The causal forest approach that measures the effect at small nodes within each tree 
significantly decreases the precision of the estimates.  As a result, statistically significant 
changes in the total medical expenditures were not observed using this approach.  
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Table II-4. Comparison of Baseline Characteristics Among the Bereaved and Not Bereaved by Relationship Type to the Hospitalized 
Characteristics 
Adult Whose Spouse Was 
Hospitalized 
Adult Whose Child Was 
Hospitalized 
Child Whose Parent Was 
Hospitalized 
Child Whose Sibling Was 
Hospitalized 
Bereaved Not Bereaved Bereaved Not Bereaved Bereaved Not Bereaved Bereaved Not Bereaved 
Number of individuals 1,195 111,297 297 41,831 639 47,304 239 24,871 
Male 53% 76% 46% 48% 51% 51% 54% 51% 
Female 47% 24% 54% 52% 49% 49% 46% 49% 
P-value <0.001 0.395 0.870 0.319 
Average age 53.7 46.5 45.9 42.1 14.8 12.2 13.2 11.2 
P-value <0.001 <0.001 <0.001 <0.001 
Living in Northeast region 13% 14% 8% 15% 13% 15% 9% 15% 
Living in North Central region 23% 26% 24% 25% 23% 24% 21% 26% 
Living in the South region 45% 40% 44% 38% 43% 37% 41% 37% 
Living in the West region 18% 20% 25% 21% 20% 24% 29% 21% 
Unknown region 0% 0% 0% 1% 1% 1% 0% 1% 
P-value 0.006 0.002 0.033 0.001 
Primary beneficiary works full-time 77% 87% 89% 94% 90% 94% 91% 95% 
Primary beneficiary works part-time 2% 1% 2% 2% 2% 2% 3% 2% 
Other employment status of primary 
beneficiary
a 
21% 12% 9% 4% 8% 4% 6% 3% 
P-value <0.001 <0.001 <0.001 0.0035 
a
Other employment status includes retired or on disability leave. Note: A Chi-Squared test was used to compare categorical variables 
by bereavement status. A t-test with pooled variance was used to compare the average age by bereavement status. Adults were ages 
19-64 and children were ages 1-24. 
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Table II-5. Effect of Bereavement on Medical Expenditures, Not Accounting for Heterogeneity 
Expenditure Outcomes Adult Whose Spouse Died Adult Whose Child Died Child Whose Parent Died Child Whose Sibling Died 
Effect P-Value Effect P-Value Effect P-Value Effect P-Value 
Overall $496 0.018 $225 0.086 -$334 0.032 $238 0.197 
Inpatient or emergency room  $186 0.026 -$715 0.236 -$57 0.062 -$136 0.223 
Outpatient grief-related $9 <0.001 $7 0.048 $1 0.462 $2 0.134 
Outpatient mental or substance use 
expenditures, no grief diagnosis 
$33 0.001 $52 0.023 -$17 0.481 $26 0.026 
Other outpatient  $130 0.015 $307 0.026 -$458 0.782 -$222 0.994 
Medications $115 0.150 $54 0.714 $37 0.041 $4 0.620 
Note: Effects were estimated using the difference in weighted means based on inverse probability of treatment weighting. P-values 
were estimated using a non-parametric Mann-Whitney U test. Each effect was estimated separately using a separate set of potential 
confounders and a unique subset of observations; thus, the subcategories of cost do not sum to the overall effect. Adults were ages 19-
64 and children were ages 1-24.   
  
 22 
Table II-6. Effect of Bereavement on Medical Expenditures, Accounting for Heterogeneity 
Expenditure Outcomes Adult Whose Spouse Died Adult Whose Child Died Child Whose Parent Died Child Whose Sibling Died 
Effect S.E. Effect S.E. Effect S.E. Effect S.E. 
Overall $1,562 $1,578 $1,882 $1,061 -$192 $374 -$8 $1,097 
Inpatient or emergency room  -$182 $849 -$599 $311 -$110 $220 $666 $875 
Outpatient grief-related $61 $56 $739 $348 -$1 $54 -$29 $43 
Outpatient mental or substance use 
expenditures, no grief diagnosis 
$842 $712 $705 $514 -$213 $260 $598 $440 
Other outpatient  $62 $89 $93 $173 $15 $51 $9 $53 
Medications $6 $6 $11 $3 -$1 $3 $16 $16 
Abbreviation: S.E., standard error. Note: effects were measured using causal forest model with a double-robust style average treatment 
effect estimator.
52,54
 Each effect was estimated separately using a separate set of potential confounders and a unique subset of 
observations; thus, the subcategories of cost do not sum to the overall effect. Adults were ages 19-64 and children were ages 1-24.   
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Discussion 
This study examined nuances in the ways that grief and bereavement impose an 
economic burden on the healthcare system in the US. Only a small part of the increases in 
expenditures were from services where grief was documented in the medical claims records.  
The majority of the increases were from inpatient or emergency services and outpatient services 
not related to recorded mental or substance use disorders.  
Some potential causes for these increases in medical expenditures include somatization of 
psychological distress, poor self-care during a time of bereavement, postponing of needed 
medical attention, and unhealthy coping behaviors such as heavy alcohol use or social 
withdrawal.
4,40,55–58
 Testing these potential causes for increases in medical expenditures was 
beyond the scope of this analysis. These potential causes may, however, have a larger impact 
among vulnerable populations and those with pre-existing health conditions. In this study, the 
group that experienced the largest increases was adults whose spouse died, which also was the 
oldest group with the greatest likelihood of pre-existing health conditions. A recent study using 
Medicare claims among adults 65 and older found increases of $5,310 over two years following 
the death of a spouse in the hospital compared to those whose spouse died outside the hospital.
43
  
Among younger children whose parent died, they experienced small but significant 
decreases in health expenditures. These decreases seemed to happen more frequently in the latter 
half of the first year after the parent’s death. One potential explanation for this decrease is that 
when the surviving parent returns to work following the death of a spouse, they may have less 
time and resources to devote to their child’s health care needs.   
This study is the first in the US to use insurance claims data to examine changes in 
medical expenditures related to bereavement among those less than 65 years old.  There are only 
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two previous US studies on the impact of bereavement on medical expenditures or on utilization 
among those younger than 65. Both pertained to bereaved parents. One study found that 
bereaved parents had self-reported increases in out-of-pocket prescription costs.
38
 The second US 
study found that within 6 months to 6 years of a child’s death, 62% of the sample received some 
form of talk therapy and 41% received some medication for their grief and mental health.
59
  
Most previous studies on the impact of bereavement on medical expenditures and 
utilization have been conducted in other nations. Regarding spousal bereavement, multiple 
studies in the UK and Denmark have found increases in prescriptions, outpatient visits, and 
length of hospital stays.
39,60,61
 This study found increases in medication expenditures for 
bereaved spouses; however, due to the high variation among participants, the change was not 
statically significant. The other changes found in outpatient visits and hospitalizations were 
consistent with the findings from other countries.  
Among children and youth that are bereaved, researchers in Canada found increases in 
the likelihood of physician visits for any condition and also specifically for mental illness.
62
  
Researchers in the UK also found increases in outpatient visits among children whose parent 
died. 
63
 This study did not identify similar changes, except for the fact that there were small but 
statistically significant increases in outpatient mental health or substance use expenditures for 
children whose sibling died.  An effect in this direction may have been obscured by the large 
variability in the outpatient expenditures of children in this study. 
One major difference in examining healthcare expenditures during a time of bereavement 
in the US compared to other developed countries is the instability of health insurance during this 
time in the US. In the identification of the study population for this analysis, approximately two 
thirds of the bereaved family members in the dataset were excluded due to a change or disruption 
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in their health insurance plan. Had the death not occurred, we would have anticipated an 
exclusion of about half of the population due to typical discontinuities in health insurance over a 
two-year period. These discontinuities limit the generalizability of the findings. This also implies 
that there may be increased challenges with access to care during a time of bereavement. This 
change in access to care could potentially reduce utilization and expenditures among the 
bereaved; however, at the same time may result in the delay of needed care, contributing to 
poorer health outcomes and the need for emergency care.  
There are several important limitations to this study. The study was limited in scope to 
deaths in US hospitals and may not be generalizable to deaths outside US hospitals. The 
identification of death and the assignment of dates of death based on discharge status and date of 
discharge were not validated identifiers of death. It would be useful to replicate this study with a 
claims database that has family linkages and linkages to validated records of deaths inside and 
outside the hospital.  
This study was also limited to only those deaths where there was a strong common 
support, or sufficient number of individuals who did not die but had a similar likelihood of death. 
It is hard to establish a true counterfactual for the bereaved group, and it is unclear whether 
situations where the death of a family member is imminent would result in larger changes in 
costs compared to situations where the death is less certain.  
The use of the causal forest method was a novel approach to identifying heterogeneous 
effects, but it yielded large standard errors of the estimates. The effects may have been more 
precise if the outcome was the quantity of medical services rather than expenditures.  
The trend analysis revealed potential increases in expenditures for the bereaved during 
the year before the death. This was particularly evident in the two adult groups. This means that 
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the effect measured in this study was diminished due to the difference-in-differences study 
design. It could also potentially undermine the causal interpretation of the changes in medical 
expenditures reported in this study. An alternative approach for future analyses could be a 
difference-in-differences estimation using the 7 to 12 months prior the event as the baseline and 
two time periods as comparisons: the 1 to 6 months prior to the event, and the year after. This 
would allow for an estimate of costs leading up to the death and an estimate of costs following 
the death. Some limitations to this approach, however, are less stability or precision in the 
estimate and potential bias from the impact of seasonal patterns on healthcare costs since the 
baseline would only use six months rather than a year of expenditures.  
Future studies need to explore in greater detail which of the increases in costs could 
potentially be offset from better care and support following grief. Future studies could also 
explore how grief and bereavement are documented in medical records, and how improving the 
identification and documentation of bereavement influences medical expenditures. Finally, more 
needs to be studied and examined regarding disruptions in insurance and access to health care 
services in the U.S., particularly among children, during a time of bereavement.  
In conclusion, the impact of bereavement on medical expenditures among those less than 
65 years old is statistically significant for many cost outcomes, but modest in magnitude. The 
amount that could be potentially offset with effective interventions in this younger population is 
likely minimal. This suggests that from a healthcare perspective, if grief support must lead to net 
cost savings over one year, interventions should be very low-cost. Outside of healthcare, and 
beyond a one-year time period, there still are substantial ways in which a death impacts the 
quality of life and productivity of surviving family members. These impacts may have greater 
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weight than medical expenditures alone in determining the value and benefit of investing in grief 
support services within the healthcare industry.   
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CHAPTER III: The Prevalence and Impact of Knowing Someone Who Died by Suicide 
Introduction 
Suicide is the tenth leading cause of death in the US.
64
 In 2016 there were 44,965 suicides 
deaths or 13.92 suicides per 100,000 people. Suicide rates have been steadily increased since the 
year 2000.
64,65
 Age-adjusted suicide rates have increased by 29% overall. The largest increases 
have been among those ages 45 to 64, with an increase of 44% since 2000. Suicide rates among 
adolescents and young adults ages 15 to 24 have also increased by 36% since 2007.  
As the rate of suicide increases, researchers are trying to understand the impact that 
suicides are having on the surviving friends and family members who were aware of the death. 
Two nationally-representative studies have estimated the prevalence of exposure to a suicide 
death among adults in the US. One was conducted in 1994 and estimated the prevalence of 
knowing someone who died by suicide in the past year to be 7.0%.
66
 The other was conducted in 
2016 and published recently, finding that 51% of the population had been exposed at any time in 
their life to a suicide death, and 35% experienced some amount of emotional distress from the 
death.
67
 Other non-nationally representative studies have found lifetime exposure to be 57% 
among Veterans, 40% to 48% among Kentucky residents, and 32% in a nationwide poll.
68–71
  
There have been fewer analyses quantifying the prevalence of exposure to a suicide death 
among adolescents in the US. Only two analyses have been conducted, and both were based on 
the same study from 1995 to 1996 that was nationally-representative of adolescents in school.
72,73
 
These analyses found that 4.4% had been exposed to a peer’s or family member’s death in the 
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past year and 19.4% had been exposed to a peer’s or family member’s suicide attempt in the past 
year.  No estimates have ever been generated in the US to understand lifetime exposure to 
suicide deaths or attempts among adolescents.  
The different levels of effect experienced by those who know someone who died by 
suicide have been described on a continuum ranging from exposed, to affected, to bereaved.
74
 
Another distinction that is often used is that of being a survivor of suicide loss, or one whose life 
has been personally affected by suicide.
33,74,75
 Those affected by another’s suicide death 
experience significant mental, physical and social health impacts.
22,24,26,27,40,76–79
 These impacts 
have even been shown to be more substantial than those who are bereaved by other causes of 
death.
27,34,80
 Studies have also shown that those affected by a suicide death have high rates of 
complicated grief, or the situation where complications have prevented an individual from 
recovering properly from the acute phase of grief.
21–25,41
 No studies, however, have examined the 
national prevalence of complicated grief among those who know someone who died by suicide 
in the US. Studies have also not quantified at a national level the self-reported ways in which the 
lives of those exposed to a suicide death have permanently changed. 
One approach to measuring and comparing different health experiences and health 
impacts is the construct of health utility.  This measure quantifies peoples’ preferences for a 
given health experience on a scale where 0 represents being dead or something equivalent to 
dead and 1 represents perfect health.
81
 There are many different approaches to directly and 
indirectly measuring health utility. Direct methods include the standard gamble and time trade-
off approaches.
82
 The standard gamble approach would not be appropriate to ask among those 
bereaved by suicide, because it asks respondents to consider taking a gamble on living with 
perfect health or immediately dying. The time trade-off question may be more appropriated, but 
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may still be challenging for those experiencing grief because they are asked to trade-off time 
from the end of their life to be healed from their current health problems. Indirect measures of 
health utility ask respondents about their functionality and health in different domains or 
attributes of life (e.g. mobility, self-care, pain, sleeping, depression, etc.).
83
  These measures are 
also known as multiattribute utility instruments.
83–85
 Individual’s responses across the different 
domains or attributes are converted to utility estimates using a formula or set of weights or tariffs 
that have previously been fitted to measurements of utility using one of the two direct 
approaches. Only one study, a cost-effectiveness analysis in Australia, has quantified the health 
utility among those who knew someone who died by suicide.
86
 It used the indirect measure of the 
EuroQol 5 dimensions (EQ-5D). Better understanding the health utility of those who know 
someone who died by suicide in the US can allow for comparisons to many other health 
experiences, and can establish necessary information for conducting cost-effectiveness analyses 
that account for all the spillover impact of a suicide death.   
The purpose of this study was to examine the prevalence and impact of knowing someone 
who died by suicide in the US. This study expands on previous studies by examining the lifetime 
prevalence in both adults and, for the first time at a national level, adolescents ages 15 to 17. It 
identifies the domains of life in which individuals feel temporarily and permanently changed by 
the suicide. It measures the prevalence of complicated grief and the health utility of those 
exposed. It also compares the characteristics and impacts among those who said they were a 
survivor of suicide loss to those who were not.  
Methods 
A US nationally-representative survey was conducted to understand the prevalence and 
impact of knowing someone who died by suicide. The development, fielding, and analysis of this 
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survey were funded primarily under a pilot grant from the American Foundation for Suicide 
Prevention, with some additional funding from the University of Michigan Rackham Graduate 
Student Research Grant, and the Health Management and Policy Hammel Award. I contracted 
with the National Opinion Research Center (NORC) to field the survey. The work was approved 
by the University of Michigan Health Sciences and Behavioral Sciences Institutional Review 
Board (IRB) (FWA00004969; IORG00000245) and the NORC IRB (FWA00000142; 
IORG0000631).    
Survey Sample 
A general population sample of US adults ages 18 and older was selected from NORC’s 
AmeriSpeak® Panel (https://amerispeak.norc.org).  A second sample of adults in the 
AmeriSpeak Panel with a child age 15 to 17 living in the same household was selected. The 
AmeriSpeak Panel is a probability-based survey panel that is representative of the US household 
population.
87
 The survey sample for the present study was selected from the AmeriSpeak panel 
using sampling strata based on age, race and Hispanic ethnicity, education, and gender. If more 
than one adult or child was eligible per household, then only one was randomly selected to 
participate. Adults who said they knew someone who died by suicide and consented to 
participate were enrolled in the study. Parents of adolescents gave consent for their children to 
participate then passed the survey to their child. Adolescents who assented and said they knew 
someone who died by suicide or attempted suicide were enrolled. 
 Survey Development and Content 
Prior to the fielding of the survey, 14 cognitive interviews were conducted among a 
convenient sample of adults who knew someone who died by suicide. These interviews were 
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designed to solicit input and understand the cognitive process of individuals as they took the 
survey. Feedback was incorporated to refine the survey instrument. Two mental health providers 
that work with adolescents also reviewed and provided feedback on the adolescent survey. The 
survey was much shorter among adolescents in order to minimize burden and maximize 
participation. The finalized survey instrument for the adults and adolescents is provided in 
Appendix B.  
The survey for adolescents included questions about gender identity and sexual 
orientation, whether they considered themselves a survivor of suicide loss or someone whose life 
had been personally affected by a suicide (this was only asked to those who knew someone who 
died from suicide and included five responses ranging from definitely yes to definitely not); the 
level of effect the suicide death or attempt had on the respondent (five responses ranging from no 
effect to extreme effect); whether the suicide death or attempt had an effect on overall emotional, 
mental, or physical health at any time, and if so for how long (less than six months, six months to 
a year, more than a year, or health is still affected); whether they felt “changed for a time” or 
“changed permanently” in eight domains of life (mental focus, emotionally, socially, life goals, 
physically, spiritually, and work or school productivity); questions from the standardized 
measure known as the EuroQol 5 dimensions (EQ-5D) youth version;
88
 and preferences for 
participating in an online social network or support group specifically for those that know 
someone who attempted suicide, died by suicide, or that care about suicide prevention in general. 
Adolescents were invited to respond about the suicide death that had the greatest impact on their 
life or, if they did not know someone who died by suicide, the suicide attempt that had the 
greatest impact.  
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Adults were asked all the same questions as adolescents; however, they were given the 
adult version of the EQ-5D which can be used to generate a health utility score.
89,90
 The EQ-5D 
was used, as opposed to other indirect measures of health utility, because it is one of the shortest 
measures of health utility and it was used in the only other study that has measured health utility 
among those experiencing suicide-related bereavement.
83,86
 Time trade-off questions were also 
asked to directly elicit health utility among those who said their health was currently affected by 
the suicide.
81,91
 This allowed for comparisons between the two approaches to measuring health 
utility, and for an exploration of the feasibility of directly measuring health utility among the 
bereaved (see Chapter IV for the comparisons and analyses). Adult survey respondents were also 
asked the Brief Grief Questionnaire as a measure of complicated grief;
41,92
 questions about the 
type of relationship, level of stress, and level of connectedness to the deceased individual; mental 
health or drug use problems prior to the death for both the respondent and the decedent; suicidal 
ideation of the respondent before and after the death; a retrospective rating of health before and 
at different time intervals after the suicide; barriers to talking about their bereavement experience 
with others; barriers to seeking professional help with their bereavement experience; and 
utilization of online social networks or online support groups to share about their bereavement 
experience. Adult respondents were asked about the number of people they knew who died by 
suicide, how many deaths happened in the past 10 years, whether the most recent suicide was the 
one that affected them the most, and the level of effect for the most recent suicide; but for all 
other questions they were asked to respond about the suicide that had the greatest impact in their 
life.  
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Survey Distribution 
The study was fielded to an initial sub-sample on January 9, 2018 and then the remaining 
sample on January 12, 2018. The initial sub-sample was sent a reminder on January 12
th
 and all 
were sent a reminder on January 15
th
. The survey closed on January 25, 2018. The study was 
offered in English and Spanish by phone and through an online platform. Adults were 
compensated $3 for completing the survey and adolescents were offered a $5 Amazon gift card 
for completing the survey.  
Survey Response 
There were 5,270 adults invited to participate and 1,294 (25%) answered the screening 
question (Table III-1). Among those screened, 785 consented to participate and 776 individuals 
knew someone who died by suicide. 666 of these exposed individuals completed the full adult 
survey. 
There were 2,858 families with adolescents invited to participate and 390 parents (14%) 
engaged in the screening and consent process. Of these 390 parents, 160 or 41% said that they 
knew their child was aware of the suicide death or attempt of another, and 336 or 86% gave 
consent for their child to participate. A chi-squared test found that there was no significant 
difference in the likelihood of knowing their child had been exposed and allowing them to 
participate in the study (p=0.941). There were 198 adolescents ages 15-17 who knew someone 
who attempted or died by suicide and started the survey, and 180 of them completed the survey.    
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Table III-1. Survey sample, screening, and completion numbers and rates 
Survey 
Population 
Sampled/ 
Invited 
Panelists 
Screening 
Interviews 
Completed 
Screener 
Completion 
Rate 
Panelists 
Eligible for 
Interview 
Incidence/ 
Eligibility 
Rate 
Survey 
Interviews 
Completed 
Interview 
Completion 
Rate 
Adults 5,270 1,294 25% 785 61% 666 85% 
Adolescents 2,858 336 12% 198 59% 180 91% 
 
Survey Weights 
Survey weights were generated to adjust for non-response rates and to better approximate 
national representativeness of the target population. The inverse probability of selection from the 
NORC National Frame (the sampling frame used to enroll participants in the AmeriSpeak panel) 
was used and adjusted to account for unknown eligibility and nonresponse among eligible 
households. This weight was combined with probability weights for being selected from the 
AmeriSpeak panel into the present study sample. The weights were further adjusted based on 
non-response to the screener questions and non-completers of the survey. Further details are 
provided in Appendix C.     
Analysis Plan 
The percent distributions for categorical variables and the averages for continuous 
variables were calculated using the national weights. Missing responses were included as a 
separate category when analyzing categorical variables; however, they were excluded from 
analyses of continuous variables.  
Among adolescent respondents, the national prevalence of knowing someone who died 
by suicide or attempted suicide was provided by NORC. From the data received, I performed 
descriptive analyses among the 180 survey completers regarding the level of impact of the 
suicide or suicide attempt.  Due to insufficient power (power<0.6), no statistical analyses were 
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done to compare those who knew someone who died by suicide vs. those who knew someone 
who attempted suicide.  
Among adults, I compared the demographic profile of those who knew someone who 
died by suicide to those who did not know anyone who died by suicide or attempted suicide. This 
was done using pre-recorded demographic characteristics among all AmeriSpeak panel 
members. I also compared demographic characteristics and the level of impact between those 
who said they “probably” or “definitely” were a survivor of suicide loss and those who were not 
but had still been exposed to a suicide death.  
A Chi-Squared test was used for categorical comparisons, and for the continuous 
outcome of household size I used a two-sample t-test with pooled variance. For comparisons of 
health utility, as measured by the EQ-5D, a Kolmogorov-Smirnov test of unequal variance was 
used. Additional analyses regarding the characteristics of the suicide decedents, barriers to 
receiving formal and informal support, the use of online social networks to share their 
experiences and get support, and preferences for an online social network or support group for 
suicide prevention are provided in Appendix D and Appendix E. 
Results 
Adolescents Knowing Someone Who Died by Suicide or Attempted Suicide 
Based on responses from the 336 adolescents who were screened, 44% of 15 to 17 year 
olds knew someone who died by suicide and an additional 17% knew someone who attempted 
suicide but did not know anyone who died by suicide. These individuals were most commonly 
male (51%), heterosexual (83%), white (54%), in a household with married parents (62%), and 
in a household with an income of less than $50,000 (42%) (Table III-2).  
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Table III-2. Characteristics of Adolescent Respondents Who Knew Someone Who Died by 
Suicide or Attempted Suicide 
Characteristics n Weighted Estimate 
Age 
15 67 32% 
16 52 42% 
17 61 27% 
Gender (reported by parent) 
Male 89 51% 
Female 90 47% 
Adolescent does not identify with either gender 1 2% 
Sexual orientation (reported by adolescent) 
Heterosexual 156 83% 
Homosexual or bisexual 15 10% 
Not sure or declined 9 7% 
Race and ethnicity 
White, non-Hispanic 94 54% 
Black, non-Hispanic 28 13% 
Other, non-Hispanic 18 9% 
Hispanic 40 24% 
Region 
Northeast 23 18% 
Midwest 59 26% 
South 59 32% 
West 39 24% 
Marital status of parent or guardian 
Married 108 62% 
Divorced or separated 35 20% 
Never married 24 12% 
Living with partner 13 7% 
Household income 
Less than $50,000 76 42% 
$50,000 to $99,999 61 34% 
$100,000 or more 43 24% 
Average household size 180 4.55 
Note: There were 180 adolescents who were exposed to a suicide death or attempt and completed 
the survey. Estimates were weighted to account for non-response and be nationally 
representative. 
 
The impact of the suicide deaths and attempts among adolescents is provided in Table III-
3. Approximately a quarter of exposed adolescents said that the death or attempt had a large or 
extreme effect; and among those who knew someone who died by suicide, 37% said that they 
“definitely” or “probably” were a survivor of suicide loss. Thus at a national level, 16% of all 
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adolescents ages 15 to 17 (37% times the 44% exposed to suicide) consider themselves survivors 
of suicide loss.  
The death or attempt had an effect on the overall health of 59% of exposed adolescents.  
21% of adolescent respondents said that their health was affected for 6 months or more, and 
another 12% said their health was affected at the time of the survey (Table III-3). Thus, at a 
national level, approximately 7% of adolescents (12% times the 61% exposed to an attempt or 
death) said their health was currently affected. 
Among those still impacted by the suicide death or attempt, responses to the EQ-5D 
youth version showed that adolescents’ current health was most affected in the domain of feeling 
worried, sad, or unhappy (Table III-3). An estimated 13% of those currently affected said they 
were very worried, sad, or unhappy; while 85% said they were a bit worried, sad, or unhappy. 
68% of respondents also said that they have some pain or discomfort. 
 
Table III-3. Impact from the Suicide Death or Attempt Among Adolescent Respondents 
Measures of Impact n 
Weighted 
Estimate 
What effect did the attempt or death have on your life? 
No effect 11 9% 
Little effect 35 20% 
Moderate effect 73 44% 
Large effect 50 21% 
Extreme effect 11 5% 
Do you consider yourself a survivor of suicide loss? 
Definitely yes 30 16% 
Probably yes 37 21% 
Might or might not 22 17% 
Probably no 16 10% 
Definitely no 11 7% 
Not exposed to suicide death 64 30% 
Did the attempt or death have an effect on your overall emotional, mental, or physical health at any time? 
Yes 115 59% 
No 65 41% 
For how long was your overall health affected?  
Overall health not affected 65 41% 
Less than 6 months 45 25% 
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Measures of Impact n 
Weighted 
Estimate 
6 months to a year 33 15% 
More than a year 15 6% 
My overall health is still affected 21 12% 
No response 1 1% 
EQ-5D Youth among those whose overall health is still affected (n=21)
a
 
D1. I have no problems walking about 18 86% 
D1. I have some problems walking about 3 14% 
D1. I have a lot of problems walking about 0 0% 
   
D2. I have no problems washing or dressing myself 18 88% 
D2. I have some problems washing or dressing myself 3 12% 
D2. I have a lot of problems washing or dressing myself 0 0% 
   
D3. I have no problems with performing usual activities 10 53% 
D3. I have some problems with performing my usual activities 10 46% 
D3. I have a lot of problems doing my usual activities 1 1% 
   
D4. I have no pain or discomfort 10 31% 
D4. I have some pain or discomfort 10 68% 
D4. I have a lot of pain or discomfort 1 1% 
   
D5. I am not worried, sad, or unhappy 1 2% 
D5. I am a bit worried, sad, or unhappy 17 85% 
D5. I am very worried, sad, or unhappy 3 13% 
a
Health utility estimates for the EQ-5D youth version have not yet been developed. The youth 
version rather than the adult version was used because the language was simpler for adolescents 
to understand. Note: Estimates were weighted to account for non-response and be nationally 
representative. 
 
The suicide death or attempt had an impact on many more domains of life than those 
measured in the EQ-5D (Figure III-1). 35% of exposed adolescents felt they changed 
permanently in some domain of their life, and 82% of exposed adolescents felt that some aspect 
of their life changed for a time. Also 12% of exposed adolescents, or approximately 7% of all 
adolescents ages 15 to 17 (12% times the 61% exposed to an attempt or death), reported being 
changed temporarily or permanently in all domains of their life. Adolescents most frequently 
experienced permanent changes in the way they felt emotionally (17%), their goals and purpose 
in life (17%), and their spirituality (17%). They most frequently experienced temporary changes 
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in how they felt emotionally (60%), how clearly they thought or focused (55%), their social life 
(43%), and their sleep (41%).  
  
Figure III-1.Perception of How Adolescent’s Life has Changed as a Result of the Death or 
Attempt 
 
Note: Estimates were weighted to account for non-response and be nationally representative. 
There were also 12% who experienced a temporary or permanent change in every domain of life. 
 
Adults Knowing Someone Who Died By Suicide 
Among adults ages 18 and older in the US, an estimated 58% (95% Confidence Interval: 
55% to 61%) knew someone who died by suicide and an additional 11% (95% Confidence 
Interval: 9% to 13%) knew someone who attempted suicide but did not know anyone who died 
by suicide. Adults knowing someone who died by suicide were significantly different in their 
characteristics than those who did not know anyone who died by suicide or attempted suicide 
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(Table III-4). Age was significantly different (p=0.019) with a larger proportion being ages 18-
29 (22% vs. 15%). Those who knew someone who died by suicide were also more likely to be 
white non-Hispanic (67% vs 60%, across all race and ethnicity categories p<0.001); in the 
Midwest region (24% vs 16%, across all regions p=0.001); have a marital status of divorced, 
separated, never married, or living with a partners (across all marital status categories p<0.001); 
and have some college education but not a BA or above (30% vs 23%, across all education 
categories p=0.013).  
 
Table III-4. Characteristics of Adults Who Were Exposed to Suicide Compared to Those Who 
Were Not Exposed to Suicide or Suicide Attempts 
Characteristics 
Exposed to Suicide 
(n=776) 
Not Exposed to Suicide or 
Suicide Attempts (n=356)  
P-Value by 
Exposure to 
Suicide n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
Gender 
Male 359 48% 179 47% 0.924 
Female 417 52% 177 53% 
Current age 
18-29 134 22% 48 15% 0.019 
30-44 236 24% 108 29% 
45-59 203 26% 86 26% 
60+ 203 28% 114 30% 
Race and ethnicity 
White, non-Hispanic  548 67% 209 60% <0.001 
Black, non-Hispanic 59 8% 54 19% 
Other, non-Hispanic 70 7% 29 6% 
Hispanic 99 17% 64 15% 
Region 
Northeast 119 18% 54 16% 0.001 
Midwest 235 24% 84 16% 
South 239 34% 139 45% 
West 183 23% 79 22% 
Marital status 
Married 326 45% 168 47% <0.001 
Widowed 27 3% 21 9% 
Divorced or separated 148 20% 64 18% 
Never married 200 24% 80 22% 
Living with partner 75 10% 23 5% 
Education 
No high school diploma 35 10% 23 15% 0.013 
High school graduate or equivalent 149 30% 70 28% 
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Characteristics 
Exposed to Suicide 
(n=776) 
Not Exposed to Suicide or 
Suicide Attempts (n=356)  
P-Value by 
Exposure to 
Suicide n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
Some college 344 30% 132 23% 
BA or above 248 31% 131 35% 
Household income 
Less than $50,000 374 50% 170 51% 0.178 
$50,000 to $99,999 246 29% 123 32% 
$100,000 or more 156 22% 63 17% 
Household size 776 2.6 356 2.5 0.184 
Notes: These were among all individuals who were screened as to whether or not they knew 
someone who died by suicide. Four of the 1296 people did not answer the questions about 
knowing someone who died by suicide or attempted suicide. Estimates were weighted to account 
for non-response and be nationally representative. P-values were calculated using a weighted 
Chi-squared test for categorical variables. For the household size variable a weighted t-test with 
pooled variance was used. 
 
Adult survey respondents on average knew two people who died from suicide, with 71% 
of them saying that the most recent suicide was the most impactful (Table III-5). The average 
time since the most impactful suicide was 10 years. An estimated 12% of those who knew 
someone who died by suicide were experiencing complicated grief and 46% of respondents said 
that they “definitely” or “probably” were a survivor of suicide loss. By multiplying these 
percentages by the estimated adult prevalence of suicide exposure, 7% of adults in the US were 
estimated to be experiencing complicated grief from a suicide death and 27% considered 
themselves survivors of suicide loss. 
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Table III-5. Timing and Reaction to Knowing Someone Who Died by Suicide 
Suicide Exposure n Weighted Estimate 
Average number of people known who have died by suicide 664 2.0 
Percent who said the most recent suicide was the most impactful 466 71% 
Average number of years since the most impactful suicide 650 10.0 
Percentage experiencing complicated grief 65 12% 
Average number of years since the most impactful suicide 
among those experiencing complicated grief
a 
65 8.7 
Do you consider yourself a survivor of suicide loss? That is, someone whose life has been personally affected by a 
suicide? 
Definitely yes 113 18% 
Probably yes 128 19% 
Might or might not 110 17% 
Probably not 167 24% 
Definitely not 145 22% 
No response 3 0% 
a
Complicated grief was identified among situations where the suicide death occurred 6 or more 
months previously and the respondent scored a 5 or more on the Brief Grief Questionnaire.
41,92 
Note: This analysis included the 666 individuals who completed the survey. Estimates were 
weighted to account for non-response and be nationally representative. Two individuals with 
missing responses were excluded from the estimate of the average number of exposures, and 16 
were excluded from the average number of years since the most impactful suicide.
 
 
Table III-6 identifies characteristics that are related to self-identifying as a survivor of 
suicide loss. Compared to those who said they were not “definitely” or “probably” a survivor of 
suicide loss, those who self-identified as a survivor were more likely to be heterosexual female 
(55% vs 41%) or homosexual, bisexual, transgender, or not sure (11% vs 8%, across all sexual 
orientation and gender identity categories p<0.001); Hispanic (23% vs 14%, across all race and 
ethnicity categories p=0.021); divorced or separated (24% vs 16%) or living with a partner (14% 
vs 7%, across all marital status categories p<0.001); have less education (across all education 
categories p=0.003); have a lower household income (across all household income categories 
p=0.001); have a history of depression (33% vs 25%, p=0.034); and have a history of post-
traumatic stress disorder (PTSD) (9% vs 4%, p=0.006).  
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Table III-6. Characteristics of Adults Who Said They Definitely or Probably Were a Survivor of 
Suicide Loss Compared to Those Who Were Not. 
Characteristics 
"Definitely" or 
"Probably" a 
Survivor of Suicide 
Loss  (n= 241) 
Not "Definitely" or 
"Probably" a 
Survivor of Suicide 
Loss (n= 422) 
P-Value by 
Survivor 
Status 
n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
Sexual orientation and gender identity 
Heterosexual male 83 33% 185 48% <0.001 
Heterosexual female 132 55% 185 41% 
Homosexual, bisexual, transgender, not sure 22 11% 43 8% 
Declined 4 1% 9 3% 
Current Age 
18-29 39 19% 88 24% 0.177 
30-44 66 21% 140 25% 
45-59 69 28% 108 26% 
60+ 67 32% 86 26% 
Age at time of suicide 
<18 22 9% 40 11% 0.166 
18-29 61 28% 156 34% 
30-44 74 29% 103 23% 
45-59 53 20% 87 21% 
60+ 29 14% 29 11% 
Missing response 2 0% 7 1% 
Race and ethnicity 
White, non-Hispanic  163 62% 300 70% 0.021 
Black, non-Hispanic 23 9% 30 8% 
Other, non-Hispanic 22 6% 40 8% 
Hispanic 33 23% 52 14% 
Region 
Northeast 37 20% 67 18% 0.332 
Midwest 70 22% 132 25% 
South 77 37% 121 32% 
West 57 21% 102 25% 
Marital status 
Married 81 37% 192 49% <0.001 
Widowed 12 5% 10 2% 
Divorced or separated 59 24% 62 16% 
Never married 60 20% 119 26% 
Living with partner 29 14% 39 7% 
Education 
No high school diploma 11 13% 15 9% 0.003 
High school graduate or equivalent 51 34% 74 27% 
Some college 120 30% 176 29% 
BA or above 59 23% 157 35% 
Household income 
Less than $50,000 135 56% 182 44% 0.001 
$50,000 to $99,999 74 29% 137 30% 
$100,000 or more 32 15% 103 26% 
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Characteristics 
"Definitely" or 
"Probably" a 
Survivor of Suicide 
Loss  (n= 241) 
Not "Definitely" or 
"Probably" a 
Survivor of Suicide 
Loss (n= 422) 
P-Value by 
Survivor 
Status 
n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
Household size 241 2.5 422 2.7 0.115 
Mental illness or drug use problems prior to the suicide 
Depression 71 33% 95 25% 0.034 
Anxiety 50 21% 77 18% 0.307 
PTSD 14 9% 15 4% 0.006 
Bipolar or schizophrenia 9 7% 18 5% 0.259 
Alcohol use problems 19 12% 33 11% 0.676 
Opioid or other drug use problems 15 10% 24 8% 0.208 
No mental illness or drug use problems 144 57% 276 62% 0.194 
Notes: Estimates were weighted to account for non-response and be nationally representative. P-
values were calculated using a weighted Chi-squared test for categorical variables. For the 
household size variable a weighted t-test with pooled variance was used. 
 
More than a quarter of exposed adults experienced a large or extreme effect from the 
most impactful suicide in their life, and 48% said that their overall health was affected by the 
death (Table III-7). 19% of exposed adults said that their emotional, mental or physical health 
was affected for 6 months or more. Another 9% said their health was still affected even though 
on average it had been 9.4 years since the suicide occurred. As expected, those who self-
identified as a survivor of suicide loss were significantly more impacted by the suicide death. 
There were still individuals, however, who said they were “definitely” or “probably” a survivor 
of suicide loss but said it had little to no effect on their life (13%). Similarly, there were people 
who did not say they were “definitely” or “probably” a survivor of suicide loss, but still 
experienced large to extreme effects (13%). There did not appear to be significant differences in 
suicidal ideation before or after the death when comparing people in the two survivorship 
categories (p=0.434). 
According to responses from the EQ-5D, the current health utility among those 
identifying as survivors of suicide loss was significantly lower than those not identifying as 
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survivors of suicide loss (0.787 vs 0.858, p=0.002). This difference was primarily among those 
who said their overall health had been affected by the death (0.747 vs 0.808, p=0.012). Among 
all adult respondents who knew someone who died by suicide, those who said their health was 
currently affected or those who said there health had been affected at any time had a significantly 
lower average health utility than those who said that their health had never been affected (0.666 
vs 0.882, p<0.001; and 0.777 vs 0.882, p<0.001 respectively). The current health utility among 
all exposed was 0.832 (Table III-7).   
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Table III-7. Measures of Impact Among Adults Who Knew Someone Who Died by Suicide, Overall and by Self-Identification as a 
Survivor of Suicide Loss 
Measures of Impact 
Overall (n=666) 
"Definitely" or "Probably" 
a Survivor of Suicide Loss 
(n= 241) 
Not "Definitely" or 
"Probably" a Survivor of 
Suicide Loss (n= 422) 
P-Value 
by 
Survivor 
Status n Weighted Estimate n Weighted Estimate n Weighted Estimate 
What effect did the death have on your life? 
No effect 60 10% 5 3% 55 14% <0.001 
Little effect 206 30% 20 10% 185 42% 
Moderate effect 246 34% 110 38% 135 31% 
Large effect 111 20% 72 34% 39 11% 
Extreme effect 39 6% 32 14% 7 2% 
Missing response 4 0% 2 0% 1 0% 
Did the death have an effect on your overall emotional, mental, or physical health at any time?  
Yes 319 48% 164 68% 152 36% <0.001 
No 345 52% 75 32% 270 64% 
Missing response 2 0% 2 1% 0 0% 
For how long was your overall health affected?  
Overall health not affected 345 52% 75 32% 270 64% <0.001 
Less than 6 months 137 20% 52 21% 84 20% 
6 months to a year 74 10% 39 13% 34 8% 
More than a year 61 9% 40 15% 21 5% 
My overall health is still affected
a 
45 9% 32 18% 13 3% 
Missing response 4 0% 3 1% 0 0% 
Suicidal ideation of the respondent before and after the death 
Ideation before and after 101 15% 41 17% 60 14% 0.434 
Ideation before but not after 106 14% 43 14% 61 14% 
Ideation after but not before 40 5% 18 5% 22 5% 
No ideation before or after 412 66% 134 63% 278 67% 
Missing response 7 1% 5 1% 1 0% 
Mean current health utility
b
 
All respondents  656 0.832 234 0.787 420 0.858 0.002 
When the death had no effect on overall health 343 0.882 75 0.868 268 0.886 0.980 
When the death had an effect on overall health 312 0.777 158 0.747 152 0.808 0.012 
P-value of affected vs. not affected 655 <0.001 233 <0.001 420 <0.001 -- 
When the overall health is still affected 44 0.666 31 0.653 13 0.706 0.096 
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Measures of Impact 
Overall (n=666) 
"Definitely" or "Probably" 
a Survivor of Suicide Loss 
(n= 241) 
Not "Definitely" or 
"Probably" a Survivor of 
Suicide Loss (n= 422) 
P-Value 
by 
Survivor 
Status n Weighted Estimate n Weighted Estimate n Weighted Estimate 
P-Value of those still affected vs. not affected 387 <0.001 106 <0.001 281 0.008 -- 
a
On average it had been 9.4 years since the suicide occurred among those whose health was still affected.
  b
Health utility was measured 
using the EQ-5D. It is preference weighted value of health-related quality of life ranging from -0.109 to 1. Note: Estimates were 
weighted to account for non-response and be nationally representative. If individuals knew more than one person who died by suicide, 
they were asked to respond regarding the one that impacted them the most. For categorical variables P-values were calculated using a 
weighted Chi-squared test. For the comparisons among health utilities, a Komolgorov-Smirnov test was used. 
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A third of exposed adults said that some domain of their life had changed permanently as 
a result of the suicide, and 70% said their life had changed for a time (Figure III-2). Also 12% of 
exposed adults, or approximately 7% of all adults, reported being changed temporarily or 
permanently in all domains of their life (12% times the 58% exposed). Respondents most 
frequently experienced permanent changes in the way they felt emotionally (16%), their goals 
and purpose in life (16%), and their spirituality (16%). They most frequently experienced 
temporary changes in how they felt emotionally (50%) and how clearly they thought or focused 
(35%). 
 
Figure III-2. Perception of How Life has Changed as a Result of the Suicide Death, Among 
Adults 
 
Note: Estimates were weighted to account for non-response and be nationally representative. 
There were also 12% who experienced a temporary or permanent change in every domain of life. 
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Discussion 
Exposure to a suicide death is a very common experience in the US and those exposed 
experience substantial impacts in many aspects of their life. This study, for the first time, 
estimated that even at the early ages of 15 to 17 more than two fifths of adolescents knew of 
someone who died by suicide and about three fifths knew someone who attempted or died by 
suicide. Among adults, this study found lifetime exposure to a suicide death was somewhat 
higher than the prevalence of 51% found in 2016.
67
 This could be related to the fact that suicide 
rates continue to rise in the US each year.
64,93
  
This study has also for the first time identified the prevalence of those whose health is 
currently affected by a suicide exposure and, among adults, the proportion that are currently 
experiencing complicated grief. The estimated proportion of adults currently experiencing 
complicate grief from suicide is similar to the proportion of adults who experience a major 
depressive episode in the past year (6.7%).
94
  
The only other study that has quantified the health utility among those bereaved by 
suicide reported a similar estimate (0.670 for those grieving) to that found in the present study 
(0.666 among those currently experiencing health effects from the suicide).
86
 This level of health 
utility is similar to that of someone with type two diabetes and heart failure (0.677) or someone 
with post-traumatic stress disorder (PTSD) (0.630 to 0.682).
95,96
 
Suicide exposure was found to impact not just the health of individuals, but all aspects of 
life among a substantial portion of the population. For adolescents this experience can have 
potential long-term impacts into adult. These long-term effects among adolescents who know 
someone who died by suicide have not been studied using longitudinal data; however, 
adolescents whose parents died by any cause experienced diminished academic accomplishments 
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and long-term economic disadvantages.
97
 Many studies have also shown the long-term health 
impacts of adverse childhood experiences (ACE).
98–103
 Bereavement, however, is not included in 
the original ACE questionnaire.
104
  
Finally, this study provides information on the demographic profile and impact 
experienced among adults who consider themselves survivors of suicide loss. Some of the 
characteristics related to suicide survivorship (e.g., lower income, being divorced or separated, 
history of depression or PTSD) are those that also may be related to increased vulnerability or 
decreased ability to cope the with stress of bereavement.
105,106
 Surprisingly, however, this study 
did not find that survivors of suicide loss were more likely to report suicidal ideation after the 
suicide death compared to non-survivors who were exposed. This could be related to the fact that 
both groups had high prevalence of suicidal ideation even before the suicide occurred. Other 
studies have shown that suicide exposure is related to increased risk of suicide death and 
attempts.
68,107–109
 In this study I was unable to consider differences in suicidal ideation between 
the exposed and not exposed group, and I did not ask about suicidal behaviors of survey 
respondents.  
There were several limitations to this study. One was the poor response rate to the initial 
screening question. This was somewhat adjusted for in the sample weights that were developed; 
however, the weights could not adjust for certain response biases. For example, adults struggling 
with a recent suicide death may have been less engaged with filling out AmeriSpeak surveys, and 
thus less likely to have participated in this study. Also, even though the percentage of adolescent 
exposures to suicide was similar for parents who gave and did not give consent, it is possible that 
those who did not give consent knew that their child had experienced a larger effect. These 
impacts could result in an underestimation of the reported estimates.    
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The survey also asked about the most impactful suicide rather than the most recent one. 
This was done because during the survey development some people shared how they still 
experienced effects from the most impactful suicide but were no longer affected by the most 
recent suicide. It is unclear how the effects of multiple suicides combine to impact a person, and 
this study was not design to assess how the effect from each suicide combines into one aggregate 
impact. By focusing on the most impactful suicide this study provides an upper estimate of how 
impactful suicide can be. These effects should not be interpreted as an impact per suicide unless 
they have been adjusted to represent the effect of the most recent suicide exposure.   
This study was cross-sectional and relied on respondents to recall their experience over 
time. This can be subject to recall bias, which includes forgotten difficulties and a changing 
perception about the experience over time. This study may also be subject to social desirability 
bias where people may have overstated the impact they experienced because it was socially 
desirable to show signs of mourning. The estimates of complicated grief may also be 
overestimated since the Brief Grief Questionnaire has been found to result in a higher prevalence 
of complicated grief than the more rigorous 22 item Inventory of Complicate Grief.
110,111
 The 
Brief Grief Questionnaire was used in this study because of survey size limitations.  
Finally, among adolescents there was a limited sample size to examine subgroup 
differences, particularly between those exposed to a suicide attempt and those exposed to a 
suicide death. Future studies with a larger nationally-representative sample of adolescents can be 
done to better understand the differences between these subgroups. Longitudinal studies on the 
impact of suicide exposure among children and adolescents should also be done.    
There are several things that can be done as a result of this increased awareness of suicide 
exposure and its impacts. First, suicide-related bereavement can be talked about more. There is 
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much stigma that needs to be overcome around talking about the death of someone by 
suicide.
30,31,112
 With more than one in two adults in the US knowing someone who died by 
suicide and just over a quarter of adults saying they probably or definitely are a survivor of 
suicide loss, there are many opportunities to offer comfort or a listening ear. As suicide is talked 
about more, it needs to be talked about in the right way so as not to glamorize it or increase its 
acceptability.
113–115
 There have been guidelines established to do this.
113,116
 Finally with 7% of 
adolescents whose health is currently impacted by another’s suicide death or attempt, and 7% of 
adults who are experiencing complicated grief from another’s suicide death, there are 
opportunities to engage these individuals in treatment and community support programs. There 
are online and in-person support groups available, but not everyone likes support groups or 
would be willing to use them.
117–119
 There is also complicated grief therapy, but this is not yet 
widely disseminated.
19,120–122
 In order to help those whose health is currently affected by suicide-
related bereavement, new and innovative approaches may need to be developed and 
disseminated to engage individuals, help them heal, and fund their therapeutic support.  
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CHAPTER IV: Approaches to Measuring Health Utility Among the Bereaved 
Introduction 
In order to capture the full impact of an illness or health condition in society, one must 
examine both the effects on the individual who experiences the health condition and the spillover 
effects on all those connected to the individual. Such spillover effects have been well 
documented in the literature.
123–127
 They include time costs among informal caregivers; out-of-
pocket costs and financial uncertainty for supportive family members; and emotional, mental, 
and physical health-related burdens experienced by caregivers, family members, and close 
friends.
127–130
 There may also be positive spillover effects that should be accounted for, such as a 
sense of fulfillment and strengthened social ties among caregivers of the sick.
131–133
 
Researchers have tried to measure and incorporate these spillover effects into economic 
evaluations of interventions.
134
 Costs of informal caregiving are most frequently included, and 
they have been recommended for inclusion in all cost-effectiveness analyses from a societal 
perspective.
135
 One recent review of economic evaluations found that including these spillover 
costs of informal caregiving usually has a modest impact on the outcome.
136
 There were, 
however, some health conditions that required substantial informal caregiving and the inclusion 
of these spillover effects had a substantial impact on the incremental cost-effectiveness ratios. 
Less commonly done is including the health-related quality of life spillover impacts in 
economic evaluations. Ground breaking work was done by Basu and Meltzer in 2005 in this 
area, in which they established a theoretical framework for a family utility function.
137
 They 
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showed that in the context of prostate cancer, including spillover impacts of treatments and 
outcomes affected the cost-effectiveness ratios and more closely aligned with patient’s actual 
behaviors in choosing treatments. Another more recent article, by Al-Janabi and colleagues, 
provided an additional framework for including spillovers in economic evaluation that involves 
the use of multipliers to adjust the cost-effectiveness ratios.
138
 They found that the multipliers 
vary substantially by health condition and can impact the optimal funding decisions within a 
cost-effectiveness framework.  
As the framework for including spillover effects in cost-effectiveness evaluations has 
developed over the years, so have the approaches for measuring these spillover effects. There are 
various well-established approaches for valuing monetary spillover effects, such as the proxy 
good method and opportunity cost method for quantifying the time spent by informal 
caregivers.
139–142
 The best approaches for measuring non-monetary health-related spillover 
effects are still under development. A literature review by Wittenberg and Prosser found that the 
majority of studies examining health-related spillover impacts have used multiattribute utility 
instruments, such as the EQ-5D or the Health Utility Index 2 or 3 (HUI-2 or HUI-3), to measure 
health status among caregivers.
143
 Other studies have developed specific instruments to measure 
caregiver quality of life, such as the CarerQol or the Carer Experience Scale (CES), which has 
been mapped to a measure of utility.
144,145
 A limitation, however, is that the utility measured by 
the CarerQol and CES are not specific to health and therefore cannot be combined with other 
measures of health utility in a cost effectiveness analysis.  
In addition to using indirect methods for measuring health utility spillovers, some studies 
have used the standard gamble and time trade-off (TTO) questions to directly measure health 
utility spillover effects. One of the first approaches was done by Prosser and colleagues.
146,147
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They used a modified TTO to have parents value the combined effect of their child’s health and 
the resulting spillover impacts from sicknesses prevented by the pneumococcal conjugate and 
influenza vaccines. Basu and colleagues also used a modified TTO to study spillover effects of 
prostate cancer outcomes on spouses.
148
 The approach by Basu and colleagues did not measure 
the combined effect, but only targeted the spillover effect among the spouses. Other researchers 
have more recently used the standard gamble question to measure the isolated spillover effect on 
family members of those with arthritis, Alzheimer’s, cancer, depression, opioid misuse, and 
treatment for opioid misuse.
149,150
          
Up to this point, the majority of work on measuring spillover effects and including them 
in economic evaluations has been for those living with health conditions. Little has been done on 
measuring and including the spillover effects of death in economic evaluations. Few studies have 
measured the health utility among bereaved individuals, and they most commonly used indirect 
multiattribute utility instruments of the EQ-5D and the HUI-3.
86,148,151,152
  One challenge with 
these multiattribute methods is that they may not be very sensitive to the emotional and mental 
health attributes that are most commonly impacted among the bereaved.  
Basu and colleagues used a TTO question to directly elicit the spillover health utility of a 
spouse dying from prostate cancer.
148
 Using a direct elicitation technique may be able to better 
capture the mental and emotional impacts from the death of a loved one, but the questions are 
also more cognitively challenging to answer especially in the context of spillover effects. Direct 
elicitation techniques may also not be well-received during a time of grief because bereaved 
respondents may not want to consider situations where they trade off time from their own life or 
take a gamble on death.     
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 The purpose of this study was to explore different measures of health-related quality of 
life and health utility among those who know someone who died by suicide. I explore how well a 
direct elicitation approach is received and how the different measures used in this study compare 
to each other.   
Methods 
A national survey was conducted among adults who knew someone who died by suicide 
(see Chapter III). In this survey there were three different approaches used to measure 
respondent’s current health-related quality of life: 
1. A TTO question which provides direct estimates of health utility  
2. The EQ-5D questionnaire with 3 levels per domain, and   
3. A visual analogue scale (VAS), where respondents were asked to rate their health on a 
scale of 0 to 100. 
All three measurements were given to the 45 individuals still experiencing health impacts 
from the most impactful suicide death; however, only 21 individuals provided valid responses to 
all three measures. The latter two measures were asked among those who at any time 
experienced any emotional, mental or physical health impacts from the suicide (319 people were 
asked, and 303 people completed both measures).   
TTO, EQ-5D and VAS Measures 
 The TTO question developed by Basu and colleagues was not used in the present study 
because survey respondents were currently experiencing the spillover effects and did not need to 
imagine what it would be like if their friend or family member had died. As a result, a chained 
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method was not necessary. The modified TTO in the present study was introduced with the 
following scenario: “Think about your overall health, including how the suicide death affects 
your emotional, mental, and physical health currently. Imagine you will live until you are 
[respondent’s life expectancy] years old but you can live a shorter life that is at peace with the 
suicide death and totally free from all of your current emotional, mental, and physical health 
burdens.” 
Using a bisection approach, respondents were then asked if they would trade off half of 
their life expectancy to be in a perfect health state.
153
 If they responded yes then they were asked 
if they would trade off three quarters of their life expectancy, and if they answered no then they 
were asked if they would trade off one quarter of their life expectancy. The life-expectancy and 
trade-off values were calculated for each respondent using their self-reported age and the Social 
Security Administration life tables.
154
  
Respondents were then given the following prompt: “In this imaginary situation, what is 
the maximum number of years you would be willing to trade off or give up from the end of your 
life so that you could be at peace and totally healed from all of your current emotional, mental, 
and physical health burdens even though this would not change the outcome of the suicide? If 
you are unwilling to trade off any years, then put 0.” 
Respondent’s health utility was calculated as one minus the maximum trade off value 
divided by the respondent’s life-expectancy.82 Respondents were also asked how confident they 
were in responding to the TTO question, and if they said 0 then they were asked why they would 
not trade off any time.   
The EQ-5D is a standardized measure that asks about the following five dimensions of 
the respondent’s current health: mobility, self-care, usual activities (e.g. work, study, housework, 
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family or leisure activities), pain / discomfort, and anxiety / depression.
89
 Each dimension has 
three levels: no problems, some or moderate problems, and completely unable or extreme 
problems. Health utility values have previously been estimated for each possible combination of 
responses among US respondents.
90
 The health utility of the health states ranges from 1 when the 
respondent has no health problems in all dimensions, to -0.109 when the respondent has the 
worst level of health in all the dimensions. The value of 0 health utility is equivalent to being 
dead, so the worst health state in the EQ-5D is considered to be worse than being dead. 
The VAS question that was used to measure current health is provided in Figure IV-1. A 
similar type of question was asked retrospectively, to understand how respondents rated their 
health the year before the suicide death, the week after, three months after, nine months after, 
and two years after the suicide. A common challenge with the VAS is ill-defined anchors at 0 
and 100.
155,156
 To more clearly define the ends of the scale, I used the health state description of 
the best EQ-5D health state as 100 and the worst EQ-5D health state as the 0 for the scale. I also 
reordered the listing of the dimensions of the EQ-5D, listing the anxiety / depression dimension 
first, since this is the dimension that would be most affected by bereavement.  
 
Figure IV-1. Modified Visual Analogue Scale Anchored With the Best and Worst EQ-5D Health 
State Descriptions 
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Note: the anchors at 0 and 100 are taken from the best and worst health state descriptions of the 
EQ-5D. Anxiety and depression was ordered first rather than last since I did not want these 
overlooked, and I anticipated this domain would be the most sensitive to the impact of 
bereavement. 
Comparison of VAS to Health Utility 
Due to the small number of respondents that provided valid responses to the TTO, and 
also the low level of confidence among those who traded off time, I did not create a 
transformation of the VAS to the health utility as measured by the TTO. Instead I compared the 
VAS score divided by 100 to the health utility as estimated by the EQ-5D. A power function has 
been suggested to transform the rescaled VAS score (V) into a measure of health utility (U) 
using the following equations: U=1-(1-V)
b
 or U=V
b
.
155,157
 Since I anchored the 0 value of the 
VAS at a health state that is estimated to have a health utility of -0.109, I adjusted the equations 
as follows: U=1-(1-V)
b 
+ 0.109*V - 0.109 and U=V
b 
+ 0.109*V - 0.109. I used the proc model 
function in SAS version 9.4 to estimate the parameter “b” that results in the best fit with the data. 
Other models were also considered but they did not result in as good of a fit as the power 
function models (see Appendix F). 
Analysis Comparing EQ-5D Item Responses to VAS 
I conducted an ordinary least squares (OLS) regression model where the VAS score 
divided by 100 was the outcome and indicator variables for each of the second and third level 
responses to the five EQ-5D domains were the predictors. I also fit a second OLS model with the 
same predictors, but the outcome was the difference between the health utility as measured by 
the EQ-5D and the VAS score divided by 100.  
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Results 
Respondents who said their overall health was still affected from the suicide were 
generally unwilling to trade off time in the TTO question (Table IV-1). Among the 94% that 
either skipped the question or said they would trade off no time, 82% were moderately or very 
confident about their response. In contrast, among the 6% who were willing to trade off time 
81% said they were a little or not at all confident about their response. A major reason for not 
being willing to trade off time was that respondents were coping well enough with their current 
burdens (44%). It had been on average 9.4 years since the suicide occurred for those answering 
the TTO question. Other common reasons for not trading off time were because they were 
morally opposed to the idea (23%), because they did not believe it possible for their burdens to 
be taken away (19%), and because they did not want their burdens to be taken away (8%). 
Among those who were willing to trade off time or were coping well enough that that they would 
not trade off time, their estimated health utility was 0.978. 
 
Table IV-1. Responses to the Time Trade-Off Question, Level of Confidence in Answering the 
Question, and Reasons for Not Being Willing to Trade Off Time 
Responses to Time Trade-off Question n Weighted Estimate 
Those unwilling to trade off time 36 70% 
Those that skipped the question 4 24% 
Those willing to trade off time 5 6% 
Level of confidence among those unwilling to trade off time or who skipped the question 
Very confident 20 39% 
Moderately confident 10 43% 
A little confident 6 12% 
Not at all confident 4 6% 
Level of confidence among those willing to trade off time 
Moderately confident 1 9% 
A little confident 1 25% 
Not at all confident 3 66% 
Reasons for not being willing trade off time among those unwilling to trade off time 
I do not want my emotional, mental, and physical burdens to be 
taken away 
1 8% 
I do not believe that it is possible for my emotional, mental, and 
physical burdens to be taken away 
6 19% 
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Responses to Time Trade-off Question n Weighted Estimate 
I am morally opposed to the idea of trading off years of my life 8 23% 
I am coping well enough with the emotional, mental, or physical 
burdens from the suicide that I would not trade off time 
18 44% 
Other 3 6% 
Health utility among  non-refusers
a 
23 0.978 
a
Non-refusers are those who were willing to trade off time (5 respondents) or those who said 
they would not trade off time because they are coping well enough with the emotional, mental or 
physical burdens (18 respondents).  Note: The time trade-off question was only asked among the 
45 respondents who said that their overall health was still affected by a suicide death, and on 
average it had been 9.4 years since the death happened for these respondents. Percentages were 
weighted to account for non-response and be more nationally representative. 
 
There was only a weak correlation between the rescaled VAS score and the health utility 
as measured by the EQ-5D (correlation coefficient: 0.439). As shown in Figure IV-2, the power 
transformation that had the best fit to the data was captured by the following equation: (Health 
Utility) = (rescaled VAS score)
0.31127 
+ 0.109*(rescaled VAS score) – 0.109. This model had a 
root mean square error of 0.214, whereas the second power function transformation had a root 
mean square error of 0.270.  
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Figure IV-2. Scatter Plot of Visual Analogue Scale Responses and EQ-5D Health Utilities, with 
Power Function Projections. 
 
Note: The EQ-5D and visual analogue scale (VAS) were asked among 303 adults who had 
experienced some health impacts from a suicide death. The correlation between the rescaled 
VAS and the EQ-5D was 0.439. The power function transformation forces the intercept to be at -
0.109 because this is the health utility of the worst EQ-5D health state which was described as 
the value of 0 in the VAS. The first power function transformation had a root mean square error 
of 0.214: (Health Utility) = (rescaled VAS score)
0.31127 
+ 0.109*(rescaled VAS score) – 0.109. 
The second power transformation had a root mean square error of 0.270: (Health Utility) = 1 – (1 
– (rescaled VAS score))2.1784 + 0.109*(rescaled VAS score) – 0.109. The functions were fit based 
on weighted data. 
 
 
The analysis of the relationship between EQ-5D responses and rescaled VAS scores 
showed that the VAS score was most sensitive to responses in the anxiety or depression domain 
(Table IV-2). Being moderately or extremely anxious or depressed was related to lower rescaled 
VAS scores. Moderate or extreme pain or discomfort was only present when other moderate to 
extreme problems were present; thus, the coefficient for these variables was positive, offsetting 
the negative decreases for all other conditions.  The pain and discomfort responses were also 
most significantly related to the discrepancies between the EQ-5D health utility and the rescaled 
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VAS score.  The difference became more negative with moderate or extreme pain and 
discomfort. On average, those reporting no problems across all domains had a health utility 
measured by the EQ-5D that was 0.117 units higher than the rescaled VAS score (p<0.001).  
   
Table IV-2. Linear Regression Parameter Estimates Predicting the Visual Analogue Scale (VAS) 
and the Difference Between the VAS and the EQ-5D Health Utility Given the Responses to the 
Five Dimensions of the EQ-5D 
Parameter 
Outcome 0 to 1: VAS 
Score 
Outcome -1 to 1: EQ-
5D Health Utility 
Minus Rescaled VAS 
Score 
Estimate P-Value Estimate P-Value 
Intercept 0.864 <0.001 0.117 <0.001 
D1.L2. I have some problems walking about -0.061 0.093 0.018 0.618 
D1.L3. I am confined to bed -0.357 0.005 -0.158 0.210 
D2.L2. I have some problems washing or dressing myself -0.107 0.014 0.021 0.625 
D3.L2. I have some problems with performing my usual activities -0.052 0.156 0.011 0.776 
D3.L3. I am unable to perform my usual activities -0.275 0.002 0.073 0.415 
D4.L2. I have moderate pain or discomfort 0.081 0.014 -0.186 <0.001 
D4.L3. I have extreme pain or discomfort 0.139 0.019 -0.497 <0.001 
D5.L2. I am moderately anxious or depressed -0.127 <0.001 0.028 0.340 
D5.L3. I am extremely anxious or depressed -0.443 <0.001 0.131 0.013 
Note: There were 303 people included in these analyses. Each second or third level (L2 or L3) of 
the domains (D1 to D5) were coded as indicator variables. No respondents said that they were 
unable to wash or dress themselves, which is the third level of the self-care domain (D2.L3.). 
The reference group for each of the domains is those that report no problems (L1). Responses 
were weighted using the national weights. 
Discussion 
This study found that a small proportion of people who are experiencing health effects 
from suicide-related bereavement are willing to participate in the TTO question. The reasons 
found in this study suggest that grief may be unique from many other health experiences. There 
is a normative expectation that everyone will grieve the death of a loved one. Thus even if the 
health impacts of bereavement are substantial, the preference for bereavement may be higher 
than for some disease-related health state resulting in similar health impediments. There is also 
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the social expectation to mourn and grieve out of respect for the deceased. This places some 
value in the grief experience which also causes the health utility to potentially be higher. 
Respondents’ willingness to trade off time was also likely influenced in this study by it having 
been so many years since the death occurred, allowing for more time to adjust and cope with the 
grief. 
The findings from the TTO question are very different than those found by Basu and 
colleagues who used a TTO to measure the impact of death from prostate cancer.
148
 Even though 
their sample size was also small for the TTO question, Basu and colleagues had a much larger 
proportion of respondents that were willing to trade-off time. One reason for this may be that 
they delivered the question in-person, whereas the present study was predominantly done online. 
Their question encouraged respondents to focus on just the spillover impacts; however, they did 
not have a statement saying that their trade-off would not affect the outcome of the death. As a 
result, it is possible that their respondents could have valued both the spillover impact and the 
death of their spouse thus resulting in an overestimate of the spillover impact. Even if 
respondents in the study by Basu and colleagues had only valued the spillover effects, it is likely 
that they were considering the immediate spillover effects of losing a spouse, or the effects at 
their largest impact. This is a major difference from the present study where respondents were 
valuing their health on average nine years after the death occurred. Another reason we would 
expect the disutility estimates from Basu and colleagues to be so much greater than those of the 
present study is because their study focused on the spillover impact among spouses, and the 
present study includes all people that were aware of the death who still felt their health was 
impacted by the death.   
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The present study also found differences from previously published literature with 
regards to the VAS transformations performed. The optimal power coefficient for transforming 
VAS scores into health utilities in the present study was smaller than what has been found in 
other studies.
155,157
 This is likely because I anchored the formula so the intercept would be at a 
health utility of -0.109 instead of 0. The unambiguous anchor points of the VAS scale may have 
helped improve consistency across responses and potentially reduced end-aversion bias; however 
VAS scores are still subject to context bias.
155
 Due to these biases, transformed VAS scores are 
not ideal for measuring health utility.
155,156
 However, this transformation was still developed so 
that in future studies the retrospective VAS questions could be used as approximate measures of 
health utility.  
There have been few studies comparing EQ-5D responses and VAS scores. Similar to 
what was found in the present study, Whynes and colleagues found that the domains of anxiety / 
depression and pain / discomfort had the largest effect in predicting VAS scores.
158
 Brazier and 
colleagues observed that the pain / discomfort domain also had a larger impact on measures of 
health utility than on VAS scores.
156
 This influence of pain / discomfort on the difference 
between the two measures confirms that the way people rate health using a VAS is different than 
a preference weighted approach captured through direct or indirect measures of health utility.
155
   
A major limitation to this study was the small sample size among those who answered the 
TTO. When combined with the high refusal rate, I was not able to make meaningful comparisons 
between the VAS score and the TTO responses. Another limitation is that the transformation 
function in this study is not generalizable to other studies. This is because the VAS scale 
developed for the present study is different than the typical VAS questions that are anchored at 
worst imaginable health and best imaginable health. The health utility reported among this 
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experienced sample may be different than how the community values grief. By using the EQ-5D 
the responses were weighted based on the community’s preferences for the health detriments 
experienced; however, future studies need to be done to directly elicit the health utility 
preferences of grief in a community sample with individuals who may or may not have 
experienced grief in their life.  
More needs to be done to develop the best approach for eliciting health utility among the 
bereaved. The standard gamble does not seem appropriate to ask bereaved individuals, but could 
potentially be asked to elicit preferences in a community sample. The TTO question should also 
be explored in a larger sample with the expectation that there still may be many who refuse to 
trade off time given the health effects of bereavement. Other indirect methods for measuring 
health utility such as the short-form six-dimensions (SF-6D) or the HUI-3 could also be used in 
additional studies, and these may be more sensitive than the EQ-5D to the domains of mental, 
emotional, and social problems that are often experienced among the bereaved.
83,159
 Qualitative 
studies need to be done to guide the development and use of health utility measures among the 
bereaved. In doing these studies it would also be worth exploring the feasibility and 
appropriateness of developing a unique multiattribute utility index for grief that captures the 
health attributes that are most impacted by grief. Once a valid and reliable measure of health 
utility among the bereaved is established, then studies will need to be done to assess how health 
utility spillovers vary by the type of death that occurs. As the health-related spillover impacts of 
death are better quantified within a preferences framework, these can be used to better inform 
policy and decision makers about the total impact and value of preventing types of death such as 
suicide, overdose, unintentional injuries, and others.   
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CHAPTER V: Quality Adjusted Life Years and Productivity Losses from Suicide 
Introduction 
Suicide rates have increased by 29% from 2000 to 2016.
64
 Not only is each suicide a 
tragedy, but research has shown that it can have significant long-term health impacts on the 
bereaved friends and family members left behind.
21,22,27,28,32,75,160
 In the United States many are 
investing money and effort into suicide prevention. In 2012 the National Strategy on Suicide 
Prevention was established.
161
 The National Action Alliance for Suicide Prevention was also 
formed to coordinate efforts across public and private agencies around suicide prevention.
162
 The 
Substance Abuse and Mental Health Services Administration (SAMHSA) invests $60 to $70 
million in suicide prevention efforts each year.
163
 The National Institutes of Health (NIH) also 
spends $60 to $90 million in suicide-related research each year.
164
 
One way to value investments is to consider how they change costs in society and also 
how they change the quality and length of life of individuals. In 2013, suicide resulted in an 
estimated loss of $50.8 billion.
165
 These losses were predominantly due to lost productivity but 
did not include the impact on those bereaved by suicide. The Centers for Disease Control and 
Prevention has also measured the potential years of life lost from suicide each year;
64
 however, 
no study has estimated the quality adjusted life years (QALYs) lost from suicide in the US. 
QALYs combine both the quality of each year of life and the length of life, and can be used to 
measure the health-related losses from both the suicide decedents and the bereaved.
166–168
 The 
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purpose of this study is to estimate the total lifetime QALY and productivity losses from suicide 
deaths in 2016 among both the decedents and the bereaved.     
Methods 
Inputs Regarding the Number of People Impacted and the Level of Effect 
In 2016 there were 44,965 suicides.
64
 From the national survey on suicide bereavement 
discussed in Chapter III, I estimated the level of effect from the most recent suicide death (Table 
V-1). Approximately 21% of recent suicide deaths had a large or extreme effect on others.  
 
Table V-1. Distribution of the Level of Effect that the Most Recent Suicide Death Had on the 
Respondents 
Level of Effect n Weighted Estimate 
95% Lower 
Confidence Limit 
95% Upper 
Confidence Limit 
No effect 49 8% 6% 10% 
Little effect 222 33% 29% 36% 
Moderate effect 266 38% 34% 41% 
Large effect 96 16% 13% 19% 
Extreme effect 30 5% 4% 7% 
Note: Three individuals had missing responses and were excluded from this analysis. Estimates 
were weighted to be nationally representative. I used binomial proportions to generate 
confidence intervals around each percentage. Random estimates were selected using a Dirichlet 
distribution.
169
 
 
The survey respondents also reported on the number of suicide deaths that they knew 
happened in the past 10 years. I estimated the number of adults exposed per suicide death over 
the years 2007 to 2016 by using this distribution of the number of exposures, as well as the 
overall prevalence of knowing anyone who died by suicide in the past 10 years, the population 
size in 2016, the number of people who died each year from 2007 to 2015 who may have been 
exposed prior to their death, the prevalence of knowing someone who died in the past year 
 70 
 
reported by Crosby and Sacks (2002), and the number of suicides that actually occurred over the 
10 year period of 2007 to 2016 (see Appendix G for details).
64,66
  
Measuring Disutility  
As discussed in Chapter IV, respondents of the survey on suicide bereavement were 
asked to recall and rate their overall health on a visual analogue scale (VAS) for the year before 
the suicide that had the greatest impact in their life and at time intervals after the death. These 
were then transformed using the following formula in order to approximate the health utility at 
the different time periods:  (Health Utility) = (rescaled VAS score)
0.31127 
+ 0.109*(rescaled VAS 
score) – 0.109. The distributions of approximate health utilities at each of the time periods are 
provided in Appendix H.  
The disutility for each person was estimated by adding the difference between the 
respondent’s estimated health utility before the death and each month after the death until they 
said their health was no longer affected. Negative disutilities were allowed, which meant that the 
health utility improved after the suicide occurred. I used a linear interpolation of health utility 
between the time periods that were reported. The estimated disutility at the middle of each month 
was discounted to present value using a monthly rate of 0.247% (3% annual rate).   
Measuring Productivity Losses 
Absenteeism and presenteeism losses were measured separately in the survey on suicide 
bereavement. Respondents were asked if how well they worked at their job or school had 
changed as a result of the most impactful suicide. If they said it had changed, then they were 
asked how long their performance at work or school was affected. They were also asked to what 
extent their performance at work or school was affected during that time; 0 being no effect or “I 
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worked just as well as everyone else,” and 100 being large effect or “I could not do any work.” 
After this question they were asked how many days or months of work or school they missed 
because of the suicide. For question details see Appendix B.  
Absenteeism costs were calculated by converting all the days and months absent into 
work-months missed. I assumed 261 work-days per year or 21.75 work-days per month.
170
 Some 
responses were changed; for example, 7 days absent was assumed to be one work-week or 5 
work-days since the respondents did not have the option of reporting weeks absent. Also, those 
that said 20 days absent or 30 days absent were both assumed to be one work-month absent. I 
also unduplicated responses so that if they said they were absent both 30 days and 1 month, I 
would only count them absent for 1 month. I restricted the number of months absent so that 
responses were no more than the number of months since the suicide happened.  
Each month or fraction of a month absent was multiplied by the average monthly age-
specific earnings and discounted using a monthly rate of 0.247% (3% annual rate). Average 
monthly earnings were taken from the Current Population Survey 2016 income estimates.
171
 The 
estimates were summed per individual and the average lifetime absenteeism cost by level of 
effect was calculated.  
To calculate presenteeism losses, I restricted the time for the losses to be less than the 
months since the suicide occurred minus the months that the person was absent from work or 
school. Presenteeism was assumed not to start until after the time respondents were absent from 
work or school. Respondents could report the length of time their work or school was impacted 
in weeks, months or years. I converted the responses into work-months, using a similar approach 
as was used for absenteeism costs. I also removed duplicate responses by not counting the 
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reported weeks if they were equal to or more than the reported months, and not counting the 
months if they were equal to or more than the reported years.  
Responses regarding the extent to which respondents’ work had been affected were 
divided by 100 to get the percentage of productivity loss. As a conservative approach, I assumed 
this percentage to be the loss immediately after the suicide. I assumed that the percentage loss 
then decreased to 0% quadratically by month until the time the respondent said their work was 
no longer affected. The estimated percentages at the middle of each month were multiplied by 
the average monthly age-specific earnings and discounted to present value using a monthly rate 
of 0.247% (3% annual rate). The estimates were summed per individual and the average lifetime 
presenteeism cost by the level of effect was calculated. The standard error and mean for both the 
presenteeism and absenteeism costs were converted to alpha and beta parameters of a gamma 
distribution, which distribution was then used to estimate 95% confidence intervals. 
Aggregating Losses for the Bereaved and Conducting Sensitivity Analyses 
The total QALY and productivity losses were the calculated as follows:  
𝑇 = 𝑑 × 𝑎 ×∑𝑝𝑒 × 𝑙𝑒
𝑒
 
Where 
T = total losses 
d=number of suicide deaths 
a= number of people aware of each suicide 
p= the percentage of people experiencing a certain level of effect 
l= the average discounted QALY or productivity losses for that level of effect 
e=categories of level of effect  
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The QALY and productivity losses per suicide were based on reports for the most 
impactful suicide; however, they were reweighted by the percentage experiencing each level of 
effect for the most recent suicide.  
 Probabilistic sensitivity analyses were conducted using 5,000 Monte Carlo simulation 
iterations. With each iteration, parameters were randomly selected from a distribution of 
plausible values. A Dirichlet distribution was used for the parameters pertaining to the level of 
effect in Table V-1.
169
 Distributions for the parameters pertaining to the average number of 
people aware of each suicide are provided in Appendix G. For the disutility, I used a normal 
distribution with the mean and standard error that resulted in the confidence intervals listed in 
Table V-2.  I used a gamma distribution for the presenteeism and absenteeism costs in Table V-
3. The results from the 5,000 iterations were ranked and then the 2.5 percentile and 97.5 
percentile were identified to calculate the 95% credible range of the QALY and productivity 
losses. 
 One-way sensitivity analyses were also conducted. To do this, I varied each of the inputs 
one at a time and reported the outcomes given the high and low parameter inputs. The 
parameters pertaining to the distribution of the level of effect could not be varied independently 
of each other. For the lower estimate of one of these distribution parameters I took the 
percentage point difference between the mean and the lower estimate and then redistributed that 
difference proportionally to the remaining categories. For the upper estimate, instead of adding 
to the remaining categories I removed the necessary percentage points proportionally from the 
other categories so that the total remained 100%. Tornado diagrams were generated to identify 
which parameter uncertainty had the largest impact on the outcomes.  
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Estimating QALY and Productivity Losses for Suicide Decedents 
To estimate QALY and productivity losses of suicide decedents I first identified the 
percent distribution of suicides by age among males and females using 2016 CDC data.
64
 I 
assumed that if the deaths had not occurred then the individuals would have lived a full life 
expectancy according to the product of the probabilities of survival each year that can be 
calculated from the Social Security Administration life tables.
154
  During the first year after the 
averted death, I assumed that individuals would have the health utility of someone of the same 
age and sex with fair health on a categorical scale of excellent, very good, good, fair and poor 
health. Every year thereafter, their health would be the same as someone reporting good health. 
Values of health utility by age, sex, and health status were calculated from the Medical 
Expenditures Panel and reported publicly by Dr. Janel Hanmer at the University of Pittsburgh.
172
  
Net productivity by age and sex was calculated as the difference in average annual 
earnings and average annual expenditures. Average earnings in 2016 by age and sex were 
available from the Current Population Survey; and the average expenditures in 2016, but only by 
age, were available from the Consumer Expenditure Survey.
171,173
 The total set of inputs by age 
and sex is provided in Appendix Table I-1.  
The net productivity and the health utility for each potential year of life lost were 
discounted using an annual rate of 3% and summed per age group. These were then multiplied 
by the percent distribution of suicides by age group and added together to get an average QALY 
and productivity loss across all ages, for males, females, and overall.     
Results 
Approximately 453 adults ages 18 and older were exposed to each suicide death. At a 
national level in 2016, there were approximately 20 million instances where adults were aware of 
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a suicide death (Table V-2). Over 12 million of these instances had a moderate to extreme effect 
on individual’s lives. 
 
Table V-2. Estimated Number of Instances Where People Were Aware of the 44,965 Suicide 
Deaths that Occurred in 2016, by Level of Effect 
Level of Effect Estimate 
No effect 1,603,441 
Little effect 6,672,517 
Moderate effect 7,693,259 
Large effect 3,312,828 
Extreme effect 1,092,052 
Total 20,374,097 
Note: This was estimated as the number of suicide deaths multiplied by the average number of 
people aware of each death (see Appendix G) multiplied by the percentage of people 
experiencing each level of effect in Table V-1. 
 
Table V-3 provides the average lifetime disutility by level of effect from the most 
impactful suicide. Those who experienced an extreme effect lost on average more than a quarter 
of a quality adjusted life year (QALY). Those experiencing a large effect had an average 
disutility that was slightly smaller than those experiencing a moderate effect because there were 
some in the survey who had increases in their health utility following the suicide.  
 
Table V-3. Average Lifetime Disutility per Suicide, by Self-Reported Level Effect 
Level of Effect Estimate 95% Lower Confidence Limit 95% Upper Confidence Limit 
No effect -0.002 -0.004 0.001 
Little effect 0.004 0.000 0.008 
Moderate effect 0.041 -0.037 0.119 
Large effect 0.023 -0.051 0.098 
Extreme effect 0.293 -0.187 0.773 
Note: The disutility was calculated for each person as the difference between the health utility 
prior to the suicide and the health utility at different intervals after the suicide. Health utility was 
approximated using the power transformation of the visual analogue scale score as outlined in 
Chapter IV. Negative disutility means that there was an improvement in health utility in the time 
after the death. Monthly disutilities were estimated using a linear interpolation between time 
periods. The monthly disutilities were discounted to present value using a monthly rate of 
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0.247% and were summed and divided by 12 to get the QALYs lost per person. People in the 
survey only reported disutility for the most impactful and not the most recent suicide.   
 
Given that the average annual earnings across all ages in 2016 was estimated to be 
$46,550, the lifetime absenteeism costs of those experiencing no effect, little effect, or moderate 
effect was equivalent to only a few hours of average earnings (Table V-4). Those experiencing 
large effect had absenteeism costs equivalent to about one week of average earnings, and those 
experiencing extreme effects had costs equivalent to about 1.5 months of earnings. Presenteeism 
resulted in much larger lifetime costs than absenteeism (Table V-4). Those who experienced 
little effect or moderate effect had presenteeism costs that were approximately equivalent to 1.5 
weeks of average earnings. The losses for those experiencing a large effect were equivalent to 
about three months of average earnings, and for those experiencing an extreme effect the losses 
were equivalent to about 8.5 months of average earnings.  
 
Table V-4. Average Lifetime Absenteeism and Presenteeism Costs per Suicide, by Self-Reported 
Level Effect 
Level of effect for 
most impactful 
n 
Percentage with 
0 Costs 
Average 
Discounted Costs 
95% Lower 
Confidence Limit 
95% Upper 
Confidence Limit 
Absenteeism costs 
No effect 60 99% $23 $0 $116 
Little effect 206 100% $21 $0 $93 
Moderate effect 246 87% $85 $42 $142 
Large effect 111 55% $1,072 $368 $2,143 
Extreme effect 39 45% $5,923 $1,191 $14,375 
Presenteeism costs 
No effect 60 100% $0 $0 $0 
Little effect 206 95% $1,651 $325 $4,036 
Moderate effect 246 77% $1,341 $625 $2,326 
Large effect 111 42% $12,351 $7,766 $17,982 
Extreme effect 39 32% $33,039 $19,362 $50,311 
Note: Monthly earnings derived from Appendix Table H-2 were counted as lost costs for each 
absent month from work or school. Presenteeism from work or school was calculated as the self-
reported length of time affected multiplied by the percent reduction in the respondent’s 
productivity. Respondents were only asked once about their percent reduction in productivity 
overall, thus I assumed this was the value at the time of the suicide which then reduced in a 
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quadratic path to zero by the end of the impacted time period. Monthly earnings were then 
multiplied by the percent reduction in productivity for each month of the affected time period. 
All monthly costs were discounted to present value using a monthly rate of 0.247%, and then 
summed per respondent. The averages are for all people, not just those that reported some costs. 
A gamma distribution was used to select random estimates that were within the plausible range. 
 
From the suicides occurring in 2016, an estimated 737,310 QALYs were lost among 
bereaved individuals (Table V-5). The 95% credible range was large due to uncertainty in the 
inputs (-119,125 to 1,601,781 QALYs lost; negative values meaning that there were increases in 
QALYS since the estimates are in terms of the amount of QALYS lost). From the probabilistic 
sensitivity analysis, there was a 93% probability that there were more than 100,000 QALYs lost 
among the bereaved. The average number of QALYs lost from bereavement per suicide death 
was 16.397.   
The total bereavement-related productivity losses from suicide deaths in 2016 were 
estimated to be $109 billion (Table V-5). 88% of the productivity losses, or $98 billion, were 
from presenteeism or reduced productivity while at work or school. The remaining $11 billion 
were from taking time off from work or school. 
 
Table V-5. Estimated QALY and Productivity Losses from Bereavement Related to Suicide 
Deaths in 2016  
Outcome Estimate 
95% Lower 
Credible Limit 
95% Upper 
Credible Limit 
Total QALYS lost 737,310 -119,125 1,601,781 
Average QALYS lost per suicide death 16.397 -2.649 35.623 
Total absenteeism costs $10,850,196,046  $4,401,231,823  $21,928,470,410 
Average absenteeism costs per suicide death $241,303 $97,881 $487,679 
Total presenteeism costs $98,329,835,098  $65,864,797,292  $139,780,284,045 
Average presenteeism costs per suicide death $2,186,808 $1,464,801 $3,108,646 
Total productivity costs (absenteeism and 
presenteeism costs) 
$109,180,031,143 $70,266,029,115 $161,708,754,455 
Average productivity costs per suicide death $2,428,111 $1,562,683 $3,596,325 
Note: Totals were calculated as the summation of the product of estimates in Table V-4 with 
those in Table V-2 and Table V-3. Averages were calculated as the total divided by the 44,965 
suicides that occurred in 2016. The upper and lower credible limits were developed using a 
Monte Carlo simulation that randomly pulled inputs from the input distributions. 5000 
 78 
 
simulations were run, the outcomes were ranked, and the 2.5 percentile and 97.5 percentile were 
selected as the credible limits. 
 
The one-way sensitivity analyses showed that there were a few inputs that had large 
impacts on the uncertainty of the outcomes (Figure V-1, Figure V-2, and Figure V-3). For QALY 
losses, the uncertainty around the average disutility for those experiencing a moderate or extreme 
effect had the largest impact on the estimated outcome (Figure V-1). Similarly for absenteeism 
losses, the uncertainty around the average costs for those experiencing an extreme effect had the 
largest impact on the estimated outcome (Figure V-2). The presenteeism outcomes were most 
affected by the uncertainty in average costs for those experiencing large or extreme effects and 
the proportion of the population that knew 1, 2, 3 or 4+ people who died by suicide. 
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Figure V-1. One-way Sensitivity Analysis of Inputs for Calculating the QALYs Lost from Suicide in 2016 
 
Note: The outcome from the lower estimate is in blue and the outcome from the higher estimate is in red. A negative disutility means 
that there was an improvement in health utility during the time following the death.  
0 200,000 400,000 600,000 800,000 1,000,000 1,200,000 1,400,000 1,600,000
Percentage of those 18+ who know someone who
died by suicide in the past year (6% to 8%)
Average disutility for no effect (-0.004 to 0.001)
Percentage experiencing moderate effect (34% to 41%)
Percentage experiencing large effect (13% to 19%)
Percentage experiencing no effect (6% to 10%)
Average disutility for little effect (0 to 0.008)
Percentage experiencing little effect (29% to 36%)
Prevalence of knowing someone who died by suicide
in the past 10 years (53% to 60%)
Percentage experiencing extreme effect (4% to 7%)
Knew 1 person who died by suicide (100% to 67%)
Knew 2 people who died by suicide (0% to 24%)
Knew 3 people who died by suicide (0% to 6%)
Knew 4+ people who died by suicide (0% to 3%)
Average disutility for large effect (-0.051 to 0.098)
Average disutility for extreme effect (-0.187 to 0.773)
Average disutility for moderate effect (-0.037 to 0.119)
QALYs Lost 
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Figure V-2. One-way Sensitivity Analysis of Inputs for Calculating the Absenteeism Costs from Suicide in 2016 
 
Note: The outcome from the lower estimate is in blue and the outcome from the higher estimate is in red.  
$0 $10,000,000,000 $20,000,000,000 $30,000,000,000
Percentage of those 18+ who know someone who
died by suicide in the past year (6% to 8%)
Average absenteeism costs for no effect ($0 to $116)
Percentage experiencing no effect (6% to 10%)
Percentage experiencing large effect (13% to 19%)
Average absenteeism costs for moderate effect
($42 to $142)
Average absenteeism costs for little effect ($0 to $93)
Percentage experiencing moderate effect (34% to 41%)
Percentage experiencing little effect (29% to 36%)
Prevalence of knowing someone who died by suicide
in the past 10 years (53% to 60%)
Percentage experiencing extreme effect (4% to 7%)
Knew 1 person who died by suicide (100% to 67%)
Knew 2 people who died by suicide (0% to 24%)
Knew 3 people who died by suicide (0% to 6%)
Knew 4+ people who died by suicide (0% to 3%)
Average absenteeism costs for large effect
($368 to $2143)
Average absenteeism costs for extreme effect
($1191 to $14375)
Absenteeism Costs 
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Figure V-3. One-way Sensitivity Analysis of Inputs for Calculating the Presenteeism Costs from Suicide in 2016 
 
Note: The outcome from the lower estimate is in blue and the outcome from the higher estimate is in red. 
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Average presenteeism costs for no effect ($0 to $0)
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Percentage experiencing no effect (6% to 10%)
Percentage experiencing little effect (29% to 36%)
Percentage experiencing moderate effect (34% to 41%)
Percentage experiencing large effect (13% to 19%)
Prevalence of knowing someone who died by suicide
in the past 10 years (53% to 60%)
Average presenteeism costs for moderate effect
($625 to $2326)
Percentage experiencing extreme effect (4% to 7%)
Average presenteeism costs for little effect
($325 to $4036)
Knew 1 person who died by suicide (100% to 67%)
Knew 2 people who died by suicide (0% to 24%)
Knew 3 people who died by suicide (0% to 6%)
Knew 4+ people who died by suicide (0% to 3%)
Average presenteeism costs for large effect
($7766 to $17982)
Average presenteeism costs for extreme effect
($19362 to $50311)
Presenteeism Costs 
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QALY and productivity losses were also substantial from those who died by suicide 
(Table IV-6). On average, 14.3 QALYs and $555,869 in net productivity were lost per suicide. 
This totaled to 640,809 QALYs and $25 billion lost from all suicide decedents in 2016.  
 
Table V-6. QALY and Productivity Losses by Sex and Overall Among Suicide Decedents 
Outcome by Sex Estimate 
Average QALYs lost for each male suicide in 2016 14.1 
Average QALYs lost for each female suicide in 2016 14.7 
Average lifetime net productivity losses for each male suicide in 2016 $652,058 
Average lifetime net productivity losses for each female suicide in 2016 $229,587 
Percentage of male suicides in 2016 77% 
Percentage of female suicides in 2016 23% 
Outcome Overall Estimate 
Average QALYs lost per decedent in 2016 14.3 
Average productivity losses per decedent in 2016 $555,869 
Total QALYs lost from suicide decedents in 2016 640,809 
Total productivity losses from suicide decedents in 2016 $24,994,654,298 
Note: This is estimated based on the 44,965 suicide deaths in 2016. Costs and QALYs have been 
discounted to 2016 present value using a 3% annual discount rate. 
 
Combining the results in Table V-5 and Table V-6, the total QALYs lost from both 
suicide decedents in 2016 and those bereaved was approximately 1.4 million QALYs. This 
averaged to about 30.6 QALYs lost per death. The total lifetime productivity losses from suicide 
decedents and the bereaved in 2016 was approximately $134 billion or $3.0 million per death. 
Discussion 
Suicide poses a substantial economic and quality-of-life burden on society. The number 
of QALYs lost from the bereaved is potentially more than the QALYs lost from the suicide 
decedents. The productivity losses from the bereaved were also more than 5 times the net 
productivity losses from the decedents.  
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The productivity losses from suicide estimated in this study were very different than 
those previously estimated in the United States. In 2010, there was an estimated total of $44.5 
billion in work loss costs and additional $0.1 billion in medical costs from suicide decedents.
174
 
In 2013, the total work loss and medical costs were $50.8 billion.
165
 These estimates do not 
include the impact among the bereaved. It is also unclear from the documentation provided how 
future costs were discounted to present value. A major difference in comparing the estimates 
among suicide decedents only is that the work loss costs in previous studies did not use estimates 
of net productivity, or average earnings minus average consumption. The net productivity 
approach is suggested by the second panel on cost-effectiveness in health and medicine, and is an 
approach that is often used in forensic economics.
135,175
 As a result the economic losses among 
decedents in this study were only about half of what has been estimated previously.  
Overall, the total productivity losses from suicide are comparable to those experienced 
from much more common health conditions in the US. In the US each year, excessive alcohol 
consumption costs $179 billion from lost productivity, deaths from cardiovascular disease cost 
$124 billion from lost earnings, and diabetes costs $69 billion from lost productivity.
176–178
 
Those estimates did not use net productivity for calculating work losses among the deceased; 
however, they may also be larger if losses due to bereavement were included. The increases in 
economic losses may not be as substantial for other conditions as they are for suicide. One study 
has shown that the likelihood of productivity losses are higher among those bereaved from a 
suicide compared to those bereaved by an accidental or natural death.
179
       
The measurement of QALYs used in this study is often an outcome in cost-effectiveness 
analyses. An intervention that costs $100,0000 to $150,000 per QALY gained is considered cost-
effective.
135
 Given the findings from this study on QALYs lost per suicide, if an intervention cost 
 84 
 
society $1 million and only prevented one suicide, the incremental cost-effectiveness ratio would 
be approximately $33,000 to  40,000 per QALY, depending on the level of bereavement 
experienced at the end of the person’s life, and would be considered very cost-effective. If the 
exposure and bereavement effects were not included in the analysis then the cost-effectiveness 
ratio would by approximately $70,000 per QALY. A recent literature review of economic 
evaluations of suicide and self-harm interventions has been done and found that the majority of 
interventions were cost-effective.
180
  One study evaluated a treatment among the bereaved; 
however, none of the other cost-effectiveness analyses included the spillover impacts from each 
suicide death among the bereaved.
86
  
The amount invested in suicide prevention and suicide research each year is substantially 
less than the amount of lifetime monetary losses experienced from suicide deaths each year. In 
2016, SAMHSA and the NIH together invested approximately 145 million in suicide prevention 
and suicide research.
163,164
 This was approximately $3,225 per suicide that occurred in 2016. In 
contrast, this study found that each suicide in 2016 resulted in approximately $3.0 million in 
lifetime productivity losses and 30.6 QALYs lost, which if valued at $100,000 per QALY would 
be another $3.1 million per suicide. Thus, the economic losses from suicide deaths occurring in 
2016 could be valued at about 1875 times the amount of money that was invested that same year 
in suicide prevention and research by the US government agencies SAMHSA and the NIH.     
There were many limitations to the estimates generated in this study. First of all, these 
were based on self-reported information. The absenteeism was not validated by work records. 
Presenteeism is more challenging to validate, but was subject to recall bias. The impact of this 
bias was reduced by assuming that the reported productivity loss while at work or school tapered 
down over time. The estimates of QALY and productivity losses were also originally based on 
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suicides that individuals reported as being the most impactful in their life. I attempted to adjust 
for this bias by stratifying responses by the level of effect and then re-weighting responses to be 
similar to the level of effect reported from the most recent suicide.  
For the impacts of bereavement, many of the inputs were only generated among adults 
and did not include the effects experienced by adolescents.  For example, the number of people 
exposed to each suicide death was only estimated for people 18 and older who were exposed to 
suicide decedents of any age. The distribution of the level of effect was also among adults and 
not among adolescents. Analyses in the technical appendix, however, showed that those adults 
who were exposed when they were adolescents experienced larger effects from the suicide than 
what was assumed for the final estimations in this study (Appendix H). 
There is a large amount of uncertainty in the health utility and QALY estimates used in 
this study. Responses to a visual analogue scale were transformed to approximate health utility, 
and other studies have argued that this is not an ideal approach.
155,156
 As discussed in Chapter IV, 
this approach was used because of the small number of people who were willing to respond to 
the time trade-off question asked in the survey. Future analyses still need to be done to identify 
better measures of health utility among the bereaved, and capture the information prospectively 
rather than retrospectively. 
Finally, in this study I assumed that if a suicide is prevented, the surviving individual 
experiences fair health the first year and then good health the remainder of his or her life. This is 
an ideal situation and may not be achievable by all interventions that prevent a suicide death. 
Even though there is much competition for money to improve health outcomes in the US, 
this study shows that there are substantial economic and quality of life losses that could 
potentially be offset or reduced by investing in the right types of suicide prevention activities. 
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CHAPTER VI: Summary of Contributions and Future Research 
In 2015, national guidelines were established in the US for responding to grief, trauma, 
and distress after a suicide.
181
 These guidelines recommended specific goals and objectives for 
research on suicide loss, which are still in great need of being addressed.
182
 This dissertation has 
been able to address and contribute to several of the recommendations in the followings ways: 
 Goal 11: This dissertation has used appropriate and rigorous scientific methods to 
identify and measure the impact of those who are exposed to a suicide death.  
 Objective 11.1: This dissertation used a large nationally representative sample. It also 
provided clear descriptions of relevant sample characteristics, comparing those who 
were exposed to those not exposed, and understanding the relationship of those 
exposed to the suicide decedent. 
 Goal 12: This dissertation has established valid and reliable estimates of the 
percentage of adults and, for the first time, the percentage of adolescents ever 
exposed to suicide. It examines the level of effects and identifies the prevalence of 
long-term bereavement complications. 
 Objective 12.1: The criteria used to define survivorship of suicide loss were clearly 
given in this dissertation. The definition was based on self-identification as someone 
whose life had been personally affected by a suicide. Other measures of effect were 
recorded and could be used in future analyses to determine a more stringent definition 
of survivors of suicide loss. 
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  Objective 12.3: Several measurements were used in this dissertation to capture the 
broader impact of suicide on the personal, interpersonal, and spiritual functioning of 
survivors of suicide loss. 
 Goal 13: This dissertation examined potential risk factors for those who self-
identified as survivors of suicide loss compared to those who did not. More analyses 
can still be done with the data that were collected to identify the characteristics of 
respondents that predict complicated grief and those that predict suicidal ideation 
following the suicide exposure. 
 Objective 13.4: Gender, culture, and ethnicity were examined to some extent in this 
dissertation. The relationship between these measures and self-identifying as a 
survivor of suicide loss was also analyzed. 
 Goal 14: No data were gathered on the efficacy of interventions; however, the use of 
and preferences for online social support was gathered in this dissertation. Barriers to 
talking about suicide loss and receiving professional help with the loss were identified 
and provided in the appendices. 
This dissertation also went beyond the scope of these national goals and 
recommendations by exploring the burden experienced among the bereaved from an economic 
and health-related quality of life perspective. Substantial quality of life and productivity losses 
were found among those bereaved by suicide. These substantial losses from suicide alone 
suggest that grief from all causes of death poses a very substantial burden on society. A small 
amount of this burden was observed in the changes in medical expenditures in Chapter II, but the 
majority of burden is experienced outside the health care setting. This suggests that a public 
health approach is needed to support and help those bereaved.  
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As a public health issue, future studies will need to quantify the economic and quality of 
life burden of bereavement in the US more completely. Such studies could examine the effects of 
bereavement on health care expenditures and utilization for specific types of death. For example, 
given the more disruptive nature of a suicide death, those bereaved by suicide may experience 
larger changes in medical expenditures compared to those bereaved by a death from natural 
causes. The QALY and productivity losses from other types of death also need to be better 
understood and compared to one another. If there are significant differences in the magnitude or 
quantity of losses across different types of death, then it may be valuable to invest more 
resources in preventing deaths that result in the greatest losses.  
 Future studies can also identify those who are at greatest risk of experiencing the largest 
impacts from bereavement. This dissertation identified large variability in the experience of 
those exposed to a death. Some individuals had large increases in medical expenditures. Others 
had large reductions in their quality of life and large productivity losses. Prediction models and 
screening tools could be developed to identify individuals at risk of experiencing large losses and 
expenditures. This targeted approach could help minimize the large burden experienced in 
society from grief and bereavement. 
 
 
 90 
 
APPENDICES 
 91 
 
APPENDIX A: Additional Analyses Exploring the Medical Costs Associated with Grief 
and Bereavement 
Determination of Relationship to the Deceased 
In the MarketScan dataset there is the variable emprel which is the individual’s 
relationship to the employee or primary beneficiary. In order to define the relationship to the 
deceased I used the SAS code outlined below. Emprel is the relationship of the bereaved or not 
bereaved to the primary beneficiary. Emprel_hosp is the relationship of the hospitalized or 
deceased individuals to the primary beneficiary. Both emprel and emprel_hosp have the 
following response options: (1) Employee (2) Spouse (3) Child/Other. To distinguish between 
“child” and “other” I used age restrictions where age2 is the age of the bereaved or not bereaved 
in 2009 and age2_hosp is the age of the hospitalized or deceased in 2009. 
SAS code: 
if emprel="3" & emprel_hosp="3" then loss="siblingdied"; 
if emprel in ("1","2") & emprel_hosp="3" & age2-age2_hosp>=16 then loss="childdied"; 
if emprel in ("1","2") & emprel_hosp="3" & age2-age2_hosp<16 then loss="otherdied"; 
if emprel in ("1","2") & emprel_hosp="2" then loss="spousedied"; *I deleted all cases 
where the deceased individual was the employee; 
if emprel="3" & emprel_hosp="2" then loss="parentdied"; 
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Trend Analysis for Additional Cost Outcomes 
Adults Whose Spouse Died 
Figure A-1. Average Monthly Inpatient (IP) and Emergency Room (ER) Costs Among Adults 
Whose Spouse Died or Was Hospitalized 
 
Note: These do not include pregnancy related costs. The error bars are 95% confidence intervals 
around the mean. 
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Figure A-2. Average Monthly Grief-Related Outpatient (OP) Costs Among Adults Whose 
Spouse Died or Was Hospitalized 
 
Note: These do not include pregnancy related costs. The error bars are 95% confidence intervals 
around the mean. 
 
Figure A-3. Average Monthly Outpatient (OP) Mental or Substance Use Disorder (MSUD) Costs 
Among Adults Whose Spouse Died or Was Hospitalized 
 
Note: These do not include pregnancy related costs. The error bars are 95% confidence intervals 
around the mean. 
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Figure A-4. Average Monthly Other Outpatient (OP) Costs Among Adults Whose Spouse Died 
or Was Hospitalized 
 
Note: These do not include pregnancy related costs. The error bars are 95% confidence intervals 
around the mean. 
 
Figure A-5. Average Monthly Medication Costs Among Adults Whose Spouse Died or Was 
Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
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Adults Whose Child Died 
Figure A-6. Average Monthly Inpatient (IP) or Emergency Room (ER) Costs Among Adults 
Whose Child Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
Figure A-7. Average Monthly Grief-Related Outpatient (OP) Costs Among Adults Whose Child 
Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
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Figure A-8. Average Monthly Outpatient (OP) Mental or Substance Use Disorder (MSUD) Costs 
Among Adults Whose Child Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
Figure A-9. Average Monthly Other Outpatient (OP) Costs Among Adults Whose Child Died or 
Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
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Figure A-10. Average Monthly Medication Costs Among Adults Whose Child Died or Was 
Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
Child Whose Parent Died 
Figure A-11. Average Monthly Inpatient (IP) or Emergency Room (ER) Costs Among Children 
Whose Parent Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
$0
$20
$40
$60
$80
$100
$120
$140
$160
$180
$200
-1
2
-1
1
-1
0 -9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 7 8 9 1
0
1
1
1
2
A
ve
ra
ge
 M
o
n
th
ly
 M
e
d
ic
al
 E
xp
e
n
d
it
u
re
s 
Months Before (-12 to -1) and After (1 to 12) the Death or Hospitalization 
Medications Costs 
Bereaved
Not Bereaved
-$300
-$200
-$100
$0
$100
$200
$300
$400
$500
$600
$700
-1
2
-1
1
-1
0 -9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 7 8 9 1
0
1
1
1
2
A
ve
ra
ge
 M
o
n
th
ly
 M
e
d
ic
al
 E
xp
e
n
d
it
u
re
s 
Months Before (-12 to -1) and After (1 to 12) the Death or Hospitalization 
IP or ER Costs 
Bereaved
Not Bereaved
 98 
 
Figure A-12. Average Monthly Grief-Related Outpatient (OP) Costs Among Children Whose 
Parent Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
Figure A-13. Average Monthly Outpatient (OP) Mental or Substance Use Disorder (MSUD) 
Costs Among Children Whose Parent Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
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Figure A-14. Average Monthly Other Outpatient (OP) Costs Among Children Whose Parent 
Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
Figure A-15. Average Monthly Medication Costs Among Children Whose Parent Died or Was 
Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
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Child Whose Sibling Died 
Figure A-16. Average Monthly Inpatient (IP) or Emergency Room (ER) Costs Among Children 
Whose Sibling Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
Figure A-17. Average Monthly Grief-Related Outpatient (OP) Costs Among Children Whose 
Sibling Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
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Figure A-18. Average Monthly Outpatient (OP) Mental or Substance Use Disorder (MSUD) 
Costs Among Children Whose Sibling Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
Figure A-19. Average Monthly Other Outpatient (OP) Costs Among Children Whose Sibling 
Died or Was Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
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Figure A-20. Average Monthly Medication Costs Among Children Whose Sibling Died or Was 
Hospitalized 
 
Note: The error bars are 95% confidence intervals around the mean. 
Trend Analysis in Categories of Procedures and Medications 
Method 
For adults whose spouse died, adults who child died, children whose parent died, and 
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6 to 1 month before, 1 to 6 months after, and 7 to 12 months after the death of a family member. 
Clinical classification software categories, made available by the Agency for Healthcare 
Research and Quality, were used to categorize claims according to the primary procedure 
performed. MarketScan Commercial Claims and Encounters Database also includes categories of 
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individuals within each timeframe were calculated for all procedure categories performed in an 
outpatient setting, procedure categories performed in an inpatient or emergency room setting, 
and outpatient medication categories. The list of categories was ranked by those categories that 
had the largest average expenditures within each timeframe. The percentage of people who had a 
claim within one of the categories was also calculated.      
Summary of Findings 
One of the main purposes of this analysis was to examine whether there were specific 
types of services that were driving increases in the 6 months prior to the death. I did see some 
increases in expenditures on durable medical equipment (DME) in the inpatient setting during 
the 6 months prior to the death of a spouse or child. Other outpatient diagnostic procedures 
(interview, evaluation, consultation) also appeared to increase some in the 6 months before and 
especially in the 6 months after the death of a child. Antidepressants increased slightly over time 
for all types of death, peaking in the 6 months after the death. Across all relationship types, there 
was also a large amount of costs per person for claims without a procedure classification.   
From this analysis it still remains unclear what the underlying drivers of changes in 
medical expenditures are. A major limitation to this analysis is the small sample size and large 
variability in expenditures. In order to quantify statistical changes in these smaller subgroups of 
procedure and medication classifications, I will need a larger sample of individuals.  
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Common Support Plots for Outcomes 
Summary 
The plots below show the regions of common support for the predicted probability of a 
family member’s death. These plots show that there is weak overlap in the predicted 
probabilities, particularly for adults whose child died and children whose parent or sibling died. I 
removed these areas of weak or no overlap, and in some cases this removed nearly half of the 
bereaved individuals from the sample. Another important finding from these graphs is that many 
of the cases of bereaved individuals had a predicted probability less than 0.5. This indicates that 
there is large uncertainty about whether a family member will die in the hospital, even when 
using hundreds of variables in a random forest model. 
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Figure A-21. Histogram of Predicted Probabilities of Death Among Adults Whose Spouse Died 
and Adults Whose Spouse Did Not Die 
 
Note: The purple region is where the predicted probabilities of those whose spouse died and 
those whose spouse did not die overlapped. The predicted probability of death was estimated 
using a random forest model including potential confounding variables that were related to the 
change in total annual expenditures. I assumed common support for all observations with 
predicted probability of less than or equal to 0.5. Those above that threshold were excluded from 
the final analysis.  
 106 
 
Figure A-22. Histogram of Predicted Probabilities of Death Among Adults Whose Child Died 
and Adults Whose Child Did Not Die 
 
Note: The purple region is where the predicted probabilities of those whose child died and those 
whose child did not die overlapped. The predicted probability of death was estimated using a 
random forest model including potential confounding variables that were related to the change in 
total annual expenditures. I assumed common support for all observations with predicted 
probability of less than or equal to 0.3. Those above that threshold were excluded from the final 
analysis.  
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Figure A-23. Histogram of Predicted Probabilities of Death Among Children Whose Parent Died 
and Children Whose Parent Did Not Die 
 
Note: The purple region is where the predicted probabilities of those whose parent died and those 
whose parent did not die overlapped. The predicted probability of death was estimated using a 
random forest model including potential confounding variables that were related to the change in 
total annual expenditures. I assumed common support for all observations with predicted 
probability of less than or equal to 0.4. Those above that threshold were excluded from the final 
analysis.  
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Figure A-24. Histogram of Predicted Probabilities of Death Among Children Whose Sibling 
Died and Children Whose Sibling Did Not Die 
 
Note: The purple region is where the predicted probabilities of those whose sibling died and 
those whose sibling did not die overlapped. The predicted probability of death was estimated 
using a random forest model including potential confounding variables that were related to the 
change in total annual expenditures. I assumed common support for all observations with 
predicted probability of less than or equal to 0.3. Those above that threshold were excluded from 
the final analysis.  
Analysis of Injury or Poisoning 
I ran the analysis for those whose family member’s hospitalization or death was related to 
poisoning or injury. Below are the preliminary results. One methodological difference in this 
analysis compared to what I did in the main paper is that I included all relationship types in one 
analysis. I also have not excluded pregnancy related costs in this analysis. 
 109 
 
There were 275 cases where a family member’s death was related to injury or poisoning. 
The cases with common support ranged between 98 (36%) and 217 (79%) depending on the 
outcome of interest, and the number of confounders ranged from 78 to 185 (Table 1). 
 
Table A-1. Number of Confounders and Sample Size for Those Who Had a Family Member Die 
from Injury or Poisoning 
Expenditure Outcomes 
Number of 
Confounders 
Bereaved 
Sample w/ 
CS 
Bereaved 
w/o CS 
(excluded) 
Not 
Bereaved 
w/ CS 
Not Bereaved 
w/ CS & No 0 
Propensities 
Overall 185 149 126 22,901 5,294 
Inpatient or emergency room  78 217 58 22,971 6,038 
Outpatient grief-related 146 98 177 22,839 3,674 
Outpatient mental or substance 
use expenditures, no grief 
diagnosis 
103 148 127 22,883 4,255 
Other outpatient  153 145 130 22,883 4,893 
Medications 78 254 21 22,999 6,207 
Abbreviations: CS, common support; w/, with; w/o, without. 
 
There did not appear to be any major changes in the unadjusted average monthly medical 
expenditures for the bereaved family members (Figure 1). There was, however, a lot of 
variability in expenditures, particularly in the 5
th
 month prior to the death of a family member, 
and in the 7-12 months after the death. 
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Figure A-25. Unadjusted Trend Analysis of Average Monthly Medical Expenditures Among 
Individuals Whose Family Member Was Hospitalized or Died from Injury or Poisoning 
 
Note: This analysis used all 275 cases, regardless of common support. Note: The error bars are 
95% confidence intervals around the mean. 
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Overall, the methods showed some increases in medical expenditures following 
bereavement (Table 2). The effect was not significant using the inverse probability of treatment 
weighting (IPTW) (p=0.273); however, it was with the causal forest approach (95% confidence 
interval: $240 to $4,442). This was an unusual finding since in the main analysis the IPTW 
approach tended to provide more significant estimates than the causal forest approach. This 
could be a result of the large variations in estimates as seen in the trend analysis above.  In the 
IPTW method the largest effect was seen in medications ($127), but it also was least significant 
using a Mann-Whitney U test. The causal forest approach indicated that the outpatient mental or 
substance use expenditures where grief was not diagnosed experienced the largest increases in 
expenditures ($637). 
 
Table A-2. Estimate Effect of Bereavement on Medical Expenditures Among Those Whose 
Family Member Died from Injury or Poisoning, by Methodological Approach 
Expenditure Outcomes 
IPTW method Causal Forest method 
Effect P-Value Effect Standard Error 
Overall $436 0.273 $2,341 $1,072 
Inpatient or emergency room  $33 0.007 $423 $407 
Outpatient grief-related $8 0.057 -$1 $55 
Outpatient mental or substance use 
expenditures, no grief diagnosis $41 0.049 $637 $617 
Other outpatient  $46 0.207 $211 $149 
Medications $127 0.738 $2 $15 
Abbreviation: IPTW, Inverse probability of treatment weighting. P-Value was determined using 
a Mann-Whitney U test.  
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Sensitivity Analyses 
Changing the Minimum Node Size 
In discussion with the creators of the causal forest algorithm I learned that the minimum 
node size specification in the R function only stops splitting the tree if the threshold has been 
met. If a node is bigger than the threshold it can split the tree into two sub nodes, one or both of 
which are smaller than the minimum node size threshold. For other users of the R package this 
has resulted in a sample of one in some nodes in the causal forest. I wanted to see how this 
specification was affecting the standard errors of the analysis. As a result I re-ran the analysis for 
overall costs among adults who had a child die, with a minimum node size splitting threshold of 
10 (the base case), 25, 50, and 100. Below, the results show that the different thresholds did not 
have a substantial impact on the estimated effect or the standard error: 
 
Table A-3. Sensitivity Analyses of the Effect Estimate Using Different Node Size Splitting 
Thresholds 
Node size splitting 
threshold 
Estimate Standard Error 
10 $1,882  $1,061  
25 $1,515  $1,105  
50 $1,828  $1,150  
100 $1,842  $1,069  
 Using months 7-12 prior to the event as a baseline among adults who had a child die 
Due to the increases in expenditures in the 6 months prior to the death of a family 
member, this diminishes the effect I have calculated using the difference-in-differences 
approach. As a sensitivity analysis I compared costs in the 7-12 months before the event vs. the 
costs the year after. I used all the covariates for the year before in this sensitivity analysis. In 
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future analyses I will need to limit the covariates to those in the 7-12 months before for the 
bereaved and not bereaved family members. The results for adults who had a child die are very 
different than comparing the year before to the year after: 
 
Table A-4. Sensitivity Analysis of Expenditure Outcomes Using Cost in the 7-12 Months Before 
the Event as the Baseline, Among Adults Whose Child Died 
Expenditure Outcomes 
Adult Whose Child Died 
Effect P-Value 
Overall $3,587 0.068 
Inpatient or emergency room  $329 0.808 
Outpatient grief-related $106 <0.001 
Outpatient mental or substance use expenditures, no grief diagnosis $1,884 <0.001 
Other outpatient  $815 0.721 
Note: this is the difference in differences between the expenditures in -365 to -180 days before 
the event and 0 to 364 days after the event.  
 
When comparing the entire year before to the year after in the main report, the overall 
estimate was $225 (P-value 0.086). 
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APPENDIX B: Suicide Bereavement Survey 
The following is the survey that was used to gather the data on suicide related 
bereavement. The text is formatted and colored in the way that was used by the developers at 
NORC to program the computer-assisted telephones interviewing (CATI) and the computer 
aided web interviewing (CAWI) versions of the survey. 
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Client University of Michigan 
Project Name Long Term Burden of Suicide 
Project Number 8128 
Survey length (median)  12-15 minute survey 
Population 425 adults + 150 teens who know someone who died by suicide or 
someone who attempted suicide  
Pretest  N=100 
Main  N=475 or 575 (depending on pretest) 
MODE Phone and web 
Language English and Spanish 
Incentive 3000 AmeriPoints (for adults); $5 Amazon gift card (for teens) 
PIMS description Burden of Suicide  
Carga de Suicidio 
Eligibility Rate 30% 
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Standard demographic preloads: 
Variable Name Variable Type Variable Label 
AGE Numeric Age 
GENDER String Gender 
RACETHNICITY Numeric Race/ethnicity 
EDUC Numeric Education 
MARITAL Numeric Marital Status 
EMPLOY Numeric Current employment status 
INCOME Numeric Household income 
STATE String State 
METRO Numeric Metropolitan area flag 
INTERNET Numeric Household internet access 
HOUSING Numeric Home ownership 
HOME_TYPE Numeric Building type of panelist’s residence 
PHONE_SERVICE Numeric Telephone service for the household 
HHSIZE Numeric Household size (including children) 
HH01 Numeric Number of HH members age 0-1 
HH25 Numeric Number of HH members age 2-5 
HH612 Numeric Number of HH members age 6-12 
HH1317 Numeric Number of HH members age 13-17 
HH18OV Numeric Number of HH members age 18+ 
These populated as a pre-load when the panelists get sampled into the survey 
 
Standard sample preloads 
Variable Name Variable Type Variable Label 
Username Numeric Analogous to Member_PIN 
P_Batch Numeric Batch Number (if only one assignment, then 
everyone will be 1) 
Dialmode Numeric CATI Dialmode (predictive, preview, etc) 
P_LCS Numeric Life cycle stage, 0=released but not touched 
LANG String Survey language (EN, ES) 
Y_FCELLP String  
S_RES Numeric  
Surveylength Numeric Estimated length of survey 
SurveyId Numeric Survey ID# in A4S 
Incentwcomma String 1,000 or 2,000 
P_Hold01 Numeric Prevents dialing cases without phone numbers 
 
Custom survey-specific preloads provided by Statistics team 
Variable Name Variable Type Variable Label 
P_PARENT Numeric 1=Parent path; 2=Adult path 
LifeExpect Numeric calculate based on age and gender 
Tradeoff1 Numeric calculate as (lifeexpectancy-age)/2 
tradeoff2 Numeric calculate as (lifeexpect-age)/4 
tradeoff3 Numeric calculate as 3*(lifeexpect-age)/4 
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This survey will use the following RND_xx variables: 
Note, these are randomized in the script (NOT preloads) 
RND_xx Associated survey Qs 
RND_00  
RND_01  
RND_02  
RND_03  
RND_04  
RND_05  
RND_06  
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PHONE SCRIPTS 
[CATI - OUTBOUND] 
INTRO 
Hello, my name is $I. I'm calling from AmeriSpeak by NORC.  May I please speak with [FIRSTNAME]?  
Hola, mi nombre es $I. Lo estoy llamando de AmeriSpeak del  NORC. ¿Podría hablar con [FIRSTNAME]? 
 
[IF RESPONDENT IS AVAILABLE] 
Thank you for your continued participation in AmeriSpeak. I am calling to let you know that your 
next survey is available. The survey takes approximately [SURVEYLENGTH] minutes to complete. 
If you complete the survey, you will receive [INCENTWCOMMA] AmeriPoints for your time.  
Gracias por su participación continúa en AmeriSpeak. Le estoy llamando para informarle que su 
próxima encuesta está lista. La encuesta toma aproximadamente [SURVEYLENGTH] minutos 
para completar. Si completa la encuesta, recibirá [INCENTWCOMMA] AmeriPoints por su 
tiempo.  
 
[IF S_AMS_SWEEP=1] Plus, get entered into the Wintry Holiday Sweepstakes for a chance to win 
$500!  
¡Además, entre al sorteo Wintry Holiday para tener la oportunidad de ganar $500! 
 
We will keep all of your answers confidential. Shall we proceed? 
Mantendremos todas sus respuestas confidenciales. ¿Desea que procedamos? 
 
Great. As always, for quality assurance purposes, this call may be recorded or monitored.  
 Excelente. Esta llamada puede ser grabada o monitoreada. 
 
 
[CATI-INBOUND] 
INTRO 
Thank you for calling AmeriSpeak by NORC.  My name is $I.  How are you today? 
Gracias por llamar a AmeriSpeak de NORC. Mi Nombre es $I. ¿Cómo está hoy? 
 
And are you calling to take your next survey? 
¿Y está llamando para tomar su próxima encuesta? 
 
I just need to confirm that I'm speaking with [FIRSTNAME] [LASTNAME]. Is that you? 
Sólo necesito confirmar que estoy hablando con [FIRSTNAME] [LASTNAME]. ¿Sería usted? 
 
Great. This survey takes approximately [SURVEYLENGTH] minutes to complete over the phone and you 
will earn [INCENTPOINTS] AmeriPoints for your time.   
Excelente. Esta encuesta dura aproximadamente [SURVEYLENGTH] minutos para completar a través del 
teléfono y usted ganará [INCENTWCOMMA] AmeriPoints por su tiempo. 
 
[IF S_AMS_SWEEP=1] Plus, get entered into the Wintry Holiday Sweepstakes for a chance to win $500!   
¡Además, entre al sorteo Wintry Holiday para tener la oportunidad de ganar $ 500! 
 
We will keep all of your answers confidential.  As always, for quality assurance purposes, this call may be 
recorded or monitored. Shall we proceed? 
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Mantendremos todas sus respuestas confidenciales. Esta llamada puede ser grabada o monitoreada. 
¿Desea que procedamos? 
 
 
 
[CATI-CALLBACK] 
CBINTRO 
Hello, my name is $I. I'm calling from AmeriSpeak by NORC.  We previously spoke with [FIRSTNAME] 
about completing an AmeriSpeak survey. Is [FIRSTNAME] available?    
Hola, mi nombre es $I. Estoy llamando de AmeriSpeak de NORC. Previamente hablamos con 
[FIRSTNAME] acerca de completar una encuesta de AmeriSpeak. ¿Esta [FIRSTNAME] disponible? 
 
[IF RESPONDENT IS AVAILABLE] 
Hello, my name is $I, calling from AmeriSpeak by NORC. We previously spoke with you about 
completing an AmeriSpeak survey. Are you available now to continue?  
Hola, mi nombre es $I, y estoy llamando de AmeriSpeak de  NORC. Previamente hablamos con 
usted acerca de completar una encuesta de AmeriSpeak. ¿Está usted disponible ahora para 
continuar?  
 
As always, for quality assurance purposes, this call may be recorded or monitored. 
Esta llamada puede ser grabada o monitoreada. 
 
 
[DISPLAY THIS AM LANGUAGE IF SurveyAccessEnd-CALLDATE>1 DAY] 
 [CATI-MISSED OUTBOUND, ANSWERING MACHINE] 
AM1 
Hello, this message is [FIRSTNAME] [LASTNAME].  I'm calling from AmeriSpeak from NORC to let you 
know that you have a survey waiting for you. The survey will take approximately [surveylength] minutes 
and you will receive [INCENTWCOMMA] AmeriPoints for your time.   
Hola, este mensaje es para [nombre y apellido del panelista]. Estoy llamando de AmeriSpeak de NORC 
para informarle que tiene una encuesta esperando. La encuesta le tomará aproximadamente 
[surveylength] minutos y recibirá [INCENTWCOMMA] AmeriPoints por su tiempo. 
 
[IF S_AMS_SWEEP=1] Plus, get entered into the Wintry Holiday Sweepstakes for a chance to win $500!  
¡Además, entre al sorteo Wintry Holiday para tener la oportunidad de ganar $500! 
 
Call us toll-free at 888-326-9424 and enter your PIN number, [MEMBER_PIN], to complete your survey 
and earn rewards.  
Llámenos al número gratuito 888-326-9424 e introduzca su número PIN, [MEMBER_PIN], para 
completar la encuesta y ganar premios. 
 
 
[DISPLAY THIS AM LANGUAGE IF SurveyAccessEnd-CALLDATE>1 DAY] 
 [CATI-ANSWERING MACHINE MISSED APPOINTMENT CALLBACK] 
AMHARD 
Hello, this message is for [FIRSTNAME] and I'm calling from AmeriSpeak from NORC. When we spoke 
previously, you requested that we call you back <at this time>.  I'm sorry that we've missed you.  We'll 
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try to contact you again soon but please feel free to return our call any time at 888-326-9424 and enter 
your PIN number, [MEMBER_PIN], to complete your survey and earn rewards. Thank you. 
Hola, este mensaje es para [FIRSTNAME]  y estoy llamando de AmeriSpeak de NORC. Cuando hablamos 
anteriormente, solicitó que le llamaramos de nuevo <en este momento>. Siento no haber podido 
contactarlo/a. Intentaremos ponernos en contacto con usted otra vez pronto, pero no dude en devolver 
nuestra llamada en cualquier momento al 888-326-9424 e introduzca su número PIN, [MEMBER_PIN], 
para completar su encuesta y ganar premios. Gracias. 
 
 
[DISPLAY THIS AM LANGUAGE IF SurveyAccessEnd-CALLDATE>1 DAY] 
 [CATI-ANSWERING MACHINE MISSED CALLBACK] 
AMSOFT 
Hello, this message is for [FIRSTNAME]. I am calling from AmeriSpeak from NORC. We are calling you 
back to complete your AmeriSpeak survey.  Remember, you will earn rewards for completing this 
survey.  
Hola, este mensaje es para [FIRSTNAME]. Estoy llamando de AmeriSpeak de NORC. Le estamos 
regresando la llamada para completar su encuesta de AmeriSpeak. Recuerde, usted ganará premios por 
completar esta encuesta. 
 
[IF S_AMS_SWEEP=1] Plus, get entered into the Wintry Holiday Sweepstakes for a chance to win $500!  
¡Además, entre al sorteo Wintry Holiday para tener la oportunidad de ganar $ 500! 
 
I'm sorry that we've missed you.  We'll try to contact you again soon but please feel free to return our 
call any time at 888-326-9424 and enter your PIN number, [MEMBER_PIN], to complete this survey.   
Siento no haber podido contactarlo/a. Intentaremos ponernos en contacto con usted otra vez pronto, 
pero no dude en devolver nuestra llamada en cualquier momento al 888-326-9424 e introduzca su 
número PIN, [MEMBER_PIN], para completar esta encuesta. 
 
Thank you. 
Gracias. 
 
 
[DISPLAY THIS AM LANGUAGE IF SurveyAccessEnd-CALLDATE=1 DAY] 
[CATI-NEARING END OF FIELD, ANSWERING MACHINE] 
AMEND 
Hello, this message is for [FIRSTNAME]. I'm calling from AmeriSpeak from NORC to let you know that a 
survey will be ending tomorrow. We’d love to hear from you so please call us toll-free at 888-326-9424 
and enter your PIN number, [MEMBER_PIN], to complete your survey and earn rewards.   Thank you. 
Hola, este mensaje es para [FIRSTNAME]. Estoy llamando de AmeriSpeak de NORC para informarle que 
una encuesta terminará mañana. Nos encantaría saber de usted, así que por favor llámenos al número 
gratuito 888-326-9424 e introduzca su número de PIN, [MEMBER_PIN], para completar su encuesta y 
ganar premios. Gracias. 
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Please include the following options for all questions in CATI: 
77 DON’T KNOW 
99 REFUSED 
 
Please code refusals in CAWI: 
98 IMPLICIT REFUSAL, WEB SKIP 
Do not code 77 Don’t Know/99 Refused options in CAWI unless written in item response options 
 
 
Text shown in green includes researcher notes and should not be included in the programming. 
Text shown in purple indicates Spanish translation that should be incorporated into the Spanish version 
of the survey 
 
 
[START OF SURVEY] 
 
CREATE DATA-ONLY VARIABLE: QUAL 
1=Qualified Complete 
2=Not Qualified 
3=In progress 
 
AT START OF SURVEY COMPUTE QUAL=3 “IN PROGRESS” 
 
 
CREATE MODE_START 
1=CATI 
2=CAWI 
 
 
(Project name) Draft 
Date: (Quex start date)  
 
 
[SHOW IF RACETHNICITY= 4] [SP] 
LANGSWITCH 
[CAWI VERSION] 
Would you like to take this survey in English or Spanish? 
¿ Le gustaría tomar esta encuesta en inglés o español? 
 
1. English/Inglés 
2. Spanish/Español 
 
[CATI VERSION] 
We are offering this survey in both English and Spanish.  Which would you prefer? 
 Estamos ofreciendo esta encuesta en inglés y español. ¿Cuál preferiría? 
1.      Continue 
1.      Continuar 
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IF LANGSWITCH=1, 77, 98, 99 continue in English (EN) 
IF LANGSWITCH=2, switch to Spanish language version of the survey (ES) 
 
 
[DISPLAY – WINTRO_1] [CAWI ONLY] 
[P_PARENT = 2] 
Thank you for agreeing to participate in our new AmeriSpeak survey! To thank you for sharing your 
opinions, we will give you a reward of [INCENTWCOMMA] AmeriPoints after completing the survey.  
¡Gracias por participar en nuestra nueva encuesta de AmeriSpeak!  Para agradecerle por compartir su 
opinión, le daremos una recompensa de [INCENTWCOMMA] AmeriPoints después de completar esta 
encuesta.  
 
[P_PARENT = 1] 
For this survey, we would like to have one of your children aged 15 through 17 complete the survey.  
Your teenager can refuse to answer any question and can stop the survey at any time.  Your decision to 
allow your teenager to take part in this research study is completely voluntary.   
Para esta encuesta, nos gustaría que uno de sus hijos de entre 15 y 17 años complete esta encuesta.  Su 
hijo adolescente puede negarse a responder cualquier pregunta y puede detener la encuesta en 
cualquier momento. Su decisión de permitir que su hijo forme parte de este estudio de investigación es 
completamente voluntaria. 
 
If you only have one child aged 15 to 17, we would like to ask the survey questions of that teen.  If you 
have more than one child in that age range, we will randomly select one for participation after you have 
completed your section of the survey.   
Si usted sólo tiene un hijo de entre 15 y 17 años de edad, nos gustaría realizarle las preguntas de esta 
encuesta a dicho adolescente.  Si usted tiene más de un hijo en ese rango de edad, seleccionaremos al 
azar a uno de ellos para que participe luego de que usted haya completado su sección de la encuesta. 
 
[SHOW TO ALL] 
[IF S_AMS_SWEEP=1] Plus, get entered into the Wintry Holiday Sweepstakes for a chance to win $500!  
Además, participe en el sorteo Wintry Holiday para una oportunidad de ganar $500! 
 
As always, your answers are confidential.  
Como siempre, sus respuestas son confidenciales. 
 
Please use the "Continue" and "Previous" buttons to navigate between the questions within the 
questionnaire. Do not use your browser buttons. 
Por favor utilice los botones “Continuar” y “Anterior” para navegar entre las preguntas del 
cuestionario. No utilice los botones de su navegador. 
 
[IF S_AMS_SWEEP=1] 
[SMALL FONT] [REMOVE BOLD] NO PURCHASE OR PAYMENT OF ANY KIND OR COMPLETION OF SURVEY IS 
NECESSARY TO ENTER OR WIN. PURCHASE OR PAYMENT DOES NOT IMPROVE YOUR CHANCE OF WINNING. The Wintry 
Holiday Sweepstakes is open only to legal residents of the 50 US and DC, 18+, who are current and active members of the 
AmeriSpeak Panel and have received an invitation to participate in a survey associated with this sweepstakes. Void elsewhere and 
where prohibited. Promotion ends January 31
st
, 2018. On or about February 14, 2018, a random drawing will be conducted from 
among all eligible entries received. Odds of winning a prize depend on the number of entries received. All potential winners will be 
contacted by telephone, email, regular mail or overnight mail. Subject to complete Official Rules at rules.promotrust.com/holiday. 
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NINGUNA COMPRA O PAGO DE NINGUNA CLASE ES NECESARIO PARA PARTICIPAR O GANAR. LA COMPRA O EL PAGO 
NO MEJORA SU PROBABILIDAD DE GANAR. El Sorteo Wintry Holiday Panel está abierto solo para residentes legales de los 50 
Estados Unidos y el DC, mayores de 18 años, que sean miembros actuales y activos del panel de AmeriSpeak y hayan recibido 
una invitación para participar en una encuesta asociada con este sorteo. No válido en otro lugar y donde esté prohibido. La 
promoción finaliza el 31 de enero de 2018. El o alrededor del 14 de febrero de 2018, se realizará un sorteo al azar entre todas las 
inscripciones elegibles recibidas. Las probabilidades de ganar un premio dependen del número de entradas recibidas. Se 
contactará a todos los posibles ganadores por teléfono, correo electrónico, correo ordinario o correo nocturno. Sujeto a las Reglas 
oficiales completas en rules.promotrust.com/holiday. 
 
 
 
GLOBAL PROGRAMMING 
 
PLEASE MAKE IT SO CLICKING ON ANY HYPERLINK OPENS A NEW WINDOW FOR THE RESPONDENT 
 
ADD FOOTER ON EVERY SCREEN DISPLAY1 TO END 
 
<CENTER> For extra help and resources click here </CENTER> 
<CENTER> Por más ayuda y recursos haga clic aquí </CENTER> 
 
Clicking on the link will open a new window with the following information: 
 
Helpful Resources: 
 afsp.org/find-support/ive-lost-someone/ - This website can help you find local support groups, 
outreach programs, and additional resource specific to survivors of suicide loss. 
 allianceofhope.org – This is an online resource and support group that allows you to connect 
with others who have lost someone to suicide and hear how they are reacting and working 
through their grief.  
 *For Teens* yourlifeyourvoice.org – This is a special website for teens were you can text, chat, 
call or email someone who can help you with your current emotional, mental, or social 
struggles. There are also videos of other teens’ experiences with grief, thoughts of suicide, 
struggles with bullying or abuse, and many other topics.   
 
Recursos útiles: 
 afsp.org/find-support/ive-lost-someone/ - Este sitio web puede ayudarle a usted a encontrar 
grupos de apoyo locales, acceder a programas, y recursos adicionales específicos para 
sobrevivientes a una pérdida por suicidio. 
 allianceofhope.org – Este es un recurso y grupo de apoyo en línea que le permite a usted 
conectarse con otras personas que hayan perdido a alguien por suicidio y escuchar cómo están  
trabajando y reaccionando frente a su dolor.  
 *Para adolescentes* yourlifeyourvoice.org – Este es un sitio especial para adolescentes en el 
cual puede enviar mensajes, chatear, llamar o enviar un correo electrónico a alguien que puede 
ayudarle con su actual lucha emocional, mental o social. También hay videos de experiencias de 
otros adolescentes con el duelo, pensamientos suicidas, luchas por acoso o abuso, y muchos 
otros temas. 
If you are having thoughts of suicide: 
Si usted está teniendo pensamientos de suicidio: 
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<u>PLEASE</u> visit suicidepreventionlifeline.org. At this website you can chat with someone online or 
you can call 1-800-273-8255 or 1-800-273-TALK to talk with someone about your thoughts and struggles 
with life. They will listen. They will help. 
<u>POR FAVOR</u> visite suicidepreventionlifeline.org/help-yourself/en-espanol. En este sitio web 
usted puede chatear con alguien en línea o usted puede llamar al 1-888-628-9454 para hablar con 
alguien sobre sus pensamientos y luchas con su vida. Ellos escucharán. Ellos le ayudarán. 
 
Teens can also visit yourlifeyourvoice.org to talk with someone and get help. 
Los adolescentes también pueden visitar yourlifeyourvoice.org para hablar con alguien y recibir ayuda. 
 
 
 
SET IF P_PARENT = 1 INSERT SECTION TIMESTAMP: TIME_PARENST, DATE_PARENST 
 
 
[SHOW IF P_PARENT=1; NUMBOX 0-10] 
QS0.  
Including yourself, how many adults, aged 18 and above, live in your household at least 50% of the 
time?  
Incluyendo usted, ¿cuántos adultos, mayores de 18 años, viven en su hogar al menos el 50% del tiempo? 
 
If no adults live in your household, please [IF CAWI, INSERT: enter] [IF CATI, INSERT: say] zero. 
Si ningún adulto vive en su hogar por favor [IF CAWI, INSERT: ingrese] [IF CATI, INSERT: diga] cero. 
 
 
[SHOW IF P_PARENT=1; NUMBOX 0-10] 
QS1.  
How many teenagers aged 15 through 17 live in your household at least 50% of the time?  
¿Cuántos adolescentes de entre 15 y 17 años viven en su hogar al menos el 50% del tiempo? 
 
If no teenagers age 15 to 17 live in your household, please [IF CAWI, INSERT: enter] [IF CATI, INSERT: say] 
zero. 
Si no hay adolescentes de entre 15 y 17 años en su hogar, por favor [IF CAWI, INSERT: ingrese] [IF CATI, 
INSERT: diga] cero. 
 
 
 
[SHOW IF QS1>0; NUMBOX 0-10] 
QS2.   
For how many of the teenagers aged 15 to 17 in your household are you the parent or legal guardian?  
¿De cuántos de los adolescentes de entre 15 y 17 años que viven en su hogar es usted el/la 
padre/madre o tutor/a legal? 
[CATI] ACCEPTABLE RANGE IS 0-10  
 
 
[NUMBOX; PROMPT] 
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[IF QS2= 1] 
QS3.   
How old is your teenager? 
¿Qué edad tiene el/la adolescente? 
[CATI] ACCEPTABLE RANGE IS 15-17 
 
[ACCEPT RANGE 15-17, 77,98,99] 
 
[SP; PROMPT] 
[IF QS2= 1] 
QS4.  
Is your teenager male or female? 
¿Su hijo/a adolescente es de género masculino o femenino? 
  
1. Male 
2. Female 
3. They don’t identify with either gender 
 
1. Masculino 
2. Femenino 
3. No se identifican con ningún género 
 
  
[SHOW IF QS2=1; SP] 
QS5.  
If you would like to tell us your child’s first name, nickname, or initials, we can customize the survey 
wording to call them by this name.  If you do not wish to share their name, just let us know.   
Si a usted le gustaría decirnos el primer nombre de su hijo, apodo o iniciales, podemos personalizar la 
encuesta para que se lo llame por su nombre.  Si no desea compartir su nombre, simplemente hágalo 
saber. 
 
CAWI RESPONSE OPTIONS: 
1. Yes, I will share his/her name, nickname, or initials: [SMALL TEXTBOX] 
2. No, I do not want to share his/her name 
 
1. Sí, compartiré su nombre, apodo, o iniciales: [SMALL TEXTBOX] 
2. No, no deseo compartir su nombre 
 
 CATI RESPONSE OPTIOINS 
1. YES, R WILL SHARE HIS/HER NAME, NICKNAME, OR INITIALS [SMALL TEXTBOX] 
2. NO, R DOES NOT WANT TO SHARE CHILD”S NAME 
 
1. SÍ, R COMPARTIRÉ SU NOMBRE, APODO, O INICIALES: [SMALL TEXTBOX] 
2. NO, R NO QUIERE COMPARTIR EL NOMBRE DEL NIÑO 
[CATI] ENTER ANSWERS IN TEXTBOX 
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[IF QS2> 1, SHOW QS7]  
[textboxes, numboxes 15-17, dropdown; number of rows equals number in QS2] 
[prompt if skip, terminate if refused] 
QS7. 
Now we would like to determine which of the children aged 15 to 17 living in your household should 
complete the rest of the survey.   
Ahora nos gustaría determinar cuál de los hijos de entre 15 y 17 que viven en su hogar debería 
completar el resto de la encuesta. 
 
[CAWI] To allow us to do this, please enter a nick name or initials for everyone aged 15 through 17 in 
your household for whom you are the parent or legal guardian below. Please also tell us their age and 
gender. 
[CAWI] Para poder hacerlo, por favor ingrese a continuación un apodo o iniciales  para cada uno de los 
integrantes de su hogar de 15 a 17 años de quien usted es el/la padre/madre o tutor legal. Por favor 
también indíquenos la edad y género. 
 
[CATI] To allow us to do this, please tell us a nick name or initials for everyone aged 15 through 17 in 
your household for whom you are the parent or legal guardian.  Please also tell us their age and gender. 
[CATI] Para poder hacerlo, por favor díganos un apodo o iniciales para cualquier persona de entre 15 y 
17 años en su hogar de quien usted sea el padre, madre o tutor legal.  Por favor también indíquenos la 
edad y género. 
 
 
 Nickname or 
INITIALS AGE GENDER 
[textboxes] [numboxes] [dropdown: 
Male/Female/Teen doesn’t 
identify with either gender] 
   
   
   
   
   
   
   
   
   
 
 
Apodo o INICIALES EDAD SEXO 
[textboxes] [numboxes] [dropdown: 
Hombre/Mujer/Adolescente 
no se identifica con ningún 
género 
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[RANDOMLY SELECT ONE TEEN AND CREATE DATA-ONLY VARIABLES TAGE, TGENDER, TNAME]. 
 
TAGE numeric (15-17) 
IF QS2=1 TAge=QS3 
IF QS2 >1 TAge= Age of child  selected in QS7  
TGENDER numberic (1, 2) 
IF QS2=1 TGender=QS4 
IF QS2 >1 TGender= Gender of child selected in QS7 
TNAME string 
IF QS2=1 and QS5=1 TName=Name of child entered in textbox 
IF QS2=1 and 
QS5=2,77,98,99 
TName= “your teenager” 
TName= “su hijo/a adolescente” 
IF QS1 >1 TName= Name of child  selected in QS7 
 
 
 
[SHOW IF P_PARENT=1 and QS2>0; SP] 
PCONSENT. 
We are asking you for permission to have [TNAME] take part in this survey to help us learn more about 
what teens think about health issues. This will take about 15 minutes to finish, depending on their 
answers.  
Le pedimos a usted su permiso para que  [TNAME] realice esta encuesta para ayudarnos a conocer más 
lo que los adolescentes piensan sobre temas de salud. Esto tomará aproximadamente 15 minutos, 
dependiendo de sus respuestas. 
 
Important things you should know are: 
Cosas importantes que usted debe saber: 
 
 Your teen will be asked questions about the impact of knowing someone who died by 
suicide. Some of these questions may make them uncomfortable. All questions are 
voluntary and they can skip questions if they wish. 
 We would encourage your teen to take the survey at any time when they will have 
privacy.  
 To help us protect your teen’s privacy, we have applied for a Certificate of 
Confidentiality from the National Institutes of Health. The researchers can use this 
Certificate to legally refuse to disclose information that may identify your teen in any 
federal, state, or local civil, criminal, administrative, legislative, or other proceedings, for 
example, if there is a court subpoena. 
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 The survey is voluntary; you can choose whether or not to let your teen take it, and they 
can stop taking the survey at any time. 
 Your teen will be compensated for their time by being sent a $5 Amazon gift card in the 
mail. 
 
 Se le realizarán a su hijo adolescente preguntas sobre el impacto de conocer a alguien 
que se suicidó. Algunas de estas preguntas pueden hacerlo/a sentir incómodo/a. Todas 
las preguntas son voluntarias y él/ella puede saltar alguna pregunta si así lo desea. 
 Recomendamos que su hijo adolescente realice la encuesta en algún momento en el 
que tenga privacidad.  
 Para ayudarnos a proteger la privacidad de su hijo adolescente, hemos aplicado un 
Certificado de Confidencialidad del Instituto Nacional de Salud. Los investigadores 
pueden utilizar este Certificado para negarse legalmente a divulgar información que 
pueda identificar a su hijo adolescente en algún procedimiento civil, penal, 
administrativo, legislativo o de otro tipo a nivel federal, estatal, o local, por ejemplo si 
hay una citación de una corte. 
 La encuesta es voluntaria; usted puede elegir si dejar o no participar a su hijo/a 
adolescente, y él/ella pueden dejar de participar en la encuesta en cualquier momento. 
 Su hijo adolescente será recompensado por su tiempo recibiendo una tarjeta de regalo 
de Amazon de valor de $5 por correo. 
 
AmeriSpeak and NORC are supporting the following researchers at the University of Michigan to do this 
survey: John Richardson, MPH; Daniel Eisenberg, PhD; Cheryl King, PhD; Lisa Prosser, PhD, MS; and 
David Hutton, PhD. These researchers will only have access to de-identified survey responses and thus 
cannot identify or link information to specific AmeriSpeak participants. If you have any questions or 
concerns about your teen’s participation in this study, you can contact AmeriSpeak Support at 
support@AmeriSpeak.org or call (888) 326-9424.  
AmeriSpeak y NORC están apoyando a los siguientes investigadores de la Universidad de Michigan para 
realizar esta encuesta: John Richardson, MPH; Daniel Eisenberg, PhD; Cheryl King, PhD; Lisa Prosser, 
PhD, MS; y David Hutton, PhD. Estos investigadores solo tendrán acceso a respuestas sin identificación y 
de esa forma no podrán identificar o unir la información con un  participante específico de AmeriSpeak. 
Si usted tiene alguna pregunta o inquietud acerca de la participación de su hijo/a adolescente en este 
estudio, puede contactar a Apoyo de AmeriSpeak  al correo electrónico ayuda@AmeriSpeak.org o 
llámenos al (888) 326-9424. 
 
Would you be willing to have a teenager in your household complete this survey? 
¿Estaría dispuesto a que un adolescente de su hogar complete esta encuesta? 
 
1. Yes 
2. No  
 
1. Sí 
2. No 
 
 
[SHOW IF P_PARENT=1 and QS2>0; SP] 
QS8 
[PCONSENT>1] We understand you do not wish to let your child participate in this study. Please answer 
just a few more questions for us. 
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[PCONSENT=1] Thank you for letting your child participate in this study. Please answer just a few more 
questions for us. 
[PCONSENT>1] Entendemos que no desea que su hijo/a participe en este estudio. Por favor responda 
sólo algunas preguntas más para nosotros. 
[PCONSENT=1] Gracias por dejar a su hijo/a participar en este estudio.  Por favor responda sólo algunas 
preguntas más para nosotros. 
 
Does your child know someone who died by suicide or attempted suicide?  
¿Conoce su hijo/a a alguien que se haya suicidado o haya intentado suicidarse? 
 
1. Yes 
2. No  
 
1. Sí 
2. No 
 
 
[SHOW IF P_PARENT=1 and PCONSENT>1 and QS8=1; SP] 
QS9 
 
Might you be willing to change your mind about your child’s participation if you knew what questions 
your child would be asked?  
¿Estaría usted dispuesto/a a cambiar de opinión sobre la participación de su hijo/a si supiera qué 
preguntas se le realizarían? 
 
1. Yes 
2. Maybe 
3. No  
 
1. Sí 
2. Quizás 
3. No 
 
 
[SHOW IF QS9=1 or 2] 
DISPLAY – QS10 
 
[CAWI] Below is the list of questions your child will be asked if you choose to let them participate: 
[CATI] Here are the questions your child will be asked if you choose to let them participate: 
[CAWI] A continuación sigue una lista de preguntas que se le realizarán  a su hijo/a si decide usted 
permitirle participar: 
[CATI] Estas son las preguntas que se le realizarán a su hijo/a si decide permitirle participar: 
 
 Do you know someone who died by suicide? 
 Not including yourself, do you know someone who has attempted suicide? 
 Do you consider yourself a survivor of suicide loss? That is, someone whose life has been 
personally affected by a suicide? 
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 What effect did the suicide attempt have on your life? 
 Did the suicide death/attempt have an effect on your overall emotional, mental, or physical 
health at any time?  
 [If yes] For how long was your overall health affected?  
 In what ways do you feel changed or not changed by the death/attempt? How clearly you think 
or focus? How you feel emotionally? Your social life? Your goals and purpose in life? The way 
you take care of yourself physically? Your sleep? Your spirituality? How well you work at school? 
 Do you have problems walking about? 
 Do you have problems washing or dressing yourself? 
 Do you have problems performing your usual activities? 
 Do you have pain or discomfort? 
 Do you feel worried sad or unhappy? 
 Would you participate in an online social network or online support group specifically for those 
that know someone who attempted suicide, died by suicide, or that care about suicide 
prevention in general? 
 [If yes] For what purposes would you use the online social network or support group? 
 
 ¿Conoce a alguien que se haya suicidado? 
 Sin incluirle a usted, ¿conoce a alguien que haya intentado suicidarse? 
 ¿Se considera usted un/a sobreviviente a una pérdida por suicidio? Eso significa, ¿alguien cuya 
vida haya sido personalmente afectada por un suicidio? 
 ¿Qué efecto tuvo el intento de suicidio en su vida? 
 ¿El suicidio/intento de suicidio tuvo un efecto en su salud emocional, mental, o física en general 
en algún momento?  
 [En  caso afirmativo] ¿Por cuánto tiempo se vio su salud general afectada?  
 ¿De qué forma se siente usted que cambió o no cambió por el suicidio/intento de suicidio? 
¿Cuán claramente usted piensa o se concentra? ¿Cómo se siente emocionalmente? ¿Su vida 
social? ¿Sus metas y propósitos en su vida? ¿La forma en que usted se cuida físicamente? ¿Su 
sueño? ¿Su espiritualidad? ¿Qué tan bien trabaja en la escuela? 
 ¿Tiene usted problemas para caminar? 
 ¿Tiene usted problemas para lavarse o vestirse solo/a? 
 ¿Tiene usted problemas para realizar sus actividades habituales? 
 ¿Tiene usted dolor o incomodidad? 
 ¿Se siente usted preocupado/a, triste, o infeliz? 
 ¿Participaría usted en una red social en línea o en un grupo de apoyo en línea específicamente 
para aquellos que conozcan a alguien que haya intentado suicidarse, se suicidara, o que le 
preocupe la prevención del suicidio en general? 
 [En caso afirmativo] ¿Con qué propósitos utilizaría usted la red social o el grupo de apoyo en 
línea? 
 
 
 
[SHOW IF QS9=1,2; SP] 
QS11 
 
Would you now be willing to have a teenager in your household complete this survey? 
¿Estaría dispuesto ahora a que un adolescente de su hogar complete esta encuesta? 
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1. Yes 
2. No  
 
1. Sí 
2. No 
 
[IF S_AMS_SWEEP=1] 
CHECKBOX 
SCONSENT 
[IF CAWI] 
 
 
[Note to TQA: If SCONSENT=1, create a Sweepstake entry in PIMS when complete or screen-out. If 
SCONSENT=2, do NOT create sweepstakes entry but proceed to survey] 
 
 
[IF S_AMS_SWEEP=1] 
[IF CATI] 
[IF P_PARENT = 2] Before we get started, we have the following question for you. 
[IF P_PARENT = 2] Antes de comenzar, tenemos la siguiente pregunta para usted. 
 
[IF P_PARENT = 1] We’re almost done with your part!  
[IF P_PARENT = 1] ¡Ya casi terminamos con su parte! 
 
[SHOW ALL] 
As mentioned previously, you will also be entered into the Wintry Holiday Sweepstakes for a chance to 
win $500. Please read the statement below carefully and check the box in order to be entered into the 
Wintry Holiday Sweepstakes.  
 
¡Ya casi terminamos! Como mencionamos anteriormente, usted también participará en el Sorteo Wintry 
Holiday por la posibilidad de ganar $500. Por favor lea cuidadosamente la siguiente oración y marque la 
casilla para poder participar en el Sorteo Wintry Holilday.   
 
Click “Continue” if you do not want to be entered into the sweepstakes.  
Haga clic en "Continuar" si no desea participar en el sorteo. 
 
  Yes, I would like to enter the sweepstakes and I agree to be bound by the terms of  
 the Official Rules and Privacy Policy. (With the underlined words linking to the respective 
terms.) 
 
Sí, me gustaría participar en los sorteos y acepto los términos de la Normativa Oficial y Política de 
Privacidad. (Las palabras subrayadas tienen enlace a los respectivos términos.) 
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[Note to TQA: If SCONSENT=1, create a Sweepstake entry in PIMS when complete or screen-out. If 
SCONSENT=2, do NOT create sweepstakes entry but proceed to survey] 
 
 
 
[IF (QS1 = 0,77,98,99) or  
(QS2=0,77,98,99) or  
(QS3 = 77, 98, 99) or  
(QS4 = 77, 98, 99) or  
(PCONSENT>1 and (QS8 = 2, 77, 98, 99 or QS9 = 3, 77, 98, 99 or QS11=2, 77, 98, 99)), TERMINATE] 
 
TERMINATE instruction should be short hand for: 
 SET QUAL=2, CO_DATE 
 GO TO TERMSORRY0 
 No back (disable browser back button) 
 auto redirect to member portal after 10 seconds 
[NO PIMS TRANSACTION] 
 
 
TERMSORRY0.   
[CAWI] Thank you for your time today and your consideration in letting your teen participate in this 
AmeriSpeak survey. We value your opinion and hope that you will participate in future AmeriSpeak 
surveys.  
[IF P_PARENT = 2] Before we get started, we have the following question for you. 
[IF P_PARENT = 2] Antes de comenzar, tenemos la siguiente pregunta para usted. 
 
[IF P_PARENT = 1] We’re almost done with your part!  
[IF P_PARENT = 1] ¡Ya casi terminamos con su parte! 
 
[SHOW ALL] 
As mentioned previously, you will also be entered into the Wintry Holiday Sweepstakes for a chance to 
win $500.  
 
¡Ya casi terminamos! Como mencionamos anteriormente, usted también participará en el Sorteo Wintry 
Holiday por la posibilidad de ganar $500.  
 
Do you agree to be bound by the Official Rules, which are available at rules.promotrust.com/holiday?  
 
¿Está de acuerdo en estar sujeto a las Reglas Oficiales, las cuales están disponibles en 
rules.promotrust.com/holiday? 
 
1. Yes, agree – create sweepstakes entry 
2. No, does not agree – do not create sweepstakes entry 
 
1. Sí, está de acuerdo – cree entrada para sorteos 
2. No, no está de acuerdo – no creer entrada para sorteos 
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[CAWI] Muchas gracias por su tiempo hoy y por su consideración de dejar participar a su hijo/a 
adolescente en esta encuesta de AmeriSpeak. Valoramos su opinión y esperamos que usted participe en 
futuras encuestas de AmeriSpeak. 
 
[IF QS8=1, INSERT: If your child knows someone who has died by suicide or attempted suicide and is 
struggling, a good resource is the website yourlifeyourvoice.org. This is a place where your child can talk 
with someone to get help and learn about other teens working through their life struggles.]    
[IF QS8=1, INSERT: Si su hijo/a conoce a alguien que se haya suicidado o haya intentado suicidarse y está 
luchando, un buen recurso es el sitio web yourlifeyourvoice.org. Este es un lugar en el cual su hijo/a 
puede hablar con alguien para recibir ayuda y conocer más sobre otros adolescentes y sus batallas de 
vida.] 
 
[CAWI] We will redirect you to the AmeriSpeak Member Portal in [n] seconds. 
[CAWI] Lo/a re direccionáremos al Portal de Usuario de AmeriSpeak en [n] segundos. 
 
[CATI] Thank you for your time today and your consideration in letting your teen participate in this 
AmeriSpeak survey. We will be in touch when your next survey is available. Have a great day/evening. 
[CATI] Muchas gracias por su tiempo hoy y por su consideración de dejar participar a su hijo/a 
adolescente en esta encuesta de AmeriSpeak. Estaremos en contacto cuando su próxima encuesta se 
encuentre disponible. Que tenga un buen día/ noche. 
 
[[CATI] ONLY OFFER THIS IF PROMPTED BY RESPONDENT:  We are looking to interview a teen age 15 to 
17 for this study and we need your consent to interview them. We appreciate your time and will be in 
touch with your next survey soon.]  
[[CATI] ONLY OFFER THIS IF PROMPTED BY RESPONDENT: Estamos interesados en entrevistar a un 
adolescente de entre 15 y 17 años para este estudio y necesitamos su consentimiento para entrevistarle. 
Le agradecemos por su tiempo y estaremos en contacto con su próxima encuesta pronto.] 
[SET QUAL=2 “Not Qualified” and END INTERVIEW, no incentive given] 
[REMOVE “PREVIOUS” BUTTON FROM PAGE]  
[CAWI NO BACK – disable web browser back button] 
CAWI auto-redirect to MEMBER PORTAL in 10 seconds, display remaining number of seconds in [n] 
 
 
 
[SHOW IF P_PARENT =1; SP; PROMPT] 
QS12.  
Could you please provide your current mailing address so that we can mail a gift card to your child if 
they end up participating in the survey? 
¿Podría usted por favor proporcionarnos su actual dirección de correo para poder enviarle una tarjeta 
de regalo a su hijo/a si decide participar en la encuesta? 
 
Current mailing address:  
Address 1 [HOMEADD1] 
Address 2 [HOMEADD2] 
City [HOMEADDCITY] 
State [HOMEADDSTATE] 
Zip code [HOMEADDZIP] 
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Dirección de correo actual:  
Dirección 1 [HOMEADD1] 
Dirección 2 [HOMEADD2] 
Ciudad  [HOMEADDCITY] 
Estado  [HOMEADDSTATE] 
Código postal [HOMEADDZIP] 
 
 
 
[SHOW IF P_PARENT =1; SP; PROMPT] 
QS13.  
Is [TNAME] currently available to take the survey? 
¿Está [TNAME]  actualmente disponible para realizar la encuesta? 
 
1. Yes 
2. No, but available at a later time 
 
1. Sí 
2. No, pero estará disponible más tarde 
 
 
[SHOW IF P_ PARENT =1 AND QS13=1] 
[DISPLAY2] 
[CAWI] Please have [TNAME] come to the computer right now to take the survey. 
[CAWI] Por favor pídale a [TNAME]  que venga ahora a la computadora para completar la 
encuesta.  
 
[CATI] Please have [TNAME] come to the phone right now to take the survey.  
[CATI] Por favor pídale a [TNAME] que venga ahora alteléfono para completar la encuesta. 
 
 
 
[SHOW IF P_PARENT =1 AND QS13>1; DISPLAY3]  
[Remove “Previous” and “Continue” buttons from screen] [NO BACK] 
Please have [TNAME] take the survey as soon as possible. They can access the survey through your 
Member Portal.   Please remind [TNAME] to take only this survey and not to complete any other 
surveys. 
Por favor pídale a [TNAME] que complete la encuesta lo antes posible. Pueden acceder a la encuesta a 
través del Portal de Usuario. Por favor recuérdele a [TNAME] que sólo complete esta encuesta y que no 
complete otras encuestas. 
 
[set qual=3 “in progress”] 
[SET POINT OF RETURN=S12] 
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SET IF P_PARENT =1 INSERT SECTION TIMESTAMP: TIME_PARENEN, DATE_PARENEN 
 
 
SET IF P_PARENT = 1 INSERT TIMESTAMP: TIME_TEENST, DATE_TEENST 
 
 
*At this point, the teen is the respondent* 
 
 
[SHOW IF QS13=1] [SP] 
LANGSWITCHTN 
[CAWI VERSION] 
Would you like to take this survey in English or Spanish? 
¿ Le gustaría tomar esta encuesta en inglés o español? 
 
3. English/Inglés 
4. Spanish/Español 
 
[CATI VERSION] 
We are offering this survey in both English and Spanish.  Which would you prefer? 
 Estamos ofreciendo esta encuesta en inglés y español. ¿Cuál preferiría? 
1.      Continue 
1.      Continuar 
  
IF LANGSWITCH=1, 77, 98, 99 continue in English (EN) 
IF LANGSWITCH=2, switch to Spanish language version of the survey (ES) 
 
 
[SHOW IF QS13=1; DISPLAY] 
TEENTRANSITION. 
Welcome to today’s Amerispeak survey [IF QS2>1 or S5=1, FILL:  : TNAME]! Your parent has invited you 
to participate in a special survey for teens just like you through the AmeriSpeak Panel conducted by 
NORC at the University of Chicago.  We will start off with a few short questions to make sure we have 
the right survey for you. You will need to answer these next couple of questions for us to know whether 
you can participate in the survey. 
Bienvenido/a a la encuesta de Amerispeak de hoy [IF QS2>1 or S5=1, FILL:  : TNAME]! Su padre/madre le 
ha invitado a participar en una encuesta especial para adolescentes como usted a través del Panel de 
AmeriSpeak realizado por NORC de la Universidad de Chicago.  Comenzaremos con unas breves 
preguntas para asegurarnos que tenemos la encuesta correcta para usted. Usted necesitará contestar 
las siguientes preguntas para saber si usted puede participar en esta encuesta. 
 
 
 
*Adults (P_PARENT=2) will start here directly* 
Q1.   
[IF P_PARENT=2, INSERT: “The next couple of questions are necessary for you to answer so that we can 
determine whether you are able to participate in this study.”] 
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[IF P_PARENT=2, INSERT: “Es necesario que usted responda las siguientes preguntas para poder 
determinar si usted puede participar en este estudio.”] 
 
Do you know someone who died by suicide? 
¿Conoce a alguien que se haya suicidado? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
[SHOW IF Q1=2, 77, 98, 99] 
[SP] 
Q2.   
Not including yourself, do you know someone who has attempted suicide?   
Sin incluirle a usted, ¿conoce a alguien que haya intentado suicidarse? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
 
[SHOW IF Q1=1 or (P_PARENT=1 and Q2=1); SP, prompt] 
CONSENT. 
[CAWI]<u>Title of the Study:</u> 
[CAWI]<The Impact of Suicide on Others 
[CAWI]<u>Título de este Estudio:</u> 
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[CAWI]<El Impacto del Suicidio en los Demás 
 
<u>Consent:</u> 
You are invited to take [CAWI: a survey; CATI: this survey “The Impact of Suicide on Others”] which is to 
help researchers understand the impact of knowing someone who died by suicide [IF P_PARENT=1, 
INSERT: “or who attempted suicide.”].  You will be asked about your relationship with the person who 
died, and how the suicide affected you emotionally, mentally, and physically.  [IF P_PARENT=2, INSERT: 
“The survey should take about 12-15 minutes.“] [IF P_PARENT=1, INSERT: “The survey should take about 
5 minutes. Even if your parent has given permission for you to take this survey, <i>you do not have to 
take it and no one will be mad if you do not take it.</i> Your parents will not have access to your survey 
answers.”] 
<u>Consent:</u> 
Usted está invitado/a a realizar [CAWI: una encuesta; CATI: esta encuesta “El Impacto del Suicidio en los 
Demás”] el cual permitirá a los investigadores comprender el impacto de conocer a alguien que se haya 
suicidado [IF P_PARENT=1, INSERT: “o haya intentado suicidarse.”]  Se le preguntará a usted sobre su 
relación con la persona que murió, y cómo el suicidio afectó a usted emocionalmente, mentalmente, y 
físicamente.  [IF P_PARENT=2, INSERT: “La encuesta tomará entre 12-15 minutos.“] [IF P_PARENT=1, 
INSERT: “La encuesta tomará entre 5 minutos. Aunque su padre/madre le haya dado permiso para que 
realice la encuesta,  <i>usted no tiene que realizarla y nadie se enojará si no lo hace.</i> Sus padres no 
tendrán acceso a las respuestas de sus encuestas.”] 
 
<u>Benefits</u> 
Although you may learn of ways to get help with your feelings about someone's death [IF P_PARENT=1, 
INSERT: “or attempt”], there are no direct benefits to you for participating in this survey. Your answers 
might help researchers better understand the total impact of suicide in the United States and how to 
better help people who know someone who died by suicide [IF P_PARENT=1, INSERT: “or attempted 
suicide”]. The researchers plan to publish their overall findings. 
<u>Beneficios</u> 
Aunque usted puede aprender formas de ayudar con sus sentimientos sobre la muerte de alguien [IF 
P_PARENT=1, INSERT: “ o intento”], no hay beneficios directos para usted por participar de este estudio. 
Sus respuestas pueden ser útiles para que los investigadores comprendan mejor el impacto total del 
suicidio en los Estados Unidos y cómo ayudar mejor a las personas que conocen a alguien que se haya 
suicidado [IF P_PARENT=1, INSERT: “ o intentó suicidarse”]. Los investigadores planean publicar sus 
hallazgos generales. 
 
<u>Risks</u> 
You might feel bad or sad as you answer questions that make you think about a person you know who 
died by suicide [IF P_PARENT=1, INSERT: “or attempted suicide”]. Other than this there is minimal risk in 
taking this survey. It is possible, but very unlikely that someone can find out about your participation in 
this study. To help minimize this risk, your privacy is protected according to the AmeriSpeak privacy 
policy (amerispeak.org/privacy).  
<u>Riesgos</u> 
Usted puede sentirse mal o triste al responder preguntas que le hagan pensar en una persona que usted 
conoce que se haya suicidado [IF P_PARENT=1, INSERT: “ o intentó suicidarse”]. Más allá de eso, hay un 
riesgo mínimo al realizar esta encuesta. Es posible, pero muy improbable que alguien pueda averiguar 
sobre su participación en este estudio. Para ayudar a minimizar el riesgo, su privacidad es protegida de 
acuerdo a la política de privacidad de AmeriSpeak (amerispeak.org/privacy). 
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<u>Confidentiality and Storage</u> 
All survey and interview responses will remain confidential. Your personal identifying information will 
not be shared with the researchers outside of AmeriSpeak who are conducting this research. If you 
complete the survey, your answers will be stored for potential future research. If you do not finish the 
survey, or you desire to withdraw your responses to the survey, any information you provide will not be 
used for research.  
<u>Confidencialidad y Almacenamiento</u> 
Todas las respuestas a las encuestas y entrevistas serán confidenciales. Su información personal 
identificación no será compartida por los investigadores fuera de AmeriSpeak, quienes están realizando 
esta encuesta. Si usted completa la encuesta, sus respuestas serán almacenadas para una futura posible 
investigación. Si usted no termina la encuesta, o usted desea retirar las respuestas de la encuesta, toda 
la información que usted brinde no será utilizada para investigación. 
 
To further help us protect your privacy, we have applied for a Certificate of Confidentiality from the 
National Institutes of Health. The researchers can use this Certificate to legally refuse to disclose 
information that may identify you in any federal, state, or local civil, criminal, administrative, legislative, 
or other proceedings, for example, if there is a court subpoena.  
Para ayudar a proteger su privacidad, hemos solicitado un Certificado de Confidencialidad del Instituto 
Nacional de Salud. Los investigadores pueden usar este Certificado para negarse legalmente a divulgar 
información que pueda identificarle en cualquier tipo de proceso civil, penal, administrativo, legislativo 
o de cualquier otro tipo a nivel federal, estatal, o local, si hay una orden judicial. 
 
<u>Compensation</u> 
[IF P_PARENT=1] You will be compensated for your time with a $5 Amazon gift card mailed to your 
house. 
[IF P_PARENT=2] You will be compensated according to the AmeriSpeak award system. 
<u>Compensación</u> 
[IF P_PARENT=1] Usted será compensado por su tiempo con una tarjeta de regalo de $5 de Amazon que 
será enviada por correo a su casa 
[IF P_PARENT=2] Usted será compensado/a de acuerdo al sistema de recompensas de AmeriSpeak. 
 
<u>Other Support Resources</u> 
If you ever need extra support or help with your feelings of loss you can visit the American Foundation 
for Suicide Prevention website: afsp.org/find-support. Alliance of Hope also offers support online: 
allianceofhope.org. Youth can also visit the following website: yourlifeyourvoice.org.  
<u>Otros Recursos de Ayuda</u> 
Si en algún momento necesita ayuda adicional con sus sentimientos de pérdida, usted puede visitar el 
sitio web de la Fundación Estadounidense de Prevención del Suicidio: afsp.org/find-support. Alianza de 
Esperanza también ofrece apoyo en línea: allianceofhope.org. Los jóvenes también pueden visitar el 
siguiente sitio web: yourlifeyourvoice.org. 
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<u>Voluntary nature of study</u> 
Participating in this study is completely voluntary. Even if you decide to participate, you may change 
your mind and stop at any time. You do not have to answer any question that you do not feel 
comfortable answering.  
<u>Naturaleza voluntaria del estudio</u> 
La participación en este estudio es completamente voluntaria. Aún si decide participar, usted puede 
cambiar de opinión y detenerse en cualquier momento. Usted no tiene que contestar aquellas 
preguntas que le hagan sentir incómodo/a. 
 
AmeriSpeak is conducting this study to support researchers at the University of Michigan: John 
Richardson, MPH; Daniel Eisenberg, PhD; Cheryl King, PhD; Lisa Prosser, PhD, MS; and David Hutton, 
PhD. This study is funded with a grant from the American Foundation for Suicide Prevention. The 
researchers at University of Michigan will only be analyzing de-identified results of this survey as a 
whole, and will not be able to link results to individual AmeriSpeak members. 
AmeriSpeak está realizando este estudio para apoyar a los investigadores de la Universidad de Michigan: 
John Richardson, MPH; Daniel Eisenberg, PhD; Cheryl King, PhD; Lisa Prosser, PhD, MS; y David Hutton, 
PhD. Este estudio es financiado por una beca de la Fundación Estadounidense de Prevención del 
Suicidio. Los investigadores de la Universidad de Michigan sólo estarán analizando resultado no 
identificación de esta encuesta en su totalidad, y no podrán vincular los resultados con los miembros 
individuales de AmeriSpeak. 
 
If you have any questions, concerns, or negative experiences with this survey, please contact the 
AmeriSpeak Support at support@AmeriSpeak.org or call (888) 326-9424 
Si usted tiene preguntas, inquietudes, o experiencias negativas con esta encuesta, por favor contacte al 
Equipo de Apoyo de AmeriSpeak a ayuda@AmeriSpeak.org o llame al (888) 326-9424 
 
If you have questions about your rights taking this survey as a member of AmeriSpeak, or if you have 
questions or concerns about this study and you want to talk with someone other than the researchers, 
please contact April Baker who works at the NORC Institutional Review Board, 55 E Monroe St, 20th 
Floor, Chicago IL 60603, email: baker-april@norc.org, phone: (312) 759-4014. 
Si usted tiene preguntas sobre sus derechos al realizar esta encuesta como miembro de AmeriSpeak, o si 
usted tiene preguntas o preocupaciones sobre este estudio y usted quiere hablar con alguien que no 
sean los investigadores, por favor contacte a April Baker quien trabaja en el Consejo de Revisión 
Institucional de NORC,  55 E Monroe St,  Piso 20, Chicago IL 60603, correo electrónico: baker-
april@norc.org, teléfono: (312) 759-4014. 
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[CAWI] Below, please choose whether you agree to participate in the study or whether you do not want 
to participate in this study. If you agree to participate, <u>please print, save, or email yourself a copy of 
this page for your records.</u> 
[CATI] Please tell me whether you agree to participate in the study or whether you do not want to 
participate in this study. If you agree to participate, <u>I can email you a copy of this consent 
information for your records.</u> 
[CAWI] A continuación, por favor elija si está de acuerdo en participar en el estudio o si no desea 
participar en el estudio. Si usted está de acuerdo en participar, <u>por favor imprima, guarde, o envíese 
por correo electrónico una copia de esta página para sus registros.</u> 
[CATI] Por favor dígame si usted desea participar en el estudio o si no desea participar en el estudio. Si 
usted desea participar, <u>puedo enviarle a usted por correo electrónico una copia de esta información 
de consentimiento para sus registros.</u> 
 
 
CAWI RESPONSE OPTIONS: 
1. I agree to participate in the study 
2. I do NOT agree, and I will NOT take this survey 
 
1. Estoy de acuerdo en participar en el estudio. 
2. NO estoy de acuerdo, y NO realizaré esta encuesta 
 
CATI RESPONSE OPTIONS: 
1. AGREE TO PARTICIPATE 
2. DO NOT AGREE 
 
1. DE ACUERDO EN PARTICIPAR 
2. NO DE ACUERDO 
 
 
*eligibility criteria: 
Teen who knows someone who died by suicide, or knows someone who attempted, plus consent 
Adult who knows someone who died by suicide, plus consent 
 
[IF  (P_PARENT=1 and Q2=2, 77, 98, 99) or (P_PARENT=2 and Q1=2, 77, 98, 99) or (CONSENT=2, 77, 98, 
99), TERMINATE] 
 
TERMINATE instruction should be short hand for: 
 SET QUAL=2, CO_DATE 
 GO TO TERMSORRY 
 No back (disable browser back button) 
 auto redirect to member portal after 10 seconds 
[NO PIMS TRANSACTION] 
 
 
TERMSORRY.   
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[CAWI] Thank you for your time today. Unfortunately you are not eligible for this study. We value your 
opinion and hope that you will participate in future AmeriSpeak surveys. Thank you for your time today. 
[CAWI] Gracias por su tiempo hoy.  Desafortunadamente no es elegible para este estudio.  Valoramos su 
opinión y esperamos que usted participe en futuras encuestas de AmeriSpeak. Gracias por su tiempo 
hoy. 
 
[CAWI] We will redirect you to the AmeriSpeak Member Portal in [n] seconds. 
[CAWI] Lo/a re direccionáremos al Portal de Usuario de AmeriSpeak en [n] segundos. 
 
[CATI] Thank you for your time today. Unfortunately you are not eligible for this study. Thank you so 
much for your participation. We will be in touch when your next survey is available. Have a great 
day/evening. 
[CATI] Gracias por su tiempo hoy.  Desafortunadamente no es elegible para este estudio.  Muchas 
gracias por su participación. Estaremos en contacto cuando su próxima encuesta se encuentre 
disponible. Que tenga un buen día/ noche. 
 
[[CATI] , ONLY OFFER THIS IF PROMPTED BY RESPONDENT:  I mentioned earlier that we would complete 
the survey if you were eligible, and it appears that you are not for this particular survey.  We appreciate 
your time and will be in touch with your next survey soon.]  
[[CATI] , ONLY OFFER THIS IF PROMPTED BY RESPONDENT:  Mencioné anteriormente que 
completaríamos la encuesta si usted era elegible, y al parecer usted no lo es para esta encuesta en 
particular.  Le agradecemos por su tiempo y estaremos en contacto con su próxima encuesta pronto.]  
[SET QUAL=2 “Not Qualified” and END INTERVIEW, no incentive given] 
[REMOVE “PREVIOUS” BUTTON FROM PAGE]  
[CAWI NO BACK – disable web browser back button] 
CAWI auto-redirect to MEMBER PORTAL in 10 seconds, display remaining number of seconds in [n] 
 
 
[DISPLAY4] 
[CAWI] Thank you for agreeing to participate in this important study. Please remember that this survey 
can touch on difficult topics so please feel free to take a break and return to finish the survey as 
necessary. 
[CAWI] Gracias por estar de acuerdo en participar en este importante estudio. Por favor recuerde que 
esta encuesta puede tocar temas difíciles así que por favor no dude en tomar un descanso y volver a 
finalizar la encuesta según sea necesario. 
[CATI] Thank you for agreeing to participate in this important study. Please remember that this survey 
can touch on difficult topics so please feel free to take a break and we can return to finish the survey as 
necessary. 
[CATI] Gracias por estar de acuerdo en participar en este importante estudio. Por favor recuerde que 
esta encuesta puede tocar temas difíciles así que por favor no dude en tomar un descanso y podemos 
volver a finalizar la encuesta según sea necesario. 
 
*teens (P_PARENT=1) will see a subset of the same Qs the adults (P_PARENT=2) see* 
**teens who know someone who died by suicide see the same Qs as teens who know someone who 
attempted** 
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[SHOW IF P_PARENT=2] [NUMBOX] 
Q3. 
How many people do you know who died by suicide? 
¿Cuántas personas conoces que se hayan suicidado? 
[CATI] ACCEPTABLE RANGE 0-100 
 
[NUMBOX; ACCEPT NUMERIC RANGE 1-100; 777, 998, 999] 
 
 
[SHOW IF P_PARENT=2 AND Q3 <>777, 998, 999] [NUMBOX] 
Q3b. 
How many of these deaths happened in the past 10 years? 
¿Cuántas de estas muertes sucedieron en los últimos 10 años? 
[CATI] ACCEPTABLE RANGE 0-MAX(Q3 Response) 
 
[NUMBOX; ACCEPT NUMERIC RANGE 0-MAX(Q3 Response); 777, 998, 999] 
 
 
[SHOW IF Q3=2-100] 
[SP] 
Q4. 
Was the most recent suicide the one that impacted your life the most? 
¿Fue el más reciente suicidio el que más impactó a su vida? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
[SHOW IF Q4=2] 
[SP] 
Q5. 
What effect did the most recent suicide have on your life? 
 ¿Qué efecto tuvo en su vida el suicidio más reciente? 
 
RESPONSE OPTIONS: 
1. No effect 
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2. Little effect 
3. Moderate effect 
4. Large effect 
5. Extreme effect 
 
1. Sin efecto 
2. Poco efecto 
3. Efecto moderado 
4. Gran efecto 
5. Efecto extremo 
 
 
[SHOW IF Q3>1] 
DISPLAY – Q6 
For the rest of the survey, please answer all questions about the suicide <u>that impacted your life the 
most.</u> 
Para el resto de la encuesta, por favor responda todas las preguntas sobre el suicidio <u>que impacto 
más su vida.</u> 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q7. 
Who was the person that died by suicide? 
¿Quién fue la persona que se suicidó? 
 
RESPONSE OPTIONS: 
1. Sibling 
2. Spouse or partner 
3. Your child 
4. Your parent 
5. Grandparent 
6. Cousin 
7. Aunt or uncle 
8. Niece or nephew 
9. Friend that was not a family member 
10. Peer or colleague at school, work, or church that was not a friend 
11. Neighbor that was not a friend 
12. Celebrity 
13. Other (please specify): [SMALL TEXTBOX] 
 
1. Hermano 
2. Esposo o pareja 
3. Su hijo/a 
4. Su padre/madre 
5. Abuelo 
6. Prima/Primo 
7. Tío o tía 
8. Sobrino o sobrina 
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9. Amigo/a que no era miembro de su familia 
10. Compañero/a o colega de la escuela, trabajo, o escuela que no era su amigo/a 
11. Vecino que no era su amigo/a 
12. Celebridad 
13. Otro (por favor, especifíquelo:) [SMALL TEXTBOX] 
 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q8A. 
 
What was the person’s sexual orientation? 
¿Cuál era la orientación sexual de la persona? 
 
RESPONSE OPTIONS: 
1. Heterosexual/straight 
2. Gay/lesbian/homosexual 
3. Bisexual 
77. Not sure 
4. Decline to state 
 
1. Heterosexual 
2. Gay/lesbiana/homosexual 
3. Bisexual 
77. No estoy seguro 
4. Se niega a contestar 
 
 
[SHOW IF P_PARENT=2] [MP] 
Q9A. 
What was the person’s gender? (Please <u>select all that apply</u>) 
¿Cuál era el género de la persona? (Por favor <u>seleccione todas las que apliquen</u>) 
 
RESPONSE OPTIONS: 
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1. Male 
2. Female 
3. Transgender, Male-to-Female (MTF) 
4. Transgender, Female-to-Male (FTM) 
5. Transgender, did not identify as male or female 
77. Not sure [SP] 
6. Decline to state [SP] 
 
1. Masculino 
2. Femenino 
3. Transexual, Masculino -a-Femenino (MTF) 
4. Transexual, Femenino-a-Masculino (FTM) 
5. Transexual, no se identificaba como hombre ni como mujer 
77. No estoy seguro [SP] 
6. Se niega a contestar [SP] 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q10A. 
Approximately, what was the person’s age?  
Aproximadamente, ¿cuál era la edad de la persona? 
 
RESPONSE OPTIONS: 
1. Less than 18 
2. 18-24 
3. 25-44 
4. 45-64 
5. 65 or older 
77. Not sure 
 
1. Menos de 18 
2. 18-24 
3. 25-44 
4. 45-64 
5. 65 años o más 
77. No estoy seguro 
 
 
 
[SHOW IF P_PARENT=2] [TEXTBOX] [NUMBOX] 
[CAWI CUSTOM PROMPT: We would really like your answer to this question. Please provide your best 
guess if you do not remember exactly.] 
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[CAWI CUSTOM PROMPT: Realmente nos interesa su respuesta a esta pregunta. Por favor, brinde su 
mejor estimación, si no recuerda exactamente.] 
[CATI] IF RESPONDENT DOES NOT PROVIDE AN ANSWER TELL THEM IT IS OK TO PROVIDE AN ESTIMATE 
Q8. 
What month and year did the suicide happen? 
¿En qué mes y año sucedió el suicidio? 
 
Q8M. Month: [dropdown January – December] 
Q8Y. Year: [NUMBOX 1900 - 2017] 
Q8M. Meses: [dropdown January – December] 
Q8Y. Año: [NUMBOX 1900 - 2017] 
 
CALCULATE DATA-ONLY VARIABLE: TIMESINCE 
WHERE TIMESINCE= number of months between survey admin date and Q8M/Q8Y 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q9. 
[CAWI] The year before the death, how connected did you feel to the person on a scale of 1 to 7, where 
1 is low connectedness and 7 is high connectedness? Z in the figures below represents the person who 
died by suicide. 
[CAWI] El año anterior a la muerte, ¿cuán conectado/a se sentía usted con esa persona en una escala del 
1 al 7, donde 1 significa baja conexión y 7 significa alta conexión? Z en las siguientes cifras representa a 
la persona que se suicidó. 
 
[CATI] The year before the death, how connected did you feel to the person on a scale of 1 to 7, where 1 
is low connectedness and 7 is high connectedness? 
[CATI] El año anterior a la muerte, ¿cuán conectado/a se sentía usted con esa persona en una escala del 
1 al 7, donde 1 significa baja conexión y 7 significa alta conexión? 
 
RESPONSE OPTIONS: 
[SHOW IF LANGSWITCH = EN, 77, 98, 99] 
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[SHOW IF LANGSWITCH = ES] 
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FOR TRANSLATION ONLY 
Low Connectedness 
High Connectedness 
You 
Z 
Baja conexión 
Alta conexión 
Usted 
Z 
 
[PROGRAMMIING NOTE: EACH SET OF CIRCLES IS A RESPONSE OPTIONS] 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q10. 
The year before the death, how stressful was your relationship with the person? 
El año anterior a la muerte, ¿cuán estresante era su relación con esa persona? 
 
RESPONSE OPTIONS: 
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1. Extremely stressful 
2. Really stressful 
3. Moderately stressful 
4. A little stressful 
5. Not at all stressful 
 
1. Extremadamente estresante 
2. Realmente estresante 
3. Moderadamente estresante 
4. Un poco estresante 
5. Nada estresante 
 
 
 
[SHOW IF P_PARENT=2] [MP] 
Q11. 
[CAWI] Please mark any mental illnesses or drug use problems that the individual who died by suicide 
had. Please <u>select all that apply.</u> If the person had none that you were aware of, then mark 
"none that I know." 
[CAWI] Por favor marque cualquier enfermedad mental o problema con uso de drogas que tuviera la 
persona que se suicidó. Por favor <u>seleccione todas las que apliquen.</u> Si la persona no tenía 
ninguna que usted supiera, marque “ninguna que yo sepa.” 
 
[CATI] Please tell me any mental illnesses or drug use problems that the individual who died by suicide 
had.  
[CATI] Por favor dígame cualquier enfermedad mental o problema con uso de drogas que tuviera la 
persona que se suicidó. 
 
[CATI] SELECT ALL THAT APPLY 
[CATI] SELECCIONE TODAS LAS OPCIONES QUE CORRESPONDAN. 
[CATI] IF RESPONDENT SAYS NONE, THEN SELECT ‘NONE THAT YOU KNOW’ 
 
CAWI RESPONSE OPTIONS: 
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1. Depression 
2. Anxiety 
3. PTSD 
4. Bipolar Disorder 
5. Schizophrenia 
6. Alcohol use problems 
7. Opioid use problems 
8. Other drug use problems 
9. Autism 
10. Other (please specify): [SMALL TEXTBOX] 
11. None that I know [SP] 
 
1. Depresión 
2. Ansiedad 
3. TEPT (El trastorno de estrés postraumático)  
4. Trastorno bipolar 
5. Esquizofrenia  
6. Problemas por consumo de alcohol 
7. Problemas por consumo de opiáceos  
8. Problemas por consumo de otras drogas 
9. Autismo  
10. Otro (por favor, especifíquelo:) [SMALL TEXTBOX] 
11. Ninguna que yo sepa [SP] 
 
CATI RESPONSE OPTIONS: 
 
1. Depression 
2. Anxiety 
3. PTSD 
4. Bipolar Disorder 
5. Schizophrenia 
6. Alcohol use problems 
7. Opioid use problems 
8. Other drug use problems 
9. Autism 
10. Other (please specify): [SMALL TEXTBOX] 
11. None that you know [SP] 
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1. Depresión 
2. Ansiedad 
3. TEPT (El trastorno de estrés postraumático)  
4. Trastorno bipolar 
5. Esquizofrenia  
6. Problemas por consumo de alcohol 
7. Problemas por consumo de opiáceos  
8. Problemas por consumo de otras drogas 
9. Autismo  
10. Otro (por favor, especifíquelo:) [SMALL TEXTBOX] 
11. Ninguna que usted sepa [SP] 
 
 
[SHOW IF P_PARENT=2] [MP] 
Q12. 
[CAWI] Please mark any mental illnesses or drug use problems that <u>you had before the suicide 
happened.</u> Please select all that apply. If you had none that you were aware of, then mark "none 
that I know." 
[CAWI] Por favor marque cualquier enfermedad mental o problemas de abuso de drogas que <u>usted 
tenía antes de que ocurriera el suicidio.</u> Por favor seleccione todas las que aplique. Si usted no tenía 
ninguno que usted supiera, marque “ninguna que yo sepa.” 
 
[CATI] Please tell me any mental illnesses or drug use problems that <u>you had before the suicide 
happened.</u> 
[CATI] Por favor dígame cualquier enfermedad mental o problema con consumo de drogas que 
<u>usted tenía antes de que ocurriera el suicidio.</u> 
 
[CATI] SELECT ALL THAT APPLY 
[CATI] SELECCIONE TODAS LAS OPCIONES QUE CORRESPONDAN. 
[CATI] IF RESPONDENT SAYS NONE, THEN SELECT ‘NONE THAT YOU KNOW’ 
 
CAWI RESPONSE OPTIONS: 
1. Depression 
2. Anxiety 
3. PTSD 
4. Bipolar Disorder 
5. Schizophrenia 
6. Alcohol use problems 
7. Opioid use problems 
8. Other drug use problems 
9. Autism 
10. Other (please specify): [SMALL TEXTBOX] 
11. None that I know [SP] 
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1. Depresión 
2. Ansiedad 
3. TEPT (El trastorno de estrés postraumático)  
4. Trastorno bipolar 
5. Esquizofrenia  
6. Problemas por consumo de alcohol 
7. Problemas por consumo de opiáceos  
8. Problemas por consumo de otras drogas 
9. Autismo  
10. Otro (por favor, especifíquelo:) [SMALL TEXTBOX] 
11. Ninguna que yo sepa [SP] 
 
CATI RESPONSE OPTIONS: 
1. Depression 
2. Anxiety 
3. PTSD 
4. Bipolar Disorder 
5. Schizophrenia 
6. Alcohol use problems 
7. Opioid use problems 
8. Other drug use problems 
9. Autism 
10. Other (please specify): [SMALL TEXTBOX] 
11. None that you know [SP] 
 
1. Depresión 
2. Ansiedad 
3. TEPT (El trastorno de estrés postraumático)  
4. Trastorno bipolar 
5. Esquizofrenia  
6. Problemas por consumo de alcohol 
7. Problemas por consumo de opiáceos  
8. Problemas por consumo de otras drogas 
9. Autismo  
10. Otro (por favor, especifíquelo:) [SMALL TEXTBOX] 
11. Ninguna que usted sepa [SP] 
 
 
*SHOWN TO ALL Rs WHO KNOW SOMEONE WHO COMMITTED SUICIDE (Q1)* 
[SHOW Q1=1] [SP] 
Q13. 
Do you consider yourself a survivor of suicide loss? That is, someone whose life has been personally 
affected by a suicide? 
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¿Se considera usted un/a sobreviviente a una pérdida por suicidio? Eso significa, ¿alguien cuya vida haya 
sido personalmente afectada por un suicidio? 
 
[CATI] IF RESPONDENT SAYS YES: Would you say definitely yes or probably yes? 
[CATI] IF RESPONDENT SAYS NO: Would you say probably not or definitely not? 
[CATI] IF RESPONDENT SAYS YES: ¿Diría usted que definitivamente sí o probablemente sí? 
[CATI] IF RESPONDENT SAYS NO: ¿Diría usted que probablemente no o definitivamente no? 
 
CAWI RESPONSE OPTIONS: 
1. Definitely yes 
2. Probably yes 
3. Might or might not 
4. Probably not 
5. Definitely not 
 
1. Definitivamente sí 
2. Probablemente sí 
3. Puede ser que sí o que no 
4. Probablemente no 
5. Definitivamente no 
 
CATI RESPONSE OPTIONS: 
1. DEFINITELY YES 
2. PROBABLY YES 
3. MIGHT OR MIGHT NOT 
4. PROBABLY NOT 
5. DEFINITELY NOT 
 
1. DEFINITIVAMENTE SÍ 
2. PROBABLEMENTE SÍ 
3. PUEDE SER QUE SÍ O QUE NO 
4. PROBABLEMENTE NO 
5. DEFINITIVAMENTE NO 
 
 
 
[SHOW IF P_PARENT=2] [TEXTBOX] 
Q14. 
What have been the three strongest feelings you have had about the suicide? 
¿Cuáles han sido los tres sentimientos más fuertes que usted ha sentido sobre el suicidio? 
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Q14_1. Feeling 1: [SMALL TEXTBOX] 
Q14_2. Feeling 2: [SMALL TEXTBOX] 
Q14_3. Feeling 3: [SMALL TEXTBOX] 
 
Q14_1. Sentimiento 1: [SMALL TEXTBOX] 
Q14_2. Sentimiento 2: [SMALL TEXTBOX] 
Q14_3. Sentimiento 3: [SMALL TEXTBOX] 
 
 
*SHOWN TO ALL ELIGIBLE Rs* 
*FIRST SURVEY Q FOR TEENS (P_PARENT=1) WHO ONLY KNOW SOMEONE WHO ATTEMPTED SUICIDE* 
[SHOW ALL] [SP] 
Q15. 
[IF Q1=1] What effect did the death have on your life? [IF P_PARENT=1, INSERT: “If more than one 
suicide deaths have affected you, then think of the one that impacted you the most for this and all other 
questions in this survey.”] 
[IF Q2=1] The questions in this survey will be about the impact of someone else’s suicide attempt on 
you.  
[IF Q1=1] ¿Qué efecto tuvo la muerte en su vida? [IF P_PARENT=1, INSERT: “Si más de un suicidio le ha 
afectado, piense en el que tuvo mayor impacto para esta pregunta y el resto de las preguntas de esta 
encuesta.”] 
[IF Q2=1] Las preguntas en esta encuesta serán sobre el impacto del intento de suicidio de otra persona 
en usted. 
 
[IF Q2=1] What effect did the suicide attempt have on your life? If there have been more than one, then 
think about the one that impacted you the most for this and all other questions in the survey. 
[IF Q2=1] ¿Qué efecto tuvo el intento de suicidio en su vida? Si ha habido más de uno, piense en la que 
tuvo mayor impacto para esta pregunta y el resto de las preguntas de esta encuesta. 
 
RESPONSE OPTIONS: 
1. No effect 
2. Little effect 
3. Moderate effect 
4. Large effect 
5. Extreme effect 
 
1. Sin efecto 
2. Poco efecto 
3. Efecto moderado 
4. Gran efecto 
5. Extremo efecto 
 
 
*SHOWN TO ALL ELIGIBLE Rs* 
 [SHOW ALL] [SP] [PROMPT TWICE] 
 Q16. 
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 [IF P_PARENT=2 or (P_PARENT=1 and Q1=1)] Did the death have an effect on your overall emotional, 
mental, or physical health at any time?  
[IF P_PARENT=1 and Q2=1] Did the suicide attempt have an effect on your overall emotional, mental, or 
physical health at any time?  
[IF P_PARENT=2 or (P_PARENT=1 and Q1=1)] ¿Tuvo la muerte un efecto en su salud emocional, mental o 
física en general en algún momento?  
[IF P_PARENT=1 and Q2=1] ¿Tuvo el intento de suicidio un efecto en su salud emocional, mental o física 
en general en algún momento? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
 
[SHOW IF Q16=1] 
[SP] 
Q17. 
For how long was your overall health affected? This includes your <u>emotional, mental, and physical 
health</u>. 
¿Por cuánto tiempo se vio afectada su salud general? Esto incluye su <u>salud emocional, mental, y 
física</u>. 
 
CAWI RESPONSE OPTIONS: 
1. Less than 6 months 
2. 6 months to a year 
3. More than a year 
4. My overall health is still affected 
 
1. Menos de 6 meses 
2. De 6 meses a un año 
3. Más de un año 
4. Mi salud general aún está afectada 
 
CATI RESPONSE OPTIONS: 
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1. Less than 6 months 
2. 6 months to a year 
3. More than a year 
4. Your overall health is still affected 
 
1. Menos de 6 meses 
2. De 6 meses a un año 
3. Más de un año 
4. Su salud general aún está afectada 
 
 
*SHOWN TO TEENS (P_PARENT=1) and ADULTS (P_PARENT=2)* 
[GRID 4,4; SP] 
Q18. 
[CAWI] Please select in what ways you feel changed or not changed by the [IF P_PARENT=2 or 
(P_PARENT=1 and Q1=1), INSERT: death][IF P_PARENT=1 and Q2=1, INSERT: suicide attempt of the 
person you know]. 
[CAWI] Por favor selecciona en qué formas se siente usted cambiado/a o no cambiado/a por [IF 
P_PARENT=2 or (P_PARENT=1 and Q1=1), INSERT: la muerte][IF P_PARENT=1 and Q2=1, INSERT: el 
intento de suicidio de la persona que usted conoce]. 
 
 
[CATI] Please tell me in what ways you feel changed or not changed by the [IF P_PARENT=2 or 
(P_PARENT=1 and Q1=1), INSERT: death][IF P_PARENT=1 and Q2=1, INSERT: suicide attempt of the 
person you know]. 
[CATI] Por favor dígame en qué formas se siente usted cambiado/a o no cambiado/a por [IF 
P_PARENT=2 or (P_PARENT=1 and Q1=1), INSERT: la muerte][IF P_PARENT=1 and Q2=1, INSERT: el 
intento de suicidio de la persona que usted conoce]. 
 
CAWI GRID ITEMS: 
Q18_1. How clearly I think or focus 
Q18_2. The way I feel emotionally 
Q18_3. My social life 
Q18_4. My goals and purpose in life 
Q18_5. The way I take care of myself physically 
Q18_6. My sleep 
Q18_7. My spirituality 
Q18_8. How well I work at my job or school 
 
Q18_1. Qué tan claramente pienso o me concentro 
Q18_2. La forma en la que me siento emocionalmente 
Q18_3. Mi vida social 
Q18_4. Mis metas y propósito en la vida 
Q18_5. La forma en la que me cuido físicamente 
Q18_6. Mi sueño 
Q18_7. Mi espiritualidad 
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Q18_8. Qué tan bien trabajo en mi empleo o escuela 
 
CATI GRID ITEMS: 
Q18_1. How clearly you think or focus 
Q18_2. The way you feel emotionally 
Q18_3. Your social life 
Q18_4. Your goals and purpose in life 
Q18_5. The way you take care of yourself physically 
Q18_6. Your sleep 
Q18_7. Your spirituality 
Q18_8. How well you work at your job or school 
 
Q18_1. Qué tan claramente pienso o me concentro 
Q18_2. La forma en la que se siente emocionalmente 
Q18_3. Su vida social 
Q18_4. Sus metas y propósito en su vida 
Q18_5. La forma en la que se cuida físicamente 
Q18_6. Su sueño 
Q18_7. Su espiritualidad 
Q18_8. Qué tan bien trabaja en su empleo o escuela 
 
RESPONSE OPTIONS: 
1. Not changed 
2. Changed for a time 
3. Changed permanently 
 
1. No ha cambiado 
2. Cambió por un tiempo 
3. Cambió permanentemente 
 
 
[SHOW IF P_PARENT=2 and Q18_8=2,3] 
[NUMBOX] 
Q19. 
[CAWI] You indicated earlier that the suicide death impacted how well you worked at your job or at 
school. About how long was your performance at work or school affected? 
[CAWI] Usted indicó anteriormente que el suicidio impactó en lo bien que trabajaba en su empleo o 
escuela. ¿Durante cuánto tiempo se vio afectado su rendimiento en su empleo o escuela? 
 
[CATI] You said earlier that the suicide death impacted how well you worked at your job or at school. 
About how long was your performance at work or school affected? 
[CATI] Usted dijo anteriormente que el suicidio impactó en lo bien que trabajaba en su empleo o 
escuela. ¿Durante cuánto tiempo se vio afectado su rendimiento en su empleo o escuela? 
 
Weeks [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Months [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Years [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Semanas [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
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Meses [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Años [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
 
 
[SHOW IF P_PARENT=2 and Q18_8=2,3] 
[CAWI – HORIZONTAL SLIDING SCALE] 
[CATI – NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Q20. 
[CAWI] To what extent was your performance <u>at work or school</u> affected during this time?  
[CATI] To what extent was your performance <u>at work or school</u> affected during this time? Please 
tell me on a scale 0 to 100, where “0” is no effect, that is, you worked just as well as everyone else, and 
“100” is a large effect where you could not do any work. 
[CAWI] ¿En qué medida su rendimiento <u>en el trabajo o escuela</u> se vio afectado durante este 
tiempo?  
[CATI] ¿En qué medida su rendimiento <u>en el trabajo o escuela</u> se vio afectado durante este 
tiempo? Por favor dígame en una escala del 0 al 100, donde “0” es sin efecto, eso significa, que usted 
trabajó tan bien como el resto, y “100” es un gran efecto en el cual usted no pudo realizar ningún 
trabajo. 
 
 
 
 
 
FOR TRANSLATION ONLY 
Effect of suicide on work or school performance 
No effect I worked just as well as everyone else 
Large effect I could not do any work 
Efecto del suicidio en el rendimiento en el empleo o escuela 
Sin efecto, trabajé tan bien como el resto 
Gran efecto, no pude trabajar 
 
[PROGRAMMING NOTE: SLIDING SCALE RANGING FROM 0 TO 100, WITH 1 UNIT INCREMENTS] 
 
 
[SHOW IF P_PARENT=2 and Q18_8=2,3] 
[NUMBOX] 
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Q21. 
How many days or months of work or school did you miss because of the suicide?  
¿Cuántos días o meses de trabajo o escuela perdió usted a causa del suicidio? 
 
[CAWI] UNBOLD </B> <i> - Type “0” if you did not miss any days. </i> 
[CAWI] UNBOLD </B> <i> - Ingrese “0” si no perdió ningún día. </i> 
[CATI]: ENTER 0 IF RESPONDENTS DID NOT MISS ANY DAYS  
 
Days [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Months [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Días [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Meses [NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q22. 
How much are you having trouble accepting the death of the person that died by suicide? 
¿Cuán difícil le está resultando aceptar la muerte de la persona que se suicidó? 
 
RESPONSE OPTIONS: 
1. Not at all 
2. Somewhat 
3. A lot 
 
1. Nada en absoluto 
2. Algo 
3. Mucho 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q23. 
How much does your grief still interfere with your life? 
¿Cuánto interfiere aún su duelo con su vida? 
 
RESPONSE OPTIONS: 
1. Not at all 
2. Somewhat 
3. A lot 
 
1. Nada en absoluto 
2. Algo 
3. Mucho 
 
 
[SHOW IF P_PARENT=2] [SP] 
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Q24. 
How much are you having images or thoughts of when the person died by suicide or other thoughts 
about the death that really bother you? 
¿En qué medida está teniendo imágenes o pensamientos del momento en que la persona se suicidó o 
pensamientos sobre la muerte que realmente le perturban? 
 
RESPONSE OPTIONS: 
1. Not at all 
2. Somewhat 
3. A lot 
 
1. Nada en absoluto 
2. Algo 
3. Mucho 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q25. 
Are there things you used to do when the person was alive that you don’t feel comfortable doing 
anymore, that you avoid? Like going somewhere you went with him/her, or doing things you used to 
enjoy together? Or avoiding looking at pictures or talking about the person? How much are you avoiding 
these things? 
¿Hay cosas que usted solía hacer cuando la persona estaba viva que ahora ya no se siente cómodo/a 
haciendo, y que evita? ¿Como ir a algún lugar que solía ir con él/ella,  o hacer cosas que solían hacer 
juntos? ¿O evitar mirar fotos o hablar de la persona? ¿En qué medida está usted evitando estas cosas? 
 
RESPONSE OPTIONS: 
1. Not at all 
2. Somewhat 
3. A lot 
 
1. Nada en absoluto 
2. Algo 
3. Mucho 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q26. 
How much are you feeling cut off or distant from other people since the person died, even people you 
used to be close to like family or friends? 
¿En qué medida se está sintiendo usted desconectado/a o distante de otras personas desde que la 
persona murió, aún de personas con las que usted era cercano/a, como familiares o amigos? 
 
RESPONSE OPTIONS: 
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1. Not at all 
2. Somewhat 
3. A lot 
 
1. Nada en absoluto 
2. Algo 
3. Mucho 
 
[SHOW IF P_PARENT=2] [SP] 
Q27. 
Before the suicide, had you ever thought about killing yourself? 
Antes del suicidio, ¿había pensado alguna vez en quitarse la vida? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
 
[SHOW IF P_PARENT=2] [SP] 
Q28. 
Since the suicide happened, have you ever thought about killing yourself? 
Desde que ocurrió el suicidio, ¿ha pensado alguna vez en quitarse la vida? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
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[SHOW IF Q27=1 OR Q28=1] 
DISPLAY – Q29 
 
[CAWI] You have marked that you have had thoughts of killing yourself at some time in your life. Many 
people who know someone who died by suicide also have thoughts of dying by suicide themselves. 
[CAWI] Usted ha marcado que ha tenido pensamientos sobre quitarse la vida en algún momento de su 
vida. Muchas personas que conocen a alguien que se ha suicidado, también han tenido pensamientos de 
suicidarse. 
 
[CATI] You have said that you have had thoughts of killing yourself at some time in your life. Many 
people who know someone who died by suicide also have thoughts of dying by suicide themselves. 
[CATI] Usted ha dicho que ha tenido pensamientos sobre quitarse la vida en algún momento de su vida. 
Muchas personas que conocen a alguien que se ha suicidado, también han tenido pensamientos de 
suicidarse. 
 
We hope you are feeling okay right now, and we want you to get help and support in any of your current 
struggles. 
Esperamos que usted se está sintiendo bien ahora, y queremos que usted reciba ayuda y apoyo en 
cualquiera de sus batallas actuales. 
 
If you are currently struggling with thoughts of suicide, <u>PLEASE</u> visit this website to see what 
help and support you can get right now: suicidepreventionlifeline.org. You can also call the national 
suicide prevention lifeline at 1-800-273-8255 to talk with someone about your thoughts and struggles 
with life. They will listen. They will help. 
Si usted está actualmente batallando con  pensamientos suicidas, <u>POR FAVOR</u> visite este sitio 
web para ver qué ayuda y apoyo usted puede recibir ahora: suicidepreventionlifeline.org. Usted también 
puede llamar a la línea de prevención del suicidio al 1-888-628-9454 para hablar con alguien sobre sus 
pensamientos y batallas en su vida. Ellos escucharán. Ellos le ayudarán. 
 
Youth can also visit the following website: yourlifeyourvoice.org. 
Los jóvenes también pueden visitar el siguiente sitio web: yourlifeyourvoice.org. 
 
 
 
[SHOW IF P_PARENT=2 and Q16=1] 
DISPLAY – Q30 
[CAWI] You marked earlier that the death affected your emotional, mental, or physical health. 
[CAWI] Usted marcó anteriormente que la muerte le afectó su salud emocional, mental, o física. 
 
[CATI] You said earlier that the death affected your emotional, mental, or physical health. 
[CATI] Usted dijo anteriormente que la muerte le afectó su salud emocional, mental, o física. 
 
The following questions will ask you about your overall health before the suicide occurred and at 
different time intervals after the suicide occurred. 
Las siguientes preguntas le consultarán sobre su salud general antes de que ocurriera el suicidio y en 
diferentes intervalos de tiempo después que el suicidio ocurrió. 
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[SHOW IF P_PARENT=2 and Q16=1] 
[CAWI – HORIZONTAL SLIDING SCALE] 
[CATI – NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Q31. 
[CAWI] <u>The year before the suicide</u>, how was your overall health? Please indicate your response 
on the scale below. 
[CAWI] <u>El año anterior al suicidio</u>, ¿cómo era su salud general? Por favor indique su respuesta 
en la siguiente escala. 
 
[CATI] <u>The year before the suicide</u>, how was your overall health? Please tell me your response 
using the same scale. 
[CATI] <u>El año anterior al suicidio</u>, ¿cómo era su salud general? Por favor dígame su respuesta 
utilizando la misma escala. 
 
0 is where you are extremely anxious or depressed, you are confined to bed, unable to wash or dress 
yourself, unable to perform your usual activities, and you have extreme pain or discomfort. 
0 es si usted está muy ansioso/a o deprimido/a, tiene que estar en la cama, es incapaz de lavarse o 
vestirse, es incapaz de realizar sus actividades cotidianas, y tiene mucho dolor o malestar. 
 
 
100 is where you are not anxious or depressed, you have no problems walking about, no problems with 
self-care, no problems performing your usual activities, and no pain or discomfort. 
100 es cuando usted no está ansioso/a o deprimido/a, no tiene problemas para caminar, no tiene 
problemas con el cuidado personal, no tiene problemas para realizar sus actividades cotidianas, y no 
tiene dolor ni malestar. 
 
 
[CAWI] A 1 unit change at the lower end of the scale should be the same as a 1 unit change at the higher 
end of the scale. 
[CAWI] Un cambio de 1 unidad en el extremo más bajo de la escala debería ser lo mismo que un cambio 
de 1 unidad en el extremo más alto de la escala. 
 
 
 
[PROGRAMMING NOTE: THIS IS A HORIZONTAL SLIDING SCALE WITH 1 UNIT INCREMENTS] 
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FOR TRANSLATION ONLY 
Overall Health 
Salud General 
 
Extremely anxious or depressed; Confined to bed; Unable to wash or dress yourself; Unable to perform 
your usual activities; and Extreme pain or discomfort 
Extremadamente ansioso/a o deprimido/a; Confinado/a a la cama; No puede lavarse ni vestirse; No 
puede desarrollar sus actividades habituales, y Dolores o molestias extremas. 
 
Not anxious or depressed; No problems walking about; No problems with self-care; No problems 
performing your usual activities; and No pain or discomfort 
Sin ansiedad ni depresión; Sin problemas para caminar; Sin problemas con auto-cuidado; Sin problemas 
para realizar sus actividades habituales; Sin dolor o molestias 
 
 
 
 
[SHOW IF P_PARENT=2 and Q16=1] 
[CAWI – HORIZONTAL SLIDING SCALE] 
[CATI – NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Q32. 
[CAWI] This question is the same as the previous question but for a different time period.  
[CAWI] Esta pregunta es la misma que la pregunta anterior pero para un  período de tiempo diferente. 
  
[CAWI] <u>Within the first week after the suicide happened</u>, how was your overall health? Please 
indicate your response on the scale below. 
[CAWI] <u>Dentro de la primera semana después que el suicidio ocurrió</u>, ¿cómo era su salud 
general? Por favor indique su respuesta en la siguiente escala. 
 
[CATI] <u>Within the first week after the suicide happened</u>, how was your overall health? Please 
tell me your response using the same scale. REPEAT THE BELOW SCALE INSTRUCTIONS IF NECESSARY 
[CATI] <u>Dentro de la primera semana después que el suicidio ocurrió</u>, ¿cómo era su salud 
general? Por favor dígame su respuesta utilizando la misma escala. REPEAT THE BELOW SCALE 
INSTRUCTIONS IF NECESSARY 
 165 
 
 
0 is where you are extremely anxious or depressed, you are confined to bed, unable to wash or dress 
yourself, unable to perform your usual activities, and you have extreme pain or discomfort. 
0 es si usted está muy ansioso/a o deprimido/a, tiene que estar en la cama, es incapaz de lavarse o 
vestirse, es incapaz de realizar sus actividades cotidianas, y tiene mucho dolor o malestar. 
 
100 is where you are not anxious or depressed, you have no problems walking about, no problems with 
self-care, no problems performing your usual activities, and no pain or discomfort. 
100 es cuando usted no está ansioso/a o deprimido/a, no tiene problemas para caminar, no tiene 
problemas con el cuidado personal, no tiene problemas para realizar sus actividades cotidianas, y no 
tiene dolor ni malestar. 
 
[CAWI] A 1 unit change at the lower end of the scale should be the same as a 1 unit change at the higher 
end of the scale. 
[CAWI] Un cambio de 1 unidad en el extremo más bajo de la escala debería ser lo mismo que un cambio 
de 1 unidad en el extremo más alto de la escala. 
 
 
 
 
FOR TRANSLATION ONLY 
Overall Health 
Salud General 
 
Extremely anxious or depressed; Confined to bed; Unable to wash or dress yourself; Unable to perform 
your usual activities; and Extreme pain or discomfort 
Extremadamente ansioso/a o deprimido/a; Confinado/a a la cama; No puede lavarse ni vestirse; No 
puede desarrollar sus actividades habituales, y Dolores o molestias extremas. 
 
Not anxious or depressed; No problems walking about; No problems with self-care; No problems 
performing your usual activities; and No pain or discomfort 
Sin ansiedad ni depresión; Sin problemas para caminar; Sin problemas con auto-cuidado; Sin problemas 
para realizar sus actividades habituales; Sin dolor o molestias 
 
 
 
[PROGRAMMING NOTE: THIS IS A HORIZONTAL SLIDING SCALE WITH 1 UNIT INCREMENTS] 
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[SHOW IF P_PARENT=2 and Q16=1 and TIMESINCE>3] 
[CAWI – HORIZONTAL SLIDING SCALE] 
[CATI – NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Q33. 
[CAWI] This question is the same as the previous question but for a different time period.  
[CAWI] Esta pregunta es la misma que la pregunta anterior pero para un  período de tiempo diferente. 
 
[CAWI] <u>About three months after the suicide happened</u>, how was your overall health? Please 
indicate your response on the scale below. 
[CAWI] <u>Aproximadamente tres meses después que el suicidio ocurrió</u>, ¿cómo era su salud 
general? Por favor indique su respuesta en la siguiente escala. 
 
[CATI] <u>About three months after the suicide happened</u>, how was your overall health? Please tell 
me your response using the same scale. REPEAT THE BELOW SCALE INSTRUCTIONS IF NECESSARY 
[CATI] <u>Aproximadamente tres meses después que el suicidio ocurrió</u>, ¿cómo era su salud 
general? Por favor dígame su respuesta utilizando la misma escala. REPEAT THE BELOW SCALE 
INSTRUCTIONS IF NECESSARY 
 
0 is where you are extremely anxious or depressed, you are confined to bed, unable to wash or dress 
yourself, unable to perform your usual activities, and you have extreme pain or discomfort. 
0 es si usted está muy ansioso/a o deprimido/a, tiene que estar en la cama, es incapaz de lavarse o 
vestirse, es incapaz de realizar sus actividades cotidianas, y tiene mucho dolor o malestar. 
 
100 is where you are not anxious or depressed, you have no problems walking about, no problems with 
self-care, no problems performing your usual activities, and no pain or discomfort. 
100 es cuando usted no está ansioso/a o deprimido/a, no tiene problemas para caminar, no tiene 
problemas con el cuidado personal, no tiene problemas para realizar sus actividades cotidianas, y no 
tiene dolor ni malestar. 
 
[CAWI] A 1 unit change at the lower end of the scale should be the same as a 1 unit change at the higher 
end of the scale. 
[CAWI] Un cambio de 1 unidad en el extremo más bajo de la escala debería ser lo mismo que un cambio 
de 1 unidad en el extremo más alto de la escala. 
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FOR TRANSLATION ONLY 
Overall Health 
Salud General 
 
Extremely anxious or depressed; Confined to bed; Unable to wash or dress yourself; Unable to perform 
your usual activities; and Extreme pain or discomfort 
Extremadamente ansioso/a o deprimido/a; Confinado/a a la cama; No puede lavarse ni vestirse; No 
puede desarrollar sus actividades habituales, y Dolores o molestias extremas. 
 
Not anxious or depressed; No problems walking about; No problems with self-care; No problems 
performing your usual activities; and No pain or discomfort 
Sin ansiedad ni depresión; Sin problemas para caminar; Sin problemas con auto-cuidado; Sin problemas 
para realizar sus actividades habituales; Sin dolor o molestias 
 
[PROGRAMMING NOTE: THIS IS A HORIZONTAL SLIDING SCALE WITH 1 UNIT INCREMENTS] 
 
 
[SHOW IF P_PARENT=2 and Q17 > 1 and TIMESINCE>9] 
[CAWI – HORIZONTAL SLIDING SCALE] 
[CATI – NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Q34. 
 
[CAWI] This question is the same as the previous question but for a different time period.  
[CAWI] Esta pregunta es la misma que la pregunta anterior pero para un  período de tiempo diferente. 
  
[CAWI] <u>About nine months after the suicide happened</u>, how was your overall health? Please 
indicate your response on the scale below. 
[CAWI] <u>Aproximadamente nueve meses después que el suicidio ocurrió</u>, ¿cómo era su salud 
general? Por favor indique su respuesta en la siguiente escala. 
 
[CATI] <u>About nine months after the suicide happened</u>, how was your overall health? Please tell 
me your response using the same scale. REPEAT THE BELOW SCALE INSTRUCTIONS IF NECESSARY 
[CATI] <u>Aproximadamente nueve meses después que el suicidio ocurrió</u>, ¿cómo era su salud 
general? Por favor dígame su respuesta utilizando la misma escala. REPEAT THE BELOW SCALE 
INSTRUCTIONS IF NECESSARY 
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0 is where you are extremely anxious or depressed, you are confined to bed, unable to wash or dress 
yourself, unable to perform your usual activities, and you have extreme pain or discomfort. 
0 es si usted está muy ansioso/a o deprimido/a, tiene que estar en la cama, es incapaz de lavarse o 
vestirse, es incapaz de realizar sus actividades cotidianas, y tiene mucho dolor o malestar. 
 
100 is where you are not anxious or depressed, you have no problems walking about, no problems with 
self-care, no problems performing your usual activities, and no pain or discomfort. 
100 es cuando usted no está ansioso/a o deprimido/a, no tiene problemas para caminar, no tiene 
problemas con el cuidado personal, no tiene problemas para realizar sus actividades cotidianas, y no 
tiene dolor ni malestar. 
 
[CAWI] A 1 unit change at the lower end of the scale should be the same as a 1 unit change at the higher 
end of the scale. 
[CAWI] Un cambio de 1 unidad en el extremo más bajo de la escala debería ser lo mismo que un cambio 
de 1 unidad en el extremo más alto de la escala. 
 
 
 
FOR TRANSLATION ONLY 
Overall Health 
Salud General 
 
Extremely anxious or depressed; Confined to bed; Unable to wash or dress yourself; Unable to perform 
your usual activities; and Extreme pain or discomfort 
Extremadamente ansioso/a o deprimido/a; Confinado/a a la cama; No puede lavarse ni vestirse; No 
puede desarrollar sus actividades habituales, y Dolores o molestias extremas. 
 
Not anxious or depressed; No problems walking about; No problems with self-care; No problems 
performing your usual activities; and No pain or discomfort 
Sin ansiedad ni depresión; Sin problemas para caminar; Sin problemas con auto-cuidado; Sin problemas 
para realizar sus actividades habituales; Sin dolor o molestias 
 
[PROGRAMMING NOTE: THIS IS A HORIZONTAL SLIDING SCALE WITH 1 UNIT INCREMENTS] 
 
 
[SHOW IF P_PARENT=2 and Q17>2 and TIMESINCE>24] 
[CAWI – HORIZONTAL SLIDING SCALE] 
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[CATI – NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Q35. 
[CAWI] This question is the same as the previous question but for a different time period.  
[CAWI] Esta pregunta es la misma que la pregunta anterior pero para un  período de tiempo diferente. 
 
[CAWI] <u>About two years after the suicide happened</u>, how was your overall health? Please 
indicate your response on the scale below. 
[CAWI] <u>Aproximadamente dos años después que ocurrió el suicidio</u>, ¿cómo era su salud 
general? Por favor indique su respuesta en la siguiente escala. 
 
[CATI] <u>About two years after the suicide happened</u>, how was your overall health? Please tell me 
your response using the same scale. REPEAT THE BELOW SCALE INSTRUCTIONS IF NECESSARY 
[CATI] <u>Aproximadamente dos años meses después que ocurrió el suicidio</u>, ¿cómo era su salud 
general? Por favor dígame su respuesta utilizando la misma escala. REPEAT THE BELOW SCALE 
INSTRUCTIONS IF NECESSARY 
 
 
0 is where you are extremely anxious or depressed, you are confined to bed, unable to wash or dress 
yourself, unable to perform your usual activities, and you have extreme pain or discomfort. 
0 es si usted está muy ansioso/a o deprimido/a, tiene que estar en la cama, es incapaz de lavarse o 
vestirse, es incapaz de realizar sus actividades cotidianas, y tiene mucho dolor o malestar. 
 
100 is where you are not anxious or depressed, you have no problems walking about, no problems with 
self-care, no problems performing your usual activities, and no pain or discomfort. 
100 es cuando usted no está ansioso/a o deprimido/a, no tiene problemas para caminar, no tiene 
problemas con el cuidado personal, no tiene problemas para realizar sus actividades cotidianas, y no 
tiene dolor ni malestar. 
 
[CAWI]  A 1 unit change at the lower end of the scale should be the same as a 1 unit change at the 
higher end of the scale.  
[CAWI]  Un cambio de 1 unidad en el extremo más bajo de la escala debería ser lo mismo que un cambio 
de 1 unidad en el extremo más alto de la escala. 
 
 
 
FOR TRANSLATION ONLY 
Overall Health 
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Salud General 
 
Extremely anxious or depressed; Confined to bed; Unable to wash or dress yourself; Unable to perform 
your usual activities; and Extreme pain or discomfort 
Extremadamente ansioso/a o deprimido/a; Confinado/a a la cama; No puede lavarse ni vestirse; No 
puede desarrollar sus actividades habituales, y Dolores o molestias extremas. 
 
Not anxious or depressed; No problems walking about; No problems with self-care; No problems 
performing your usual activities; and No pain or discomfort 
Sin ansiedad ni depresión; Sin problemas para caminar; Sin problemas con auto-cuidado; Sin problemas 
para realizar sus actividades habituales; Sin dolor o molestias 
 
[PROGRAMMING NOTE: THIS IS A HORIZONTAL SLIDING SCALE WITH 1 UNIT INCREMENTS] 
 
 
[SHOW IF P_PARENT=2 and Q16=1] 
[CAWI – HORIZONTAL SLIDING SCALE] 
[CATI – NUMBOX; ACCEPT NUMERIC RANGE 0-100; 777, 998, 999] 
Q36. 
[CAWI] This question is the same as the previous question but for a different time period.  
[CAWI] <u>Today</u>, how is your overall health? Please indicate your response on the scale below. 
[CAWI] Esta pregunta es la misma que la pregunta anterior pero para un  período de tiempo diferente.  
[CAWI] <u>Hoy</u>, ¿cómo es su salud general? Por favor indique su respuesta en la siguiente escala. 
 
[CATI] <u>Today</u>, how is your overall health? REPEAT THE BELOW SCALE INSTRUCTIONS IF 
NECESSARY 
[CATI] <u>Hoy</u>, ¿cómo es su salud general? Por favor dígame su respuesta según la misma escala. 
REPEAT THE BELOW SCALE INSTRUCTIONS IF NECESSARY 
 
0 is where you are extremely anxious or depressed, you are confined to bed, unable to wash or dress 
yourself, unable to perform your usual activities, and you have extreme pain or discomfort. 
0 es si usted está muy ansioso/a o deprimido/a, tiene que estar en la cama, es incapaz de lavarse o 
vestirse, es incapaz de realizar sus actividades cotidianas, y tiene mucho dolor o malestar. 
 
100 is where you are not anxious or depressed, you have no problems walking about, no problems with 
self-care, no problems performing your usual activities, and no pain or discomfort. 
100 es cuando usted no está ansioso/a o deprimido/a, no tiene problemas para caminar, no tiene 
problemas con el cuidado personal, no tiene problemas para realizar sus actividades cotidianas, y no 
tiene dolor ni malestar. 
  
[CAWI]  A 1 unit change at the lower end of the scale should be the same as a 1 unit change at the 
higher end of the scale. 
[CAWI]  Un cambio de 1 unidad en el extremo más bajo de la escala debería ser lo mismo que un cambio 
de 1 unidad en el extremo más alto de la escala. 
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FOR TRANSLATION ONLY 
Overall Health 
Salud General 
 
Extremely anxious or depressed; Confined to bed; Unable to wash or dress yourself; Unable to perform 
your usual activities; and Extreme pain or discomfort 
Está muy ansioso/a o deprimido/a; Tiene que estar en la cama; Es incapaz de lavarse o vestirse; Es 
incapaz de realizar sus actividades cotidianas; y Tiene mucho dolor y malestar 
 
Not anxious or depressed; No problems walking about; No problems with self-care; No problems 
performing your usual activities; and No pain or discomfort 
No está ansioso/a o deprimido/a; No tiene problemas para caminar; No tiene problemas con el cuidado 
personal; No tiene problemas para realizar sus actividades cotidianas; y No tiene dolor ni malestar 
 
[PROGRAMMING NOTE: THIS IS A HORIZONTAL SLIDING SCALE WITH 1 UNIT INCREMENTS] 
 
 
*show to all eligible teens, all eligible adults* 
 [SP] 
DISPLAY – Q37 
[CAWI] Under each heading, please click the ONE statement that best describes your health TODAY. 
[CAWI] Bajo cada título, por favor haga clic en el enunciado que mejor describe su salud HOY. 
 
[CATI] For each of the following phrases, please tell me the one statement that best describes your 
health today. 
[CATI] Para cada una de las siguientes frases, por favor dígame el enunciado que describe mejor su salud 
hoy. 
 
 
*show to teens whose health is still affected, all adults* 
 [SP] 
Q38. 
Mobility [IF P_PARENT=1, INSERT: “<i>(walking about)</i>”] 
Mobilidad [IF P_PARENT=1, INSERT: “<i>(desplazarse)</i>”] 
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[P_PARENT=1] CAWI RESPONSE OPTIONS: 
1. I have <u>no</u> problems walking about 
2. I have <u>some</u> problems walking about 
3. I have <u>a lot</u> of problems walking about 
 
1. <u>No</u> tengo problemas para caminar 
2. Tengo <u>algunos</u> problemas para caminar 
3. Tengo <u>muchos</u> problemas para caminar 
 
[P_PARENT=1] CATI RESPONSE OPTIONS: 
1. You have <u>no</u> problems walking about 
2. You have <u>some</u> problems walking about 
3. You have <u>a lot</u> of problems walking about 
 
1. <u>No</u> tiene problemas para caminar 
2. Tiene <u>algunos</u>  problemas para caminar 
3. Tiene <u>muchos</u> problemas para caminar 
 
[P_PARENT=2] CAWI RESPONSE OPTIONS: 
1. I have no problems walking about 
2. I have some problems walking about 
3. I am confined to bed 
 
1. No tengo problemas para caminar 
2. Tengo algunos problemas para caminar 
3. Tengo que estar en la cama 
 
[P_PARENT=2] CATI RESPONSE OPTIONS: 
1. You have no problems walking about 
2. You have some problems walking about 
3. You are confined to bed 
 
1. No tiene problemas para caminar 
2. Tiene algunos problemas para caminar 
3. Tiene que estar en la cama 
 
 
*show to all eligible teens, all eligible adults* 
 [SP] 
 Q39. 
[IF P_PARENT=1] Looking after myself 
[IF P_PARENT=2] Self-care 
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[IF P_PARENT=1] Cuidado Personal 
[IF P_PARENT=2] Cuidado Personal 
  
[P_PARENT=1] CAWI RESPONSE OPTIONS: 
1. I have <u>no</u> problems washing or dressing myself 
2. I have <u>some</u> problems washing or dressing myself 
3. I have <u>a lot</u> of problems washing or dressing myself 
4. <u>No</u> tengo problemas para lavarme o vestirme 
5. Tengo <u>algunos</u>  problemas para lavarme o vestirme 
6. Tengo <u>muchos</u>  problemas para lavarme o vestirme 
 
CATI RESPONSE OPTIONS: 
1. You have <u>no</u> problems washing or dressing yourself 
2. You have <u>some</u> problems washing or dressing yourself 
3. You have <u>a lot</u> of problems washing or dressing yourself 
 
1. <u>No</u> tiene problemas para lavarse o vestirse 
2. Tiene <u>algunos</u>  problemas para lavarse o vestirse 
3. Tiene <u>muchos</u>  problemas para lavarse o vestirse 
  
[P_PARENT=2] CAWI RESPONSE OPTIONS: 
1. I have no problems with self-care 
2. I have some problems washing or dressing myself 
3. I am unable to wash or dress myself 
 
1. No tengo problemas con el cuidado personal 
2. Tengo algunos problemas para lavarme o vestirme 
3. Soy incapaz de lavarme o vestirme 
 
CATI RESPONSE OPTIONS: 
1. You have no problems with self-care 
2. You have some problems washing or dressing yourself 
3. You are unable to wash or dress yourself 
 
1. No tiene problemas con el cuidado personal 
2. Tiene algunos problemas para lavarse o vestirse 
3. Es incapaz de lavarse o vestirse 
 
 
*show to all eligible teens, all eligible adults* 
[SHOW IF (P_PARENT=1 and Q17=4) or P_PARENT=2] [SP] 
 Q40. 
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[P_PARENT=1] Doing usual activities <i>(for example, going to school, hobbies, sports, playing, doing 
things with family or friends)</i> 
[P_PARENT=2] Usual activities (e.g. work, study housework, family, or leisure activities) 
[P_PARENT=1] Hacer actividades habituales <i>(por ejemplo, ir a la escuela, pasatiempos, deportes, 
jugar, hacer cosas con familiares y amigos)</i> 
[P_PARENT=2] Actividades cotidianas (por. ej. trabajar, estudiar, hacer las tareas domésticas, actividades 
familiares, o actividades durante el tiempo libre) 
  
[P_PARENT=1] CAWI RESPONSE OPTIONS: 
1. I have <u>no</u> problems with performing my usual activities 
2. I have <u>some</u> problems with performing my usual activities 
3. I have <u>a lot</u> of problems doing my usual activities 
 
1. <u>No</u> tengo problemas al hacer actividades habituales 
2. Tengo <u>algunos</u>  problemas al hacer mis actividades habituales 
3. Tengo <u>muchos</u>  problemas al hacer mis actividades habituales 
CATI RESPONSE OPTIONS: 
1. You have <u>no</u> problems with performing your usual activities 
2. You have <u>some</u> problems with performing your usual activities 
3. You have <u>a lot</u> of problems doing your usual activities 
 
1. <u>No</u> tiene problemas al hacer actividades habituales 
2. Tiene <u>algunos</u>  problemas al hacer sus actividades habituales 
3. Tiene <u>muchos</u>  problemas al hacer sus actividades habituales 
 
[P_PARENT=2] CAWI RESPONSE OPTIONS: 
1. I have no problems with performing my usual activities 
2. I have some problems with performing my usual activities 
3. I am unable to perform my usual activities 
 
1. No tengo problemas para realizar mis actividades cotidianas 
2. Tengo algunos problemas para realizar mis actividades cotidianas 
3. Soy incapaz de realizar mis actividades cotidianas 
 
CATI RESPONSE OPTIONS: 
1. You have no problems with performing your usual activities 
2. You have some problems with performing your usual activities 
3. You are unable to perform your usual activities 
 
1. No tiene problemas para realizar sus actividades cotidianas 
2. Tiene algunos problemas para realizar sus actividades cotidianas 
3. Es incapaz de realizar sus actividades cotidianas 
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**show to all eligible teens, all eligible adults* 
 [SP] 
Q41. 
[P_PARENT=1] Having pain or discomfort 
[P_PARENT=2] Pain/Discomfort 
[P_PARENT=1] Tener dolor o malestar 
[P_PARENT=2] Dolor/Malestar 
 
[P_PARENT=1] CAWI RESPONSE OPTIONS: 
1. I have <u>no</u> pain or discomfort 
2. I have <u>some</u> pain or discomfort 
3. I have <u>a lot</u> of pain or discomfort 
 
1. <u>No</u> tengo dolor ni me siento mal 
2. Tengo <u>un poco</u> de dolor o me siento mal 
3. Tengo <u>mucho</u>  dolor o malestar 
 
CATI RESPONSE OPTIONS: 
1. You have <u>no</u> pain or discomfort 
2. You have <u>some</u> pain or discomfort 
3. You have <u>a lot</u> of pain or discomfort 
 
1. <u>No</u> tiene dolor ni se siente mal 
2. Tiene <u>un poco</u> de dolor o se siente mal 
3. Tiene <u>mucho</u>  dolor o malestar 
 
[P_PARENT=2] CAWI RESPONSE OPTIONS: 
1. I have no pain or discomfort 
2. I have moderate pain or discomfort 
3. I have extreme pain or discomfort 
 
1. No tengo dolor ni malestar 
2. Tengo moderado dolor o malestar 
3. Tengo mucho dolor o malestar 
 
CATI RESPONSE OPTIONS: 
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1. You have no pain or discomfort 
2. You have moderate pain or discomfort 
3. You have extreme pain or discomfort 
 
1. No tiene dolor ni malestar 
2. Tiene moderado dolor o malestar 
3. Tiene mucho dolor o malestar 
 
 
 
*show to all eligible teens, all eligible adults* 
 [SP] 
Q42. 
[P_PARENT=1] Feeling worried, sad, or unhappy 
[P_PARENT=2] Anxiety/Depression 
[P_PARENT=1] Sentimiento de preocupación, tristeza, o infelicidad 
[P_PARENT=2] Ansiedad/Depresión 
 
[P_PARENT=1] CAWI RESPONSE OPTIONS: 
1. I am <u>not</u> worried, sad, or unhappy 
2. I am <u>a bit</u> worried, sad, or unhappy 
3. I am <u>very</u> worried, sad, or unhappy 
 
1. <u>No</u> estoy preocupado/a, triste o infeliz 
2. Estoy <u>un poco</u>  preocupado/a, triste o infeliz 
3. Estoy <u>muy</u>  preocupado/a, triste o infeliz 
 
CATI RESPONSE OPTIONS: 
1. You are <u>not</u> worried, sad, or unhappy 
2. You are <u>a bit</u> worried, sad, or unhappy 
3. You are <u>very</u> worried, sad, or unhappy 
 
1. <u>No</u> está preocupado/a, triste o infeliz 
2. Está <u>un poco</u>  preocupado/a, triste o infeliz 
3. Está <u>muy</u>  preocupado/a, triste o infeliz 
 
[P_PARENT=2] CAWI RESPONSE OPTIONS: 
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1. I am not anxious or depressed 
2. I am moderately anxious or depressed 
3. I am extremely anxious or depressed 
 
1. No estoy ansioso/a o deprimido/a 
2. Estoy moderadamente ansioso/a o deprimido/a 
3. Estoy muy ansioso/a o deprimido/a 
 
CATI RESPONSE OPTIONS: 
1. You are not anxious or depressed 
2. You are moderately anxious or depressed 
3. You are extremely anxious or depressed 
 
1. No está ansioso/a o deprimido/a 
2. Está moderadamente ansioso/a o deprimido/a 
3. Está muy ansioso/a o deprimido/a 
 
 
[SHOW IF P_PARENT=2 and Q17=4] 
DISPLAY – Q43 
Now please imagine being able to trade off or give up years from the end of your life in order to be 
healed and relieved of all the health burdens you currently have. 
Ahora por favor imagine que puede cambiar o renunciar a años al final de su vida para poder ser 
curado/a y aliviado/a de todas  las cargas de salud que tiene ahora. 
 
 
[SHOW IF P_PARENT=2 and Q17=4] 
 
[SP] 
Q44. 
Think about your overall health, including how the suicide death affects your emotional, mental, and 
physical health <u>currently</u>. Imagine you will live until you are <u>[lifeexpect] years</u> old but 
you can live a shorter life that is at peace with the suicide death and totally free from all of your current 
emotional, mental, and physical health burdens. 
Piense en su salud general, incluyendo cómo el suicidio afectó su salud emocional, mental y física 
<u>actual</u>. Imagine que usted vivirá hasta los <u>[lifeexpect] años</u> de edad pero usted puede 
vivir una vida más corta en paz con el suicidio y totalmente libre de todas sus actuales cargas 
emocionales, mentales y físicas de salud. 
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In this imaginary situation, would you trade off <u>[tradeoff1] years</u> from the end of your life so 
that <u>you</u> could be at peace and totally healed from <u>all of your current emotional, mental 
and, physical health burdens</u> even though this would not change the outcome of the suicide?  
En dicha situación imaginaria, ¿cambiaría usted <u>[tradeoff1] años</u> del final de su vida para que 
<u>usted</u> pudiera estar en paz y totalmente sanado/a de <u>todas las  cargas emocionales, 
mentales y físicas de salud actuales</u> aunque esto no cambie el resultado del suicidio?  
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
[SHOW IF Q44=2] 
[SP] 
Q45. 
In this imaginary situation, would you trade off <u>[tradeoff2] years</u> from the end of your life so 
that you could be at peace and totally healed from <u>all of your current emotional, mental, and 
physical health burdens</u> even though this would not change the outcome of the suicide? 
En dicha situación imaginaria, ¿cambiaría usted <u>[tradeoff2] años</u> del final de su vida para que 
usted pudiera estar en paz y totalmente sanado/a de <u>todas las cargas emocionales, mentales y 
físicas de salud actuales</u> aún esto no cambie el resultado del suicidio? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
[SHOW IF Q44=1] 
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[SP] 
Q46. 
In this imaginary situation, would you trade off <u>[tradeoff3] years</u> from the end of your life so 
that you could be at peace and totally healed from <u>all of your current emotional, mental, and 
physical health burdens</u> even though this would not change the outcome of the suicide? 
En dicha situación imaginaria, ¿cambiaría usted <u>[tradeoff3] años</u> del final de su vida para que 
usted pudiera estar en paz y totalmente sanado/a de <u>todas las cargas emocionales, mentales y 
físicas de salud actuales</u>  aunque esto no cambie el resultado del suicidio? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
[SHOW IF P_PARENT=2 and Q17=4] 
[NUMBOX] 
Q47. 
[CAWI] In this imaginary situation, what is the <u>maximum number of years</u> you would be willing 
to trade off or give up from the end of your life so that you could be at peace and totally healed from all 
of your current emotional, mental, and physical health burdens even though this would not change the 
outcome of the suicide? If you are unwilling to trade-off any years, then put 0. 
[CAWI] En esta situación imaginaria, ¿cuál es el <u>máximo número de años</u> que usted estaría 
dispuesto/a a cambiar del final de su vida para que usted pudiera estar en paz y totalmente sanado/a de 
todas las cargas emocionales, mentales y físicas de salud actuales aunque esto no cambie el resultado 
del suicidio? Si no está dispuesto/a a cambiar años, ponga 0. 
 
[CATI] In this imaginary situation, what is the <u>maximum number of years</u> you would be willing to 
trade off or give up from the end of your life so that you could be at peace and totally healed from all of 
your current emotional, mental, and physical health burdens even though this would not change the 
outcome of the suicide? If you are unwilling to trade-off any years, then you can say that too. 
[CATI] En esta situación imaginaria, ¿cuál es el <u>máximo número de años</u> que usted estaría 
dispuesto/a a cambiar del final de su vida para que usted pudiera estar en paz y totalmente sanado/a de 
todas las actuales cargas emocionales, mentales y físicas de salud aún esto no cambie el resultado del 
suicidio? Si no está dispuesto/a a cambiar años, entonces también puede decirlo. 
 
[NUMBOX; ACCEPT NUMERIC RANGE 0 - (lifeexpect-age) ] 
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[SHOW IF P_PARENT=2 and Q17=4] 
[SP] 
 Q48. 
How confident are you in your response to the previous question? 
¿Cuán seguro/a está usted de su respuesta a la pregunta previa? 
 
RESPONSE OPTIONS: 
1. Very confident 
2. Moderately confident 
3. A little confident 
4. Not at all confident 
 
1. Muy seguro/a 
2. Moderadamente seguro/a 
3. Un poco seguro/a 
4. Nada seguro 
 
 
[SHOW IF Q47=0] 
[SP] 
Q49. 
What is the main reason why you are not willing to trade off any years? 
¿Cuál es la principal razón por la que no está dispuesto/a a cambiar años? 
 
CAWI RESPONSE OPTIONS: 
1. I do not want my emotional, mental, and physical burdens to be taken away 
2. I do not believe that it is possible for my emotional, mental, and physical burdens to be taken away 
3. I am morally opposed to the idea of trading off years of my life 
4. I am coping well enough with the emotional, mental, or physical burdens from the suicide that I 
would not trade off time from the end of my life 
5. Other (please specify): [SMALL TEXTBOX]   
 
1. No quiero que me quiten mis cargas emocionales, mentales y físicas 
2. No creo que sea posible que me quiten mis cargas emocionales, mentales y físicas 
3. Me opongo moralmente a la idea de cambiar años de mi vida 
4. Estoy lidiando bastante bien con mis cargas emocionales, mentales y físicas del suicidio por lo que 
no cambiaría años del final de mi vida 
5. Otro (por favor, especifíquelo:) [SMALL TEXTBOX] 
 
CATI RESPONSE OPTIONS: 
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1. You do not want your emotional, mental, and physical burdens to be taken away 
2. You do not believe that it is possible for your emotional, mental, and physical burdens to be 
taken away 
3. You are morally opposed to the idea of trading off years of your life 
4. You are coping well enough with the emotional, mental, or physical burdens from the suicide 
that you would not trade off time from the end of your life 
5. Other (please specify): [SMALL TEXTBOX]   
 
1. Usted no quiere que me quiten mis cargas emocionales, mentales y físicas 
2. Usted no cree que sea posible que le quiten sus cargas emocionales, mentales y físicas 
3. Se opone moralmente a la idea de cambiar años de su vida 
4. Usted está lidiando bastante bien con sus cargas emocionales, mentales y físicas del suicidio por 
lo que no cambiaría años del final de su vida 
5. Otro (por favor, especifíquelo:) [SMALL TEXTBOX] 
 
 
[SHOW IF P_PARENT=2] [MP] 
Q50. 
Currently, what are the biggest barriers you face to talking with others about your feelings and 
experiences regarding the death?  
Actualmente, ¿cuáles son las barreras más grandes que usted enfrente a la hora de hablar con otras 
personas sobre sus sentimientos y experiencias en relación a la muerte? 
 
[CAWI] UNBOLD </B> <i> - Please select all that apply. </i> 
[CATI] PLEASE SELECT ALL THAT APPLY. 
[CAWI] UNBOLD </B> <i> - Por favor seleccione todas las que apliquen. </i> 
[CATI] POR FAVOR SELECCIONE TODO LO QUE CORRESPONDA. 
  
 
CAWI RESPONSE OPTIONS: 
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1. A sense of stigma or shame 
2. Not wanting to burden others with my feelings and experiences 
3. Believing that talking with others would not help me 
4. Thinking that others do not want to talk with me about the suicide 
5. Fear and uncertainty about how others might react 
6. Wanting to grieve alone 
7. Emotional pain talking about my feelings and experiences 
8. Other (please specify): [SMALL TEXTBOX]  
9. I do not have major barriers to talking with others about my feelings and experiences [SP] 
 
1. Un sentido de estigma o vergüenza  
2. No querer cargar a los demás con mis sentimientos y experiencias 
3. Creer que hablar con los demás no va a ayudarme 
4. Pensar que los demás no quieren hablar conmigo sobre el suicidio 
5. Temor e incertidumbre sobre cómo los demás pudieran reaccionar 
6. Querer hacer el duelo solo/a 
7. Dolor emocional al hablar sobre mis sentimientos y experiencias 
8. Otro (por favor, especifíquelo:) [SMALL TEXTBOX]  
9. No tengo grandes barreras al momento de hablar con otras personas sobre mis sentimientos y 
experiencias [SP] 
 
CATI RESPONSE OPTIONS: 
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1. A sense of stigma or shame 
2. Not wanting to burden others with your feelings and experiences 
3. Believing that talking with others would not help you 
4. Thinking that others do not want to talk with you about the suicide 
5. Fear and uncertainty about how others might react 
6. Wanting to grieve alone 
7. Emotional pain talking about your feelings and experiences 
8. Other (please specify): [SMALL TEXTBOX]  
9. You do not have major barriers to talking with others about your feelings and experiences [SP] 
 
1. Un sentido de estigma o vergüenza  
2. No querer ser una carga para otros con sus sentimientos y experiencias 
3. Creer que hablar con los demás no va a ayudarle a usted 
4. Pensar que los demás no quieren hablar con usted sobre el suicidio 
5. Temor e incertidumbre sobre cómo los demás pudieran reaccionar 
6. Querer hacer el duelo solo/a 
7. Dolor emocional al hablar sobre sus sentimientos y experiencias 
8. Otro (por favor, especifíquelo:) [SMALL TEXTBOX]  
9. No tiene grandes barreras al momento de hablar con otras personas sobre sus sentimientos y 
experiencias [SP] 
 
 
 
[SHOW IF P_PARENT=2] [MP] 
Q51. 
What have been the biggest barriers to seeking professional bereavement or grief support after the 
death?  
¿Cuáles han sido las barreras más grandes a la hora de buscar ayuda  profesional o apoyo para su dolor 
luego de la muerte? 
 
[CAWI] UNBOLD </B> <i> - Please select all that apply. </i> 
[CATI] PLEASE SELECT ALL THAT APPLY. 
[CAWI] UNBOLD </B> <i> - Por favor seleccione todas las que apliquen. </i> 
[CATI] POR FAVOR SELECCIONE TODO LO QUE CORRESPONDA. 
  
 
CAWI RESPONSE OPTIONS: 
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1. Feeling like I do not want, need, or deserve professional help 
2. Not knowing what support was available 
3. Feeling like the mental healthcare system has failed to help me in times past 
4. A sense of stigma or shame in talking about the suicide or getting help 
5. It costs too much 
6. Services are too far away or too hard to get to 
7. My family does not think I need help 
8. Other (please specify): [SMALL TEXTBOX]  
9. I have not experienced major barriers to seeking professional help [SP] 
 
1. Sentir que no quiero, necesito o merezco ayuda profesional 
2. No saber que tipo de ayuda estaba disponible 
3. Sentir que el sistema de salud mental ha fallado al ayudarme anteriormente 
4. Una sensación de estigma o vergüenza al hablar sobre el suicidio o recibir ayuda 
5. Cuesta demasiado 
6. Los servicios están demasiado lejos o es muy difícil acceder a ellos 
7. Mi familia no cree que yo necesite ayuda 
8. Otro (por favor, especifíquelo:) [SMALL TEXTBOX]  
9. No he experimentado mayores barreras a la hora de buscar ayuda profesional [SP] 
 
CATI RESPONSE OPTIONS: 
1. Feeling like you do not want, need, or deserve professional help 
2. Not knowing what support was available 
3. Feeling like the mental healthcare system has failed to help you in times past 
4. A sense of stigma or shame in talking about the suicide or getting help 
5. It costs too much 
6. Services are too far away or too hard to get to 
7. Your family does not think you need help 
8. Other (please specify): [SMALL TEXTBOX]  
9. You have not experienced major barriers to seeking professional help [SP] 
 
1. Sentir que usted no quiere, necesita, o merece ayuda profesional 
2. No saber que tipo de ayuda estaba disponible 
3. Sentir que el sistema de salud mental ha fallado al ayudarle a usted anteriormente 
4. Una sensación de estigma o vergüenza al hablar sobre el suicidio o recibir ayuda 
5. Cuesta demasiado 
6. Los servicios están demasiado lejos o es muy difícil acceder a ellos 
7. Su familia no cree que usted necesite ayuda 
8. Otro (por favor, especifíquelo:) [SMALL TEXTBOX]  
9. No ha experimentado usted mayores barreras a la hora de buscar ayuda profesional [SP] 
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[SHOW IF P_PARENT=2] [SP] 
Q52. 
Have you used online social networks or online support groups to share your feelings or get support 
regarding the suicide? 
¿Ha utilizado usted redes sociales en línea o grupos de apoyo en línea para compartir sus sentimientos o 
recibir ayuda en relación al suicidio? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
[SHOW IF Q52=1] 
[MP] 
Q53. 
What online social networks or online support groups have you used to share your feelings or get 
support? 
¿Qué redes sociales en línea o grupo de apoyo ha utilizado para compartir sus sentimientos o recibir 
ayuda? 
 
[CAWI] UNBOLD </B> <i> - Please select all that apply. </i> 
[CATI] PLEASE SELECT ALL THAT APPLY. 
[CAWI] UNBOLD </B> <i> - Por favor seleccione todas las que apliquen. </i> 
[CATI] POR FAVOR SELECCIONE TODO LO QUE CORRESPONDA. 
 
RESPONSE OPTIONS: 
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1. A suicide-related online support group 
2. Another grief-related online support group 
3. Facebook 
4. Twitter 
5. Snapchat 
6. Instagram 
7. Other (please specify): [SMALL TEXTBOX]  
 
1. Un grupo de apoyo en línea relacionado al suicidio 
2. Otro grupo de apoyo en línea relacionado al duelo 
3. Facebook 
4. Twitter 
5. Snapchat 
6. Instagram 
7. Otro (por favor, especifíquelo:) [SMALL TEXTBOX] 
 
 
*SHOWN TO TEENS ALL ELIGIBLE Rs* 
[SHOW ALL] [SP] 
Q54. 
Would you participate in an online social network or online support group specifically for those that 
know someone who [IF Q2=1, insert: attempted suicide,] died by suicide, or that care about suicide 
prevention? 
¿Participaría usted en una red social o grupo de apoyo en línea específicamente para aquellas personas 
que han conocen a alguien que [IF Q2=1, insert: intentó suicidarse,] se suicidó, o que se preocupe por la 
prevención del suicidio? 
 
CAWI RESPONSE OPTIONS: 
1. Yes   
2. No 
 
1. Sí   
2. No 
 
CATI RESPONSE OPTIONS: 
1. YES   
2. NO 
 
1. SÍ   
2. NO 
 
 
[SHOW IF Q54=1] 
[MP] 
Q55. 
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For what purposes would you use the online social network or support group?  
¿Con qué fin utilizaría una red social en línea o grupo de apoyo? 
 
[CAWI] UNBOLD </B> <i> - Please select all that apply. </i> 
[CATI] PLEASE SELECT ALL THAT APPLY. 
[CAWI] UNBOLD </B> <i> - Por favor seleccione todas las que apliquen. </i> 
[CATI] POR FAVOR SELECCIONE TODO LO QUE CORRESPONDA. 
  
 
1. Communicate with others about their and your experiences 
2. Organize efforts to encourage suicide prevention 
3. Communicate with people who are worried about someone dying by suicide 
4. Personally track your mood 
5. Learn about and share support resources or information 
6. Learn about or organize local group meetings or activities 
7. Other suggestions (please specify): [SMALL TEXTBOX]  
 
1. Para comunicarse con otros sobre sus experiencias 
2. Para organizar esfuerzos para alentar la prevención del suicidio 
3. Para comunicarse con personas que están preocupadas por alguien que se suicidó 
4. Personalmente registrar su estado de ánimo 
5. Conocer y compartir recursos de ayuda e información 
6. Conocer u organizar encuentros o actividades de grupos locales 
7. Otras sugerencias (por favor especifique): [SMALL TEXTBOX] 
 
 
 
[SHOW IF P_PARENT=2 and Q54=1] 
[SP] 
Q56. 
How frequently would you use or visit such a platform?  
¿Con qué frecuencia usaría usted o visitaría dicha plataforma?  
 
RESPONSE OPTIONS: 
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1. Multiple times a day 
2. About once a day 
3. A few times each week 
4. About once a week 
5. A couple times each month 
6. About once a month or less 
 
1. Múltiples veces por día 
2. Una vez al día 
3. Varias veces por semana 
4. Alrededor de una vez por semana 
5. Un  par de veces al mes 
6. Una vez por mes o menos 
 
 
[SHOW IF P_PARENT=1 OR P_PARENT=2] [SP] 
Q57. 
 
[CAWI] Finally, please tell us a little more about yourself. 
[CATI] Finally, please tell me a little more about yourself. 
[CAWI] Finalmente, cuéntenos un poco más sobre usted. 
[CATI] Finalmente, cuénteme un poco más sobre usted. 
 
Do you consider yourself to be: 
Usted se considera: 
 
RESPONSE OPTIONS: 
1. Heterosexual/straight 
2. Gay/lesbian/homosexual 
3. Bisexual 
77. Not sure 
90. Decline to state 
 
1. Heterosexual 
2. Gay/lesbiana/homosexual 
3. Bisexual 
77. No estoy seguro 
90. Se niega a contestar 
 
 
[SHOW IF P_PARENT=1 OR P_PARENT=2] [MP] 
Q58. 
What is your gender?  
¿Cuál es su género? 
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[CAWI] UNBOLD </B> <i> - Please select all that apply. </i> 
[CATI] PLEASE SELECT ALL THAT APPLY. 
[CAWI] UNBOLD </B> <i> - Por favor seleccione todas las que apliquen. </i> 
[CATI] POR FAVOR SELECCIONE TODO LO QUE CORRESPONDA. 
  
RESPONSE OPTIONS: 
1. Male 
2. Female 
3. Transgender, Male-to-Female (MTF) 
4. Transgender, Female-to-Male (FTM) 
5. Transgender, do not identify as male or female 
77. Not sure [SP] 
90. Decline to state [SP] 
 
1. Masculino 
2. Femenino 
3. Transexual, Masculino -a-Femenino (MTF) 
4. Transexual, Femenino-a-Masculino) (FTM) 
5. Transexual, no me identifico como masculino ni femenino 
77. No estoy seguro [SP] 
90. Se niega a contestar [SP] 
 
 
[IF P_PARENT=1; SP]  
[CUSTOM PROMPT 
Information about any possible Hispanic ethnicity is very important. We greatly appreciate your 
response to this question. ] 
Información sobre cualquier posible etnia hispana es muy importante. Realmente apreciamos su 
respuesta a esta pregunta. 
QS9A. 
This is about Hispanic ethnicity.  Are you of Spanish, Hispanic, or Latino descent? 
Esto se trata de etnia hispana.  ¿Es usted de ascendencia  española, hispana o latina? 
 
No, I am not ...1 
Yes, Mexican, Mexican-American 
 Chicano ...2 
Yes, Puerto Rican ...3 
Yes, Cuban, Cuban American ...4 
Yes, Central or South American ...5 
Yes, Other Spanish/Hispanic/Latino [specify] ...8 [SMALL TEXTBOX] 
No, no soy ...1 
Sí, Mexicano, Mexicano-Americano 
Chicano ...2 
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Sí, Puertorriqueño ...3 
Sí, Cubano/a, Cubano-Americano ...4 
Sí, de América Central y América del Sur ...5 
Sí, Otro Español/Hispano/Latino [especifique] ...8 [SMALL TEXTBOX] 
 
 
 
[IF P_PARENT=1; DISPLAY]  
RACEINTRO. 
[CAWI] Please tell us what you consider your racial background to be.  These race categories may not 
fully describe you, but they do match those used by the U.S. government. 
[CAWI] Por favor díganos cuál considera que es su origen racial.  Estas categorías raciales quizá no le 
describan a usted completamente, pero coinciden con las utilizadas por el gobierno de los Estados 
Unidos. 
[CATI] Please tell me what you consider your racial background to be.  These race categories may not 
fully describe you, but they do match those used by the U.S. government. 
[CATI] Por favor dígame a qué origen étnico usted considera pertenecer.  Estas categorías raciales quizá 
no le describan a usted completamente, pero coinciden con las utilizadas por el gobierno de los Estados 
Unidos. 
 
 
 
[IF P_PARENT=1] [MP]  
[PROMPT UP TO 2 TIMES] 
Information about your racial background is very important to us. We greatly appreciate your response 
and will keep it strictly confidential.  
La información sobre su origen racial es muy importante para nosotros. Estamos muy agradecidos por su 
respuesta y la mantendremos estrictamente confidencial. 
 
QS10.   
[CAWI] Please check one or more categories below to indicate what <b> race(s) </b> you consider 
yourself to be.  
[CAWI] Por favor marque una o más de las siguientes categorías para indicar a qué <b> raza(s) </b> 
usted considera que pertenece. 
 
[CATI] Please tell me what <b> race or races </b> you consider yourself to be. 
[CATI] Por favor dígame a qué <b> raza o razas </b> usted considera que pertenece. 
[CATI] DO NOT READ RESPONSE LIST, WAIT FOR R’S ANSWER AND CODE APPROPRIATELY 
 
 
1. White 
2. Black or African American  
3. American Indian or Alaska Native – [CAWI]Type in name of enrolled or principal tribe [TEXT 
BOX] 
[CATI] TYPE IN NAME OF ENROLLED OR PRINCIPAL TRIBE [TEXT BOX] 
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[SPACE]  
4. Asian Indian   
5. Chinese    
6. Filipino  
7. Japanese 
8. Korean 
9. Vietnamese 
10. Other Asian – [CAWI] Type in race [TEXT BOX] 
[CATI] TYPE IN RACE [TEXT BOX]  
[SPACE] 
11. Native Hawaiian 
12. Guamanian or Chamorro 
13. Samoan 
14. Other Pacific Islander –  [CAWI] Type in race [TEXT BOX] 
[CATI] TYPE IN RACE [TEXT BOX]  
[SPACE] 
15. Some other race – [CAWI] Type in race [TEXT BOX] 
[CATI] TYPE IN RACE [TEXT BOX]  
 
1. Blanco/a 
2. Negro/a o Afroamericano/a  
3. Indígena americano/a o Nativo/a de Alaska – [CAWI]Escriba el nombre inscrito o de la tribu 
principal. [TEXT BOX] 
[CATI] TYPE IN NAME OF ENROLLED OR PRINCIPAL TRIBE [TEXT BOX] 
[SPACE]  
4. Indio Asiático 
5. Chino 
6. Filipino  
7. Japonés 
8. Coreano 
9.  Vietnamita  
10. Otra asiática  – [CAWI] Escriba la  raza [TEXT BOX] 
[CATI] TYPE IN NAME OF ENROLLED OR PRINCIPAL TRIBE  [TEXT BOX]  
[SPACE] 
11. Nativo de Hawái 
12. Guameña o Chamoarro 
13. Samoano 
14. Otra isla del Pacífico –  [CAWI] Escriba la raza [TEXT BOX] 
[CATI] TYPE IN NAME OF ENROLLED OR PRINCIPAL TRIBE  [TEXT BOX]  
[SPACE] 
15. Alguna otra raza  – [CAWI] Tipo en raza [TEXT BOX] 
[CATI] TYPE IN NAME OF ENROLLED OR PRINCIPAL TRIBE  [TEXT BOX] 
 
  
 
DISPLAY – Q62 
[IF P_PARENT=1] If you are sad or burdened by the suicide attempt or death of someone you know, you 
are not alone. There are many resources that you can access to help you. We encourage you to seek 
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help and support. One place to receive direction and support is the website yourlifeyourvoice.org. This is 
a special website for teens that are going through struggles in life. You can also learn about other 
resources from the American Foundation for Suicide Prevention website: afsp.org/find-support/ive-lost-
someone.   
[IF P_PARENT=1] Si usted está triste y abrumado por el intento de suicidio o muerte de una persona a la 
cual conocía, usted no está solo/a. Hay muchos recursos a los cuales usted puede acceder a ayuda. Le 
alentamos a usted a buscar apoyo y ayuda. Un lugar para recibir orientación y apoyo es el sitio web 
yourlifeyourvoice.org. Este es un sitio web especial para adolescentes que están atravesando una batalla 
en sus vidas. También puede conocer sobre otros recursos en el sitio web de la Fundación 
Estadounidense de Prevención del Suicidio: afsp.org/find-support/ive-lost-someone.   
 
[IF P_PARENT=2] If you grieve and are burdened by the suicide of someone you know, you are not alone. 
There are many resources that you can access to help you in your bereavement. We encourage you to 
seek help and support. One place to receive direction and support is the American Foundation for 
Suicide Prevention: afsp.org/find-support/ive-lost-someone.  Another group that offers an online 
support for those who have lost a loved one to suicide is the Alliance of Hope: allianceofhope.org. 
[IF P_PARENT=2] Si usted está sufriendo y está abrumado/a por el suicidio de alguien a quien conoció, 
usted no está solo/a. Hay muchos recursos a los que usted puede acceder para ayudarle con su pérdida. 
Le alentamos a usted a buscar apoyo y ayuda. Un lugar para recibir dirección y apoyo es la Fundación 
Estadounidense de Prevención del Suicidio: afsp.org/find-support/ive-lost-someone.  Otro grupo que 
ofrece ayuda en línea para aquellas personas que han perdido a un ser querido por suicidio es la Alianza 
de Esperanza (Alliance of Hope): allianceofhope.org. 
 
If you are struggling with any thoughts of suicide yourself, please go to suicidepreventionlifeline.org or 
call the national suicide prevention lifeline at 1-800-273-8255 or 1-800-273-TALK.  
Si usted está teniendo pensamientos suicidas, por favor ingrese a suicidepreventionlifeline.org o llame a 
la línea nacional de prevención del suicidio al 1-888-628-9454. 
 
Thank you for your participation in this survey! 
Gracias por su participación en esta encuesta! 
 
 
RE-COMPUTE QUAL=1 “COMPLETE” 
 
SET CO_DATE, CO_TIME, CO_TIMER VALUES HERE 
 
CREATE MODE_END 
1=CATI 
2=CAWI 
 
 
 
SCRIPTING NOTES: PUT QFINAL1, QFINAL2, QFINAL3 in the same screen.  
[SINGLE CHOICE] 
[IF P_PARENT = 2] 
QFINAL1.  
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Thank you for your time today. To help us improve the experience of AmeriSpeak members like yourself, 
please give us feedback on this survey.  
Gracias por su tiempo hoy. Para ayudarnos a mejorar la experiencia de los miembros de AmeriSpeak 
como usted, por favor envíenos sus comentarios sobre esta encuesta. 
 
 [RED TEXT – CAWI ONLY] If you do not have any feedback for us today, please click “Continue” through 
to the end of the survey so we can make sure your opinions are counted and for you to receive your 
AmeriPoints reward. 
[RED TEXT – CAWI ONLY] Si usted no tiene ningún comentario para nosotros hoy, por favor haga clic en 
"Continuar" hasta el final de la encuesta para que podamos hacer que sus opiniones sean contadas y 
para que usted pueda recibir su recompensa de AmeriPoints. 
 
Please rate this survey overall from 1 to 7 where 1 is Poor and 7 is Excellent. 
Por favor califique esta encuesta en términos generales del 1 al 7, siendo 1 Pobre y 7 Excelente. 
 
Poor      Excellent 
1 2 3 4 5 6 7 
 
Pobre      Excelente 
1 2 3 4 5 6 7 
 
[SINGLE CHOICE – CAWI ONLY] 
QFINAL2. 
Did you experience any technical issues in completing this survey?  
Yes – please tell us more in the next question 
No 
¿Experimentó algún inconveniente técnico al completar esta encuesta?  
Sí - por favor, cuéntenos más en la próxima pregunta 
No 
 
[TEXT BOX] [CATI version needs “no” option] 
QFINAL3.  
Do you have any general comments or feedback on this survey you would like to share?  If you would 
like a response from us, please email support@AmeriSpeak.org or call (888) 326-9424. 
¿Tiene algún comentario general o comentarios sobre esta encuesta que le gustaría compartir con 
nosotros?  Si desea recibir una respuesta de nosotros, por favor envíe un correo electrónico a 
ayuda@AmeriSpeak.org o llámenos al (888) 326-9424. 
 
 
[IF P_PARENT = 2] 
[DISPLAY] 
END.  
[CATI version] 
Those are all the questions we have. You have earned a reward of [INCENTWCOMMA] AmeriPoints for 
completing the survey. If you have any questions at all for us, you can email us at 
support@AmeriSpeak.org or call us toll-free at 888-326-9424. Let me repeat that again: email us at 
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support@AmeriSpeak.org or call us at 888-326-9424. Thank you for participating in our new AmeriSpeak 
survey!   
Esas fueron todas las preguntas.  Usted ha ganado una recompensa de [INCENTWCOMMA] Ameripoints 
por  completar esta encuesta. Si tiene alguna pregunta para nosotros, puede mandarnos un correo 
electrónico a ayuda@AmeriSpeak.org o llámenos  gratis al 888-326-9424. Permítame repetirlo 
nuevamente: envíenos un correo electrónico a ayuda@AmeriSpeak.org o llámenos al 888-326-9424. 
¡Gracias por participar en nuestra nueva encuesta AmeriSpeak!  
 
[CAWI version] 
Those are all the questions we have. You have earned a reward of [INCENTWCOMMA] AmeriPoints for 
completing the survey. If you have any questions at all for us, you can email us at 
support@AmeriSpeak.org or call us toll-free at 888-326-9424. Thank you for participating in our new 
AmeriSpeak survey!  
Esas fueron todas las preguntas.  Usted ha ganado una recompensa de [INCENTWCOMMA] Ameripoints 
por  completar esta encuesta. Si tiene alguna pregunta para nosotros, puede mandarnos un correo 
electrónico a ayuda@AmeriSpeak.org o llámenos  gratis al 888-326-9424. ¡Gracias por participar en 
nuestra nueva encuesta AmeriSpeak!  
 
You can close your browser window now if you wish or click Continue below to be redirected to the 
AmeriSpeak member website. 
Ya puede cerrar la ventana de su explorador si lo desea o puede hacer clic en Continuar para ser 
redireccionado al sitio web de usuario de AmeriSpeak. 
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APPENDIX C: AmeriSpeak Field Report 
Below is the field report that was provided by NORC:  
  
 
LONG-TERM BURDEN OF SUICIDE 
UNIVERSITY OF MICHIGAN 
AMERISPEAK FIELD REPORT 
March 6, 2018 
 
 
 
 
 
Client Contact: John Richardson 
NORC Account Manager: Stefan Subias | Subias-Stefan@norc.org 
NORC Project Manager: Stephanie Jwo | Jwo-Stephanie@norc.org 
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Study Introduction 
NORC conducted the Long-term Burden of Suicide Study on behalf of John Richardson 
at University of Michigan using NORC’s AmeriSpeak® Panel for the sample source. The main 
focus of the research was to target and survey teens age 15-17 and adults age 18+ on their 
experience with suicide and the effect on one’s emotional and mental health. In addition, NORC 
estimated weighted prevalence rates for the teens and young adults. Among teens, 43.6% of 
teens reported knowing a person who died by suicide, and another 17.4% reported knowing a 
person who attempted suicide. Among adults, 58.1% reported knowing a person who died by 
suicide. 
This study was offered in English and Spanish via phone and web. 
This AmeriSpeak Field Report supplements the information provided in the NORC Card, 
which provides an in-depth profile of sample quality metrics for the adult sample for this study, 
the data collection field period, interview sample size, response rate statistics, the design effect, 
and sampling margins of error, among other statistics. Please refer to the NORC Card for 
information useful for compliance with the AAPOR Transparency Initiative, in addition to 
information provided in this AmeriSpeak Field Report. 
For more detailed information on the AmeriSpeak panel recruitment and management 
methodology, please see the Technical Overview at the end of this AmeriSpeak Field Report. 
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Study-specific Details 
Sampling 
A general population sample of U.S. adults age 18 and older was selected from NORC’s 
AmeriSpeak Panel for this study to reach 425 interviews. A second sample of adults with a child 
age 15-17 living in the same household was selected to reach 150 teen interviews. 
Adult respondents were screened to identify eligible adults who knew a person who died 
by suicide. 
The second sample of adults were screened to identify parents of children age 15-17, then 
pass the survey to their teen. Teen respondents who know a person who attempted suicide or a 
person who died by suicide were eligible for the study. 
The sample for a specific study is selected from the AmeriSpeak Panel using sampling 
strata based on age, race/Hispanic ethnicity, education, and gender (48 sampling strata in total). 
The size of the selected sample per sampling stratum is determined by the population distribution 
for each stratum. In addition, sample selection takes into account expected differential survey 
completion rates by demographic groups so that the set of panel members with a completed 
interview for a study is a representative sample of the target population. If panel household has 
one more than one active adult panel member, only one adult in the household is eligible for 
selection (random within-household sampling). Panelists selected for an AmeriSpeak study 
earlier in the business week are not eligible for sample selection until the following business 
week. 
For technical information about the AmeriSpeak Panel, including recruitment process and 
panel management policies, please see the Technical Overview. 
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Field 
A sub-sample AmeriSpeak web-mode panelists were invited to the survey on January 9 
in a soft-launch. The initial data from the soft-launch was reviewed and the remainder of 
sampled AmeriSpeak panelists were invited to the survey on January 12. 
In total NORC collected 846 interviews, 180 teens and 666 adults. 
Please see NORC Card for field period, sample sizes, and the AAPOR response rate 
documentation of the adult respondent. 
Survey Completion Rates 
The screening and main interview stages of data collection were conducted during a 
single survey session for the respondents. There was a screening stage to identify qualified and 
eligible panelists. These are the eligible respondents qualified to participate in the second stage, 
which is the main study interview. 
Teen respondents were brought to the survey interview by adult AmeriSpeak parent. The 
parent respondents reconfirmed their parent status and were asked to provide consent for their 
teen to participate. All parents with an identified teen age 15-17 were asked if their teen knew 
someone who died or attempted suicide. 
Among parents, 41% reported that their teen knew someone who died or attempted 
suicide. Parents who did not provide consent were given more information about the types of 
questions their teen would answer in the survey, however no parents changed their answer to 
provide consent for their teen to participate. 
Teen respondents, after their parent provided consent, who answered the screener 
questions about knowing a person who died by suicide or knowing a person who attempted 
suicide, are considered a screener complete. 
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Adult respondents who answered the screener question about knowing a person who died 
by suicide, regardless of eligibility, are considered a screener complete. 
Respondents who were determined to be eligible for the study, based on the screener, 
then completed the survey are considered a survey complete. The summary statistics on sample 
performance are shown below. 
Sample Performance Summary 
Table C-1. Sample Response and Completion Rates 
 
 
Sampled/ 
Invited 
Panelists 
No. 
Screening 
Interviews 
Completed 
 
Screener 
Completion 
Rate 
No. 
Panelists 
Eligible for 
Interview 
 
Incidence/ 
Eligibility 
Rate 
No. Survey 
Interviews 
Completed 
 
Interview 
Completion 
Rate 
Adults 5,270 1,294 24.6% 785 60.6% 666 84.8% 
Teens 2,858 336 11.8% 198 58.9% 180 90.9% 
 
Please see NORC Card for the AAPOR response rate documentation of the adult 
respondents. 
Gaining Cooperation of AmeriSpeak Panelists for the Study 
To encourage study cooperation, NORC sent email reminders to sampled web-mode 
panelists on the following dates: 
January 9 – Soft-launch 
January 12 – reminder to soft-launch sample, invite for remainder of sample 
January 15 – reminder for all 
To administer the phone-survey, NORC dialed the sampled phone-mode panelists on 
January 23 to encourage participation if they had not already participated via the web. 
Adult respondents were offered the cash equivalent of $3 for completing the survey. Teen 
respondents were offered a $5 Amazon gift card for completing the survey. 
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Data Processing 
NORC prepared a fully labeled data file of adult and teen respondent survey data and 
demographic data. 
NORC prepared a second fully labeled data file of all screened adults demographic data 
and screener question data. 
Statistical Weighting 
Statistical weights for the study eligible respondents were calculated using panel base sampling 
weights to start. 
Panel base sampling weights for all sampled housing units are computed as the inverse of 
probability of selection from the NORC National Frame (the sampling frame that is used to 
sample housing units for AmeriSpeak) or address-based sample. The sample design and 
recruitment protocol for the AmeriSpeak Panel involves subsampling of initial non-respondent 
housing units. These subsampled non-respondent housing units are selected for an in-person 
follow-up. The subsample of housing units that are selected for the nonresponse follow-up 
(NRFU) have their panel base sampling weights inflated by the inverse of the subsampling rate. 
The base sampling weights are further adjusted to account for unknown eligibility and 
nonresponse among eligible housing units. The household-level nonresponse adjusted weights 
are then post-stratified to external counts for number of households obtained from the Current 
Population Survey. Then, these household-level post-stratified weights are assigned to each 
eligible adult in every recruited household. Furthermore, a person-level nonresponse adjustment 
accounts for nonresponding adults within a recruited household. 
Finally, panel weights are raked to external population totals associated with age, sex, 
education, race/Hispanic ethnicity, housing tenure, telephone status, and Census Division. The 
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external population totals are obtained from the Current Population Survey. The weights adjusted 
to the external population totals are the final panel weights. 
Study-specific base sampling weights are derived using a combination of the final panel 
weight and the probability of selection associated with the sampled panel member. Since not all 
sampled panel members respond to the screener interview, an adjustment is needed to account 
for and adjust for screener non-respondents. This adjustment decreases potential nonresponse 
bias associated with sampled panel members who did not complete the screener interview for the 
study. 
Furthermore, among eligible sampled panel members (as identified via the survey 
screener questions), not all complete the survey interview for the study. Thus, the screener 
nonresponse adjusted weights for the study are adjusted via a raking ratio method to age 15 and 
older general population totals associated with the following socio-demographic characteristics: 
age, sex, education (for adults), race/Hispanic ethnicity, and Census Division. The weights 
adjusted to the external population totals are the final study weights. 
At the final stage of weighting, any extreme weights were trimmed based on a criterion of 
minimizing the mean squared error associated with key survey estimates, and then, weights re-
raked to the same population totals. 
Raking and re-raking is done during the weighting process such that the weighted 
demographic distribution of the survey completes resemble the demographic distribution in the 
target population. The assumption is that the key survey items are related to the demographics. 
Therefore, by aligning the survey respondent demographics with the target population, the key 
survey items should also be in closer alignment with the target population. 
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Deliverables 
The following files were created as part of the study deliverables: 
 Survey interview data file in SPSS formats 
 Codebook in Excel format 
 Final programming questionnaire in Word document 
 Field report documenting study procedures 
 NORC Card 
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Technical Overview of the AmeriSpeak® Panel NORC’s Probability-Based Research Panel 
Updated August 28, 2017 
Prepared by J. Michael Dennis, Ph.D. 
Detailed methodological information about AmeriSpeak is located on the “Research” 
page of AmeriSpeak.norc.org. 
Overview 
Funded and operated by NORC at the University of Chicago, AmeriSpeak® is a 
probability-based panel designed to be representative of the US household population. Randomly 
selected US households are sampled with a known, non-zero probability of selection from the 
NORC National Frame, and then contacted by US mail, telephone interviewers, overnight 
express mailers, and field interviewers (face to face). AmeriSpeak panelists participate in NORC 
studies or studies conducted by NORC on behalf of NORC’s clients. 
In 2016, the AmeriSpeak Panel expanded to 20,000 households, with a large oversample 
of young African- American, Hispanic, and Asian adults (age 18 to 30). AmeriSpeak will expand 
to 23,000 households in 2017 by creating new panels specific to Latino and teen research. 
Sample Frame 
In order to provide a nationally representative sample, AmeriSpeak leverages the NORC 
National Sample Frame, constructed by NORC to cover over 97 percent of U.S. households. The 
2010 National Frame used a two-stage probability sample design to select a representative 
sample of households in the United States. The first stage—the sampling unit—is a National 
Frame Area (NFA), which is either an entire metropolitan area (made up of one or more 
 204  
counties) or a county (some counties were combined so that each NFA contains a population of 
at least 10,000). The largest NFAs with a population of at least 1,543,728 (0.5 percent of the 
2010 Census U.S. population) were selected with certainty; these areas have a high-population 
density, and are dominated by tracts with street-style addresses. These areas contain 56 percent 
of the population within 8 percent of the geographic area of the United States. The remaining 
areas were stratified into areas where street-style addresses predominate, and the remaining 
areas, which are less likely to have street -style addresses. The latter stratum (“rural” areas) 
comprises 81 percent of the geographic area, but only 14 percent of the population. 
Within the selected NFAs, the second stage sampling unit is a segment, defined either in 
terms of Census tracts or block groups, containing at least 300 housing units according to the 
2010 Census. A stratified probability sample of 1,514 segments was selected with probability 
proportional to size. For most of the 1,514 segments, the USPS DSF provided over 90 percent 
coverage of the segment in terms of city-style addresses that are geo-codeable. For the 123 
segments where the DSF provided insufficient coverage, we enhanced the DSF address list with 
in-person listing. The National Sample Frame contains almost 3 million households, including 
over 80,000 rural households added through the in-person listing. 
The National Frame involves addresses in almost every state. For the remaining states, 
AmeriSpeak added some address-based sampling (ABS) addresses in 2016 and 2017 from the 
USPS DSF to assure AmeriSpeak sample representation for all US States. In 2017, a targeted 
address-based sample was added to AmeriSpeak recruitment in order to develop a new Latino 
Panel with adequate representation of Spanish-dominant Hispanics. Census tracts with high 
incidence (at least 30%) of Spanish-dominant Hispanics were targeted for this recruitment. 
Furthermore, within these Census tracts, households that were flagged as Hispanic based on 
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consumer vendor data were oversampled. This Latino Panel has 5,500 panelists with around 23% 
of those panelists being Spanish-dominant. As of July 2017, 13% of AmeriSpeak Panel 
(including the Latino Panel) recruited adults were sourced from the ABS (87% from the National 
Frame). Proper weights allow the full use of the combined sample. 
Sample Selection for Panel Recruitment 
The 2014-2017 AmeriSpeak Panel sample consists of nationally representative housing 
units drawn from the 2010 NORC National Sample Frame and 14% from address-based 
sampling. The 2010 NORC National Sample Frame is stratified based on segment (Census tract 
or Census block group) characteristics such as age and race/Hispanic ethnicity composition of 
the segment, and then, a stratified simple random sample of housing units is selected. 
Specifically, based on Census tract-level data, segments were classified as having a higher 
concentration of 18-24 year old adults or not, and a higher concentration of Hispanics, non-
Hispanic African Americans, and other. Based on these strata definitions, 6 strata (2 based on 
age times 3 based on race/ethnicity) were used to oversample housing units in segments higher in 
young adults and/or Hispanics and non-Hispanic African-Americans. This is referred to as the 
initial sample or first stage of panel recruitment. 
In the second stage of panel recruitment, initially sampled but nonresponding housing 
units are subsampled for a nonresponse follow-up (NRFU). At this stage, consumer vendor data 
are matched to housing units, and housing units that are flagged (based on consumer vendor 
data) as having a young adult or minority (Hispanic and non-Hispanic African American) are 
oversampled for the nonresponse follow-up. Overall, approximately one in five initially 
nonresponding housing units are subsampled for NRFU. However, as mentioned previously, 
selection of housing units for NRFU is a stratified simple random sample based on consumer 
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vendor data. Due to NRFU, these initially nonresponding housing units have a much higher 
selection probability compared to the housing units that were recruited during the first stage of 
panel recruitment. 
Note that a small fraction of initially nonresponding housing units are not eligible for 
NRFU due to these housing units being classified as “hard refusals” or having an appointment 
for a call back from NORC. 
In summary, there are two reasons why the sampling design for AmeriSpeak Panel 
recruitment deviates from EPSEM sampling: (a) oversampling of housing units in segments with 
a higher concentration of young adults and minorities results in the sample selection probabilities 
being higher for housing units in these segments; and (b) the nonresponse follow-up effort results 
in initially nonresponding housing units having a much higher selection probability. 
Furthermore, oversampling associated with NRFU results in higher selection probabilities for 
initially nonresponding housing units that are flagged (based on consumer vendor data) as having 
a young adult or minority. 
AmeriSpeak Panel Recruitment Procedures 
Recruitment is a two-stage process: initial recruitment using less expensive methods and 
then non-response follow-up using personal interviewers. For the initial recruitment, sample 
units are invited to join AmeriSpeak online by visiting the panel website AmeriSpeak.org or by 
telephone (in-bound/outbound supported). English and Spanish language are supported for both 
online and telephone recruitment. Study invitations are communicated via an over-sized pre-
notification postcard, a USPS recruitment package in a 9”x12” envelope (containing a cover 
letter, a summary of the privacy policy, FAQs, and a study brochure), two follow-up post cards, 
and also follow-up by NORC’s telephone research center for matched sample units. 
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The second-stage non-response follow-up targets a stratified random sub-sample of the 
non-responders from the initial recruitment. Stratification is based on consumer vendor data and 
stratification variables from the initial recruitment stage in order to increase sample 
representation of young adults, non-Hispanic African Americans, and Hispanics. Units sampled 
for the non-response follow-up are sent by Federal Express a new recruitment package with an 
enhanced incentive offer. NORC field interviewers then make personal, face-to- face visits to the 
respondents’ homes to encourage participation. NORC field interviewers administer the 
recruitment survey in-person using CAPI or else encourage the respondents to register at 
AmeriSpeak.org or call the toll-free AmeriSpeak telephone number to register. 
Recruiting Non-Internet and “Net Averse” Households. 
Under certain conditions, AmeriSpeak gives respondents a choice regarding their 
preferred mode for future participation in AmeriSpeak surveys. For the 2014-2017 recruitment, 
82% of panelists were enrolled in AmeriSpeak to receive online surveys, while 18% of panelists 
agreed to participate in AmeriSpeak telephone mode surveys. For the 2016 and 2017 
recruitment, respondents provided an option of online or telephone modes include: persons 
without internet access, persons whose only internet access is via a smartphone, and persons with 
internet access but unwilling to share an email address. A recruited household can consist of both 
web-mode and phone-mode panelists residing in the same household. 
Impact of Non-Response Follow-up 
The non-response follow-up improves the representativeness of the AmeriSpeak sample 
with respect to certain demographic segments, including but not limited to rural and/or lower 
income households, cell- phone only households, persons age 18 to 34, African Americans, 
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Hispanics, and persons without a high school degree on have only a high school degree (no 
college). Compared to panelists recruited in the initial stage, panelists recruited via the non-
response follow-up campaign are more politically conservative, are less knowledgeable about 
science, report less interest in current events and topics in the news (such as climate change), and 
are less likely to read a print newspaper. 
AmeriSpeak Panel Recruitment Response Rate and Other Sample Metrics 
Between October 2014 and July 2017, 25,657 households were recruited to the 
AmeriSpeak Panel. The AAPOR RR3 (response rate) for the panel recruitment during this time 
frame is 33.5% (weighted to take into account selection probabilities).
1 The estimated cumulative 
AAPOR RR3 for client surveys is 10% to 20% (varying according to study parameters and 
taking into account all sources of non-response including panel recruitment, panel household 
attrition, and survey participation).
2 NORC documented the AAPOR response rate calculation 
methodology for 2014-2015 recruitment.
3
 
Key statistics with respect to the 2014-2017 recruited households are as follows: 52% 
recruited via the non- response follow-up recruitment using overnight Federal Express mailers 
and face-to-face methodology (with NORC field staff visiting households); 19% indicated a 
preference for the telephone mode of data collection for participating in AmeriSpeak studies; 
                                                 
1
 The response rate calculation incorporates the selection probabilities of the samples for the 
initial recruitment and non-response follow-up stages, as calculated by the US Bureau of the 
Census for the American Community Survey. 
2
 A properly calculated AAPOR response rate for panel-based research takes into account all 
sources of non-response at each stage of the panel recruitment, management, and survey 
administration process. A common misapplication of the term “response rate” in online panel 
surveys is representing the survey-specific cooperation rate as the “survey response rate.” 
3
 See “Response Rate Calculation Methodology for Recruitment of a Two-Phase Probability-
Based Panel: The Case of AmeriSpeak” authored by Robert Montgomery, J. Michael Dennis, 
Nada Ganesh. The paper is available at amerispeak.norc.org on the “research” page. 
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23% of the recruited households are non-Internet; 79% are cell- phone only or cell-phone mostly; 
17% are non-Hispanic African-American and 24% Hispanic; and 36% have household income 
below $30,000 (compared to CPS benchmark of 27%). 
Mixed-Mode Data Collection 
Panelists may participate in 2 to 3 AmeriSpeak Panel studies per month via online 
(computer, tablet, or smartphones) or by CATI phone. CATI phone mode respondents represent 
a population currently under- represented in web panels that exclude non-internet households or 
“net averse” persons. NORC’s telephone interviewers administer the phone mode of survey 
questionnaires using a data collection system supporting both the CATI phone and web modes of 
data collection, providing an integrated sample management and data collection platform. For 
panelists using smartphones for web-mode AmeriSpeak surveys, the NORC survey system 
renders an optimized presentation of the survey questions for these mobile users. For general 
population client studies, approximately 20% of the completed interviews are completed by the 
telephone mode. 
Panel Management Policies 
NORC maintains strict rules to limit respondent burden and reduce the risk of panel 
fatigue. On average, AmeriSpeak panel members typically participate in AmeriSpeak web-based 
or phone-based studies two to three times a month. 
Because the risk of panel attrition increases with the fielding of poorly constructed survey 
questionnaires, the AmeriSpeak team works with NORC clients to create surveys that provide an 
appropriate user experience for AmeriSpeak panelists. AmeriSpeak will not field surveys that in 
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our professional opinion will result in a poor user experience for our panelists and in panel 
attrition. 
About NORC at the University of Chicago 
As one of the world’s foremost independent research institutions, NORC at the 
University of Chicago delivers objective data and meaningful analysis to help decision-makers 
and leading organizations make informed choices and identify new opportunities. Since 1941, 
NORC has applied sophisticated methods and tools, innovative and cost-effective solutions, and 
the highest standards of scientific integrity and quality to conduct and advance research on 
critical issues. Today, NORC expands on this tradition by partnering with government, business, 
and nonprofit clients to create deep insight across a broad range of topics and to disseminate 
useful knowledge throughout society. 
Headquartered in downtown Chicago, NORC works in over 40 countries around the 
world, with additional offices on the University of Chicago campus, the DC metro area, Atlanta, 
Boston, and San Francisco. 
Additional Resources 
To learn more about AmeriSpeak or to share an RFP, please contact AmeriSpeak at 
AmeriSpeak- BD@norc.org. Information about AmeriSpeak capabilities and research papers are 
available online at AmeriSpeak.NORC.org. 
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APPENDIX D: Characteristics of Suicide Decedents Known to Adult Survey Respondents 
The characteristics of the suicide decedents were only identified among the adult survey 
respondents. The results are provided below.  
 
Table D-1. Characteristics of the Suicide Decedent and Relationship Between the Respondent 
and the Decedent 
Characteristics n Weighted Estimate
 
 
Decedent's sexual orientation and gender identity 
Heterosexual male 376 55% 
Heterosexual female 139 22% 
Homosexual, bisexual, or transgender 53 6% 
Not sure or declined 98 18% 
Decedent's age 
<18 88 13% 
18-24 171 28% 
25-44 253 36% 
45-64 122 18% 
65+ 27 4% 
Not sure or missing 5 1% 
Decedent's mental illness or drug use problems that were known to the respondent 
Depression 353 54% 
Anxiety 135 21% 
PTSD 48 7% 
Bipolar disorder 53 8% 
Schizophrenia 17 4% 
Alcohol use problems 181 27% 
Opioid use problems 66 13% 
Other drug use problems 126 21% 
None that were known 184 27% 
Relationship to the respondent 
Nuclear family 38 7% 
Extended family 135 22% 
Friend 322 48% 
Peer, colleague, co-worker, or client 96 13% 
Neighbor 21 2% 
Celebrity 6 1% 
Student or patient 10 1% 
Other 38 6% 
Level of connectedness the year before the suicide (1 to 7) 
1 - Low connectedness 187 28% 
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Characteristics n Weighted Estimate
 
 
2 133 19% 
3 71 9% 
4 88 11% 
5 79 13% 
6 62 12% 
7 - High connectedness 44 9% 
Missing response 2 0% 
Stressfulness of relationship the year before the suicide 
Extremely stressful 10 2% 
Really stressful 19 2% 
Moderately Stressful 40 7% 
A little stressful 101 17% 
Not at all stressful 495 72% 
Missing response 1 0% 
Notes: Estimates were weighted to adjust for non-response and be nationally representative. 
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APPENDIX E: Barriers to Seeking Support and Desire for Online Support Tools 
 
Table E-1. Preferences for Online Social Network or Support Group, Among Adolescents 
Preferences n 
Weighted 
Estimate 
Would you participate in an online social network or support group for those that know someone who attempted 
suicide, died by suicide, or that care about suicide prevention? 
Yes 66 38% 
No 112 61% 
Missing 2 1% 
Among those that would participate in an online social network or support group (n=66) 
For what purposes would you use the online social network or support group? 
Communicate with others about their and your experiences 39 58% 
Organize efforts to encourage suicide prevention 33 43% 
Communicate with people who are worried about someone dying by suicide 39 51% 
Personally track your mood 10 22% 
Learn about and share support resources or information 25 45% 
Learn about or organize local group meetings or activities 12 16% 
Note: Estimates were weighted to adjust for non-response and be nationally representative. 
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Table E-2. The Biggest Barriers Faced in Talking with Others About Feelings and Experiences 
Regarding the Death 
Barriers 
Overall (n=666) 
"Definitely" or 
"Probably" a Survivor 
of Suicide Loss  
(n= 241) 
Not "Definitely" or 
"Probably" a Survivor 
of Suicide Loss  
(n= 422) 
P-Value 
by 
Survivor 
Status 
n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
A sense of stigma or shame 68 11% 25 16% 43 8% 0.003 
Not wanting to burden others 
with your feelings and 
experiences 
178 26% 82 34% 96 22% 0.001 
Believing that talking with others 
would not help you 
78 13% 31 16% 47 12% 0.118 
Thinking that others do not want 
to talk with you about the 
suicide 
90 15% 44 20% 46 13% 0.016 
Fear and uncertainty about how 
others might react 
90 14% 37 18% 52 11% 0.006 
Wanting to grieve alone 87 11% 42 13% 43 10% 0.229 
Emotional pain talking about you 
feelings and experiences 
83 14% 48 25% 34 7% <0.001 
Other  22 3% 10 4% 12 2% 0.260 
You do not have major barriers 
to talking with others about my 
feelings and experiences 
354 55% 100 42% 254 62% <0.001 
Notes: Estimates were weighted to adjust for non-response and be nationally representative. P-
values were calculated using a weighted Chi-square test. 
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Table E-3. The Biggest Barriers to Seeking Professional Bereavement or Grief Support After the 
Death 
Barriers 
Overall (n=666) 
"Definitely" or 
"Probably" a Survivor 
of Suicide Loss  
(n= 241) 
Not "Definitely" or 
"Probably" a Survivor 
of Suicide Loss  
(n= 422) 
P-Value 
by 
Survivor 
Status 
n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
Feeling like you do not want, 
need, or deserve professional 
help 
113 18% 48 20% 65 17% 0.242 
Not knowing what support was 
available 
55 10% 26 16% 28 6% <0.001 
Feeling like the mental 
healthcare system has failed to 
help you in times past 
65 9% 31 14% 34 6% 0.000 
A sense of stigma or shame in 
talking about the suicide or 
getting help 
33 8% 21 14% 12 4% <0.001 
It costs too much 92 15% 44 20% 47 12% 0.004 
Services are too far away or too 
hard to get to 
31 6% 14 8% 17 5% 0.104 
Your family does not think you 
need help 
19 5% 10 9% 9 2% <0.001 
Other 15 3% 5 2% 10 3% 0.244 
You have not experienced major 
barriers to seeking professional 
help  
402 60% 122 53% 280 65% 0.003 
Notes: Estimates were weighted to adjust for non-response and be nationally representative. P-
values were calculated using a weighted Chi-square test. 
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Table E-4. Use of Online Social Networks or Online Support Groups for Suicide Bereavement 
Utilization Questions n Weighted Estimate 
Have you used online social networks or online support groups to share your feelings or get support regarding the 
suicide? 
Yes 73 11% 
No 588 88% 
Missing response 5 1% 
What online social networks or online support groups have you used to share feelings or get support? 
A suicide-related online support group 25 6% 
Another grief-related online support group 15 2% 
Facebook 42 7% 
Twitter 4 0% 
Snapchat 2 2% 
Instagram 13 3% 
Other 4 1% 
Notes: Estimates were weighted to adjust for non-response and be nationally representative. 
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Table E-5. Preferences Regarding an Online Social Network or Support Group for Suicide 
Bereavement and Suicide Prevention 
Preferences n Weighted Estimate 
Would you participate in an online social network or support group for those that know someone who attempted 
suicide, died by suicide, or that care about suicide prevention? 
Yes 179 27% 
No 484 72% 
Missing response 3 0% 
Among those that would participate in an online social network or support group (n=179) 
For what purposes would you use the online social network or support group? 
Communicate with others about their and your experiences 116 66% 
Organize efforts to encourage suicide prevention 81 48% 
Communicate with people who are worried about someone dying by suicide 87 51% 
Personally track your mood 43 28% 
Learn about and share support resources or information 84 51% 
Learn about or organize local group meetings or activities 42 34% 
Other 3 4% 
How frequently would you use or visit such a platform? 
Multiple times a day 14 10% 
About once a day 23 13% 
A few time each week 42 21% 
About once a week 33 16% 
A couple times each month 26 15% 
About once a month or less 39 22% 
Missing response 2 3% 
Notes: Estimates were weighted to adjust for non-response and be nationally representative. 
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Table E-6. Characteristics of Those Who Would Participate Compared to Those Who Would Not 
Participate in an Online Social Network or Support Group for Suicide Bereavement and Suicide 
Prevention 
Characteristics 
Would Participate 
(n=179) 
Would not Participate 
(n=484) 
P-Value 
n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
Sexual orientation and gender identity 
Heterosexual male 64 42% 204 43% 0.208 
Heterosexual female 88 46% 230 46% 
Homosexual, bisexual, transgender, not sure 25 12% 40 8% 
Declined 2 0% 10 2% 
Age 
18-29 44 28% 83 20% 0.030 
30-44 65 27% 142 22% 
45-59 41 23% 135 28% 
60+ 29 22% 124 30% 
Race and ethnicity 
White, non-Hispanic  108 58% 356 70% <0.001 
Black, non-Hispanic 26 15% 27 5% 
Other, non-Hispanic 18 8% 44 7% 
Hispanic 27 18% 57 17% 
Region 
Northeast 25 19% 78 18% 0.804 
Midwest 54 25% 150 24% 
South 58 31% 140 35% 
West 42 25% 116 23% 
Marital status 
Married 52 31% 221 49% <0.001 
Widowed 4 1% 18 4% 
Divorced or separated 36 22% 85 18% 
Never married 64 36% 114 19% 
Living with partner 23 10% 46 10% 
Education 
No high school diploma 10 10% 16 10% 0.246 
High school graduate or equivalent 34 33% 91 28% 
Some college 77 24% 218 32% 
BA or above 58 33% 159 30% 
Household income 
Less than $50,000 100 54% 217 46% 0.031 
$50,000 to $99,999 51 31% 161 30% 
$100,000 or more 28 15% 106 24% 
Household size 179 2.7 484 2.6 0.785 
Mental illness or drug use problems prior to the suicide 
Depression 57 32% 110 27% 0.178 
Anxiety 48 24% 79 17% 0.047 
PTSD 8 3% 21 6% 0.124 
Bipolar or schizophrenia 14 7% 13 5% 0.566 
Alcohol use problems 14 12% 38 12% 0.877 
Opioid or other drug use problems 11 5% 28 10% 0.078 
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Characteristics 
Would Participate 
(n=179) 
Would not Participate 
(n=484) 
P-Value 
n 
Weighted 
Estimate 
n 
Weighted 
Estimate 
No mental illness or drug use problems 99 55% 320 62% 0.105 
Note: Estimates were weighted to adjust for non-response and be nationally representative. There 
were three individuals that did not respond to the question about preferences for online social 
networks or support groups. P-values were calculated using a weighted Chi-square test. 
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APPENDIX F: Exploration of the Relationships Between Measures of Health Utility 
Among the Bereaved 
Below are additional relationships and comparisons between the VAS and the TTO and 
EQ-5D.  
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Figure F-1. Comparison of Health Utility Measured by the Time Trade-Off (TTO) Question and 
the Rescaled Visual Analogue Scale Score 
  
Note: There were 21 observations that reported that they currently experienced health effects 
from the grief, were non-refusers to the TTO question, and provided an estimate of the visual 
analogue scale.  
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Figure F-2. Linear and Quadratic Predictions of Health Utility from the Visual Analogue Scale 
 
Note: Linear prediction 1 had a root mean squared error (RMSE) of 0.247 is the function U=V; 
where U is the health utility measured by the EQ-5D and V is the rescaled visual analogue scale. 
The linear prediction 2 had a RMSE or 0.272 and is the function U=1.109*V – 0.109. The 
quadratic prediction had a RMSE of 0.251 and is the function U=1.839*V – 0.730*V – 0.109. 
Predictions were based on weighted outcomes. 
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APPENDIX G: Number of People Age 18 and Older Who Are Aware of Each Suicide 
Death 
 In the 1970’s, Dr. Alfred Shneidman suggested that with each suicide death there are six 
people who become “survivor-victims.”183 Even though this number has often been restated, 
there have been several studies that found more than just six people affected by each suicide. In 
2011, one study surveyed survivors of suicide loss and estimated 59 people were directly and 
intimately affected by each suicide.
184
 This was based on respondents’ reports of the number of 
people who had been affected by the same suicide death. A very recent study estimated that 135 
people were exposed to each suicide.
185
 This estimate includes people who were aware of the 
suicide death but may not have been intimately affected by the suicide. Its estimates were also 
based on a survey in Kentucky that was then generalized to the US population. One study that 
used a nationally representative sample to determine exposure to suicide in the past year 
estimated that 425 adults were exposed for every suicide that occurred.
66
 This estimate was 
similar to the 453 adults exposed per suicide as determined in the present study.  
 All of these estimates align to some extent with the average social network sizes 
proposed and identified based on the social brain hypothesis.
186
 This theory suggests and that due 
to the cognitive limits of our brains, humans maintain an average active network size of about 
150 people. This has been validated in other studies.
187,188
 Additional studies have found 
hierarchical layers within the network of 150 people. These include a “support clique” of about 5 
people, a “sympathy group” of about 15 people, and an “affinity group” of about 50 people.189,190  
Beyond the active network of about 150 people, there are two additional layers that are the 
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acquaintances (500 people) and the number of faces one can put to names (1500 people).
191
 The 
original value of six people affected by each suicide is comparable to the size of the support 
clique network. The estimate of 60 individuals in the 2011 study is similar to the size of the 
affinity group network. From the estimates in the present study, it appears that the number of 
people exposed to a suicide is similar to the number of people in the acquaintances group.  
The tables below include the various assumptions I have made to estimate the number of 
people exposed to each suicide death. The final estimate only pertains to those 18 and older who 
were exposed to each suicide over the past 10 years. 
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Table G-1. Inputs with Random Variability Pertaining to the Prevalence of Knowing Someone 
Who Died by Suicide 
Input Description Estimate Low High Distribution  Source 
Prevalence of knowing someone who 
died by suicide in the past 10 years 
57% 53% 60% Beta Multiplication of two 
categories below 
Prevalence of knowing someone 
who died by suicide at any time 
58% 55% 61% -- Bereavement Survey 
If exposed, prevalence of knowing 
someone who died in the past 10 
years 
97% 96% 98% -- Bereavement Survey 
Percentage of people knowing 1 person 
who died by suicide in the past 10 years 
84% 100% 67% Uniform
a
 Bereavement Survey,  
Author judgment 
Percentage of people knowing 2 people 
who died by suicide in the past 10 years 
12% 0% 24% Uniform
a
 Bereavement Survey,  
Author judgment 
Percentage of people knowing 3 people 
who died by suicide in the past 10 years 
3% 0% 6% Uniform
a
 Bereavement Survey,  
Author judgment 
Percentage of people knowing 4+ people 
who died by suicide in the past 10 years 
1% 0% 3% Uniform
a
 Bereavement Survey,  
Author judgment 
Percentage of those 18+ who know 
someone who died by suicide in the past 
year 
7% 6% 8% Beta Crosby and Sacks (2002) 
a
This was taken from a set of distributions with equal probability of being used that ranged 
between the high and low estimates. The high estimate is the proportion reported in the 
bereavement survey. The low estimate assumes that over the 10 years even if they knew more 
than 1 person they are only impacted once. To establish the set of distributions, I started at the 
high distribution and shifted the distribution incrementally closer to the low distribution. Each 
distribution shifts 1% point that is taken proportionally from the distribution of respondents 
knowing 2, 3, or 4+ suicides and adds it to the percentage knowing only 1 suicide. The average 
was used as the point estimate. 
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Table G-2. Fixed Inputs Regarding Suicide Decedents, Population Size, and Deaths Each Year 
from 2007 to 2015 
Input Description Estimate Source 
Total suicide deaths over 10 years (2007-2016) 399,157 WISQARS, CDC 
Number of people 18+ who died in 2007  2,377,750 WISQARS, CDC 
Number of people 18+ who died in 2008  2,428,011 WISQARS, CDC 
Number of people 18+ who died in 2009  2,395,523 WISQARS, CDC 
Number of people 18+ who died in 2010  2,429,527 WISQARS, CDC 
Number of people 18+ who died in 2011  2,477,265 WISQARS, CDC 
Number of people 18+ who died in 2012  2,505,846 WISQARS, CDC 
Number of people 18+ who died in 2013  2,559,906 WISQARS, CDC 
Number of people 18+ who died in 2014  2,589,866 WISQARS, CDC 
Number of people 18+ who died in 2015  2,675,256 WISQARS, CDC 
Number of people 18+ living in 2016  249,485,228 WISQARS, CDC 
Note: The people who die each year could have been aware of suicide deaths that occurred 
between 2007 and 2015 prior to their own death. 
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Table G-3. Assumptions Regarding the Percentage of Those Who Died Each Year and Were 
Exposed to Suicide Prior to Their Death, Each Year from 2007 to 2015 
Suicide exposure among those who die each year Estimate 
Percentage of those who died in 2007 that were aware of a suicide in the past year
a
 7% 
Percentage of those who died in 2008 that were aware of a suicide in the past 2 years 13% 
Percentage of those who died in 2009 that were aware of a suicide in the past 3 years 18% 
Percentage of those who died in 2010 that were aware of a suicide in the past 4 years 24% 
Percentage of those who died in 2011 that were aware of a suicide in the past 5 years 29% 
Percentage of those who died in 2012 that were aware of a suicide in the past 6 years 35% 
Percentage of those who died in 2013 that were aware of a suicide in the past 7 years 40% 
Percentage of those who died in 2014 that were aware of a suicide in the past 8 years 46% 
Percentage of those who died in 2015 that were aware of a suicide in the past 9 years 51% 
Exposed to suicides over the 10 years from 2007-2016
b 
57% 
a
This estimate is based on the input in table 1 from Crosby and Sacks (2002). 
b
A linear 
interpolation was used to estimate the exposure for each additional year until it reached the 57% 
of knowing anyone who died by suicide in the past 10 years, as reported in table 1.  
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Table G-4. Estimates for the Number of People Aware of Suicide Deaths Overall and on 
Average from 2007-2016 
Outcome Point Estimate 
Number of instances where people ages 18 and older alive in 2016 were aware of 
suicide deaths in 2007-2016
a 
 
172,747,447 
Number of instances where people ages 18 and older who died between 2007 to 2015 
were aware of suicide deaths in 2007-2015
b 
8,114,630 
Total number of instances where people ages 18 and older were aware of suicide 
decedents in 2007-2016 
180,862,077 
Average number of people 18 and older who are aware of each suicide death 453 
a
This was calculated as follows: (number of people living)*(percentage exposed)*[1*(percentage 
exposed to 1) + 2*(percentage exposed to 2) +3*(percentage exposed to 3) + 4*(percentage 
exposed to 4+)]. 
b
This was calculated similar to the first note; however, the numbers of deaths 
each year reported in Table G-2 were multiplied by the percentage exposed assumed in Table G-
3. 
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APPENDIX H: Additional Outputs for the QALY and Productivity Losses Among the 
Bereaved 
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Figure H-1. Approximate Health Utility Before and After the Suicide Among Those Who 
Reported that Their Overall Health Was Affected for Less Than 6 months 
 
Abbreviations: Std, standard deviation. Note: Health utility was approximated using the 
transformed VAS score as described in Chapter IV. The length of the box is from the 25
th
 to 75
th
 
percentile and the whiskers extend to the maximum and minimum values. The diamond in each 
box is the mean, and the line in each box is the median. 
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Figure H-2. Approximate Health Utility Before and After the Suicide Among Those Who 
Reported that Their Overall Health Was Affected for 6 Months to a Year 
 
Abbreviations: Std, standard deviation. Note: Health utility was approximated using the 
transformed VAS score as described in Chapter IV. The length of the box is from the 25
th
 to 75
th
 
percentile and the whiskers extend to the maximum and minimum values. The diamond in each 
box is the mean, and the line in each box is the median. 
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Figure H-3. Approximate Health Utility Before and After the Suicide Among Those Who 
Reported that Their Overall Health Was Affected for More Than a Year 
 
Abbreviations: Std, standard deviation. Note: Health utility was approximated using the 
transformed VAS score as described in Chapter IV. The length of the box is from the 25
th
 to 75
th
 
percentile and the whiskers extend to the maximum and minimum values. The diamond in each 
box is the mean, and the line in each box is the median. 
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Table H-1. The Level of Effect Among Those Who Were Less Than 18 When They Knew 
Someone Who Died by Suicide 
Level of Effect n 
Weighted 
Estimate 
95% Lower Confidence 
Limit 
95% Upper Confidence 
Limit 
No effect 6 7% 1% 12% 
Little effect 25 33% 23% 44% 
Moderate effect 25 34% 24% 45% 
Large effect 13 22% 13% 31% 
Extreme effect 3 4% 0% 8% 
Note: Estimates were weighted to be nationally representative. Three people provided missing 
responses and were excluded from the analysis. The average time since the suicide happened was 
19.5 years. 
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Table H-2. Assumed Monthly Earnings by Age Group 
Age Group  
Average Monthly 
Earnings 2018 
< 25 $1,471.58 
25 to 34 $3,572.33 
35 to 44 $4,848.08 
45 to 54 $5,051.17 
55 to 64 $4,623.92 
65 to 74 $3,631.58 
75+ $2,606.58 
Note: Annual earnings were taken from the Current Population Survey 2016 estimate
171
 as 
suggested in the book Cost-Effectiveness in Health and Medicine, Second Edition.
135
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Figure H-4. Probability of Outcomes for QALYs Lost Given the Uncertainty of Inputs 
 
Note: This distribution was developed using 5,000 Monte Carlo simulations. Negative values 
mean that the health utility of individuals improved after the death, compared to the year before 
the death.    
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Figure H-5. Probability of Outcomes for Absenteeism Costs Given the Uncertainty of Inputs 
 
Note: This distribution was developed using 5,000 Monte Carlo simulations.     
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Figure H-6. Probability of Outcomes for Absenteeism Costs Given the Uncertainty of Inputs 
 
Note: This distribution was developed using 5,000 Monte Carlo simulations. 
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Figure H-7. Total and Average Undiscounted QALYs Lost from Suicide Decedents and the 
Bereaved in 2016 
Outcome Estimate 
95% Lower 
Credible Limit 
95% Upper 
Credible Limit 
Total QALYs lost from suicide decedents in 2016 1,130,601 -- -- 
Average QALYs lost from suicide decedents in 2016 25.144 -- -- 
Total QALYS lost from bereavement 1,226,951 -650,217 3,314,628 
Average QALYS lost from bereavement per suicide death 27.287 -14.461 73.716 
Note: In the main text QALYS were discounted by 0.247% monthly which is equivalent to 3% 
annually; however, in this analysis QALYs were not discounted. 
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APPENDIX I: Inputs for QALY and Productivity Losses Among Suicide Decedents 
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Table I-1. Inputs for Calculating QALY and Productivity Losses Among Suicide Decedents by Age and Sex 
Age  
Percentage 
of Suicide 
Deaths 
Among 
Males
a 
Percentage 
of Suicide 
Deaths 
Among 
Females
a 
Probability 
of Surviving 
One Year 
for Males
b 
Probability 
of Surviving 
One Year 
for 
Females
b 
Health 
Utility for 
Males with 
"Good" 
Health
c 
Health 
Utility for 
Females 
with 
"Good" 
Health
c 
Health 
Utility for 
Males with 
"Fair" 
Health
c 
Health 
Utility for 
Females 
with "Fair" 
Health
c 
Net 
Productivity 
for Males
d 
Net 
Productivity 
for 
Females
d
 
10 0.0% 0.0% 0.999907 0.999916 0.810 0.779 0.717 0.686 $2,620 -$1,793 
11 0.1% 0.1% 0.999899 0.999913 0.810 0.779 0.717 0.686 $2,620 -$1,793 
12 0.1% 0.3% 0.999864 0.9999 0.810 0.779 0.717 0.686 $2,620 -$1,793 
13 0.2% 0.5% 0.999795 0.999876 0.810 0.779 0.717 0.686 $2,620 -$1,793 
14 0.3% 0.8% 0.999701 0.999843 0.810 0.779 0.717 0.686 $2,620 -$1,793 
15 0.6% 0.9% 0.999599 0.999806 0.810 0.779 0.717 0.686 $2,620 -$1,793 
16 0.7% 1.2% 0.999495 0.999768 0.810 0.779 0.717 0.686 $2,620 -$1,793 
17 0.9% 1.1% 0.99938 0.999731 0.810 0.779 0.717 0.686 $2,620 -$1,793 
18 1.1% 0.9% 0.999253 0.999696 0.810 0.779 0.717 0.686 $2,620 -$1,793 
19 1.3% 1.0% 0.999121 0.999662 0.809 0.778 0.716 0.685 $2,620 -$1,793 
20 1.4% 1.1% 0.998981 0.999627 0.808 0.777 0.715 0.684 $2,620 -$1,793 
21 1.8% 1.3% 0.998849 0.999591 0.808 0.776 0.714 0.683 $2,620 -$1,793 
22 1.7% 1.2% 0.998748 0.999558 0.807 0.775 0.714 0.682 $2,620 -$1,793 
23 1.9% 1.4% 0.998691 0.999529 0.806 0.774 0.713 0.681 $2,620 -$1,793 
24 1.8% 1.2% 0.998665 0.999503 0.805 0.773 0.712 0.680 $2,620 -$1,793 
25 1.9% 1.2% 0.998651 0.999476 0.804 0.772 0.711 0.679 $29,760 $16,354 
26 1.8% 1.4% 0.998631 0.999447 0.803 0.772 0.710 0.679 $29,760 $16,354 
27 1.8% 1.3% 0.998609 0.999418 0.802 0.771 0.709 0.678 $29,760 $16,354 
28 1.8% 1.4% 0.998578 0.999389 0.801 0.770 0.708 0.677 $29,760 $16,354 
29 1.7% 1.4% 0.998541 0.999359 0.801 0.769 0.707 0.676 $29,760 $16,354 
30 1.6% 1.4% 0.998502 0.999327 0.800 0.768 0.707 0.675 $29,760 $16,354 
31 1.6% 1.7% 0.998464 0.99929 0.799 0.767 0.706 0.674 $29,760 $16,354 
32 1.6% 1.6% 0.998424 0.999247 0.798 0.766 0.705 0.673 $29,760 $16,354 
33 1.6% 1.4% 0.998384 0.999195 0.797 0.765 0.704 0.672 $29,760 $16,354 
34 1.6% 1.5% 0.998339 0.999136 0.796 0.765 0.703 0.672 $29,760 $16,354 
35 1.6% 1.7% 0.998284 0.999068 0.795 0.764 0.702 0.671 $51,539 $25,060 
36 1.7% 1.7% 0.998218 0.998995 0.794 0.763 0.701 0.670 $51,539 $25,060 
37 1.6% 1.7% 0.998146 0.998918 0.794 0.762 0.700 0.669 $51,539 $25,060 
38 1.5% 1.8% 0.998069 0.99884 0.793 0.761 0.700 0.668 $51,539 $25,060 
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Age  
Percentage 
of Suicide 
Deaths 
Among 
Males
a 
Percentage 
of Suicide 
Deaths 
Among 
Females
a 
Probability 
of Surviving 
One Year 
for Males
b 
Probability 
of Surviving 
One Year 
for 
Females
b 
Health 
Utility for 
Males with 
"Good" 
Health
c 
Health 
Utility for 
Females 
with 
"Good" 
Health
c 
Health 
Utility for 
Males with 
"Fair" 
Health
c 
Health 
Utility for 
Females 
with "Fair" 
Health
c 
Net 
Productivity 
for Males
d 
Net 
Productivity 
for 
Females
d
 
39 1.5% 1.5% 0.997982 0.998757 0.792 0.760 0.699 0.667 $51,539 $25,060 
40 1.4% 1.7% 0.997877 0.998664 0.791 0.759 0.698 0.666 $51,539 $25,060 
41 1.5% 1.6% 0.997748 0.998558 0.790 0.758 0.697 0.665 $51,539 $25,060 
42 1.4% 1.7% 0.997587 0.998438 0.789 0.758 0.696 0.664 $51,539 $25,060 
43 1.5% 1.7% 0.997389 0.998302 0.788 0.757 0.695 0.664 $51,539 $25,060 
44 1.6% 1.8% 0.997155 0.998151 0.787 0.756 0.694 0.663 $51,539 $25,060 
45 1.6% 1.8% 0.996891 0.997986 0.787 0.755 0.693 0.662 $49,589 $20,540 
46 1.8% 2.2% 0.996598 0.997805 0.786 0.754 0.693 0.661 $49,589 $20,540 
47 1.6% 2.0% 0.996264 0.997598 0.785 0.753 0.692 0.660 $49,589 $20,540 
48 1.6% 1.9% 0.995886 0.997361 0.784 0.752 0.691 0.659 $49,589 $20,540 
49 1.6% 1.9% 0.995467 0.997097 0.783 0.751 0.690 0.658 $49,589 $20,540 
50 1.7% 2.0% 0.995013 0.996811 0.782 0.751 0.689 0.657 $49,589 $20,540 
51 1.8% 2.2% 0.994527 0.996512 0.781 0.750 0.688 0.657 $49,589 $20,540 
52 2.1% 2.7% 0.994003 0.996205 0.780 0.749 0.687 0.656 $49,589 $20,540 
53 2.0% 2.7% 0.99344 0.995895 0.779 0.748 0.686 0.655 $49,589 $20,540 
54 2.1% 2.5% 0.992841 0.995577 0.779 0.747 0.686 0.654 $49,589 $20,540 
55 2.0% 2.3% 0.992197 0.995225 0.778 0.746 0.685 0.653 $40,343 $15,488 
56 1.9% 2.5% 0.99152 0.994847 0.777 0.745 0.684 0.652 $40,343 $15,488 
57 2.0% 2.2% 0.99083 0.994472 0.776 0.744 0.683 0.651 $40,343 $15,488 
58 1.7% 2.2% 0.990137 0.994107 0.775 0.744 0.682 0.650 $40,343 $15,488 
59 1.7% 1.9% 0.989428 0.993734 0.774 0.743 0.681 0.650 $40,343 $15,488 
60 1.7% 2.1% 0.988646 0.993312 0.773 0.742 0.680 0.649 $40,343 $15,488 
61 1.6% 1.7% 0.987798 0.992824 0.772 0.741 0.679 0.648 $40,343 $15,488 
62 1.4% 1.8% 0.986939 0.992276 0.772 0.740 0.678 0.647 $40,343 $15,488 
63 1.2% 1.4% 0.98608 0.991661 0.771 0.739 0.678 0.646 $40,343 $15,488 
64 1.2% 1.6% 0.985181 0.990966 0.770 0.738 0.677 0.645 $40,343 $15,488 
65 1.3% 1.2% 0.984174 0.990168 0.769 0.737 0.676 0.644 $28,525 $3,437 
66 1.2% 1.2% 0.983014 0.98926 0.768 0.737 0.675 0.643 $28,525 $3,437 
67 1.0% 1.1% 0.981705 0.988246 0.767 0.736 0.674 0.643 $28,525 $3,437 
68 1.1% 1.1% 0.980224 0.987119 0.766 0.735 0.673 0.642 $28,525 $3,437 
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Age  
Percentage 
of Suicide 
Deaths 
Among 
Males
a 
Percentage 
of Suicide 
Deaths 
Among 
Females
a 
Probability 
of Surviving 
One Year 
for Males
b 
Probability 
of Surviving 
One Year 
for 
Females
b 
Health 
Utility for 
Males with 
"Good" 
Health
c 
Health 
Utility for 
Females 
with 
"Good" 
Health
c 
Health 
Utility for 
Males with 
"Fair" 
Health
c 
Health 
Utility for 
Females 
with "Fair" 
Health
c 
Net 
Productivity 
for Males
d 
Net 
Productivity 
for 
Females
d
 
69 1.1% 1.1% 0.978552 0.985859 0.765 0.734 0.672 0.641 $28,525 $3,437 
70 0.9% 0.7% 0.97662 0.984388 0.765 0.733 0.671 0.640 $28,525 $3,437 
71 0.8% 0.9% 0.974451 0.982725 0.764 0.732 0.671 0.639 $28,525 $3,437 
72 0.9% 0.6% 0.972115 0.980953 0.763 0.731 0.670 0.638 $28,525 $3,437 
73 1.0% 0.7% 0.969626 0.979091 0.762 0.730 0.669 0.637 $28,525 $3,437 
74 0.7% 0.7% 0.966901 0.977061 0.761 0.729 0.668 0.636 $28,525 $3,437 
75 0.8% 0.4% 0.963746 0.974703 0.760 0.729 0.667 0.636 $16,426 $126 
76 0.7% 0.4% 0.960118 0.971955 0.759 0.728 0.666 0.635 $16,426 $126 
77 0.7% 0.6% 0.956121 0.968869 0.758 0.727 0.665 0.634 $16,426 $126 
78 0.7% 0.3% 0.951744 0.965418 0.758 0.726 0.664 0.633 $16,426 $126 
79 0.8% 0.4% 0.946877 0.961533 0.757 0.725 0.664 0.632 $16,426 $126 
80 0.6% 0.4% 0.941289 0.956992 0.756 0.724 0.663 0.631 $16,426 $126 
81 0.7% 0.4% 0.934919 0.951825 0.755 0.723 0.662 0.630 $16,426 $126 
82 0.5% 0.2% 0.927861 0.946228 0.754 0.722 0.661 0.629 $16,426 $126 
83 0.5% 0.4% 0.920088 0.94023 0.753 0.722 0.660 0.628 $16,426 $126 
84 0.5% 0.3% 0.911471 0.933633 0.752 0.721 0.659 0.628 $16,426 $126 
85+ 3.1% 1.4% 0.901852 0.926172 0.751 0.720 0.658 0.627 $16,426 $126 
a
Distribution of suicide by age was calculated based on suicide deaths in 2016 in the US as reported by the Centers for Disease 
Control and Prevention Web-based Injury Statistics Query and Reporting System (WISQARS). 
b
Probability of one-year survival was 
calculated as one minus the probability of death provided in the Social Security Administration’s 2014 Period Life Table 
(https://www.ssa.gov/oact/STATS/table4c6.html). Probabilities all the way to age 119 were used in the simulation even though this 
table only shows estimates to age 85. Survival up to a given index year was calculated as the product of each of the one-year survival 
probabilities from the year the suicide was averted to the index year. 
c
These were calculated by Dr. Janel Hanmer at the University of 
Pittsburgh using the Medical Expenditures Panel Survey and the National Health Interview Survey. The estimates of health utility by 
age and sex are made publicly available at http://janelhanmer.pitt.edu/QALE.html. For calculating QALYs lost, I assumed that those 
less than 18 had the same health utility values of those who were 18. 
d
These were calculated as the difference between the average 
annual earnings for males and females in 2016, reported in the Current Population Survey, and the overall average annual 
expenditures in 2016, reported in the Consumer Expenditure Survey (expenditures by age and sex were not available).
171,173
 The 
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expenditures were adjusted using the same methodology reported in the book Cost-Effectiveness in Health and Medicine, Second 
Edition,  where the consumer unit expenditures was divided by the number of people in each consumer unit.
135
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APPENDIX J: Infographic of Dissertation 
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Figure J-1. First Page of Dissertation Infographic 
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